The Critical Investor
Uncertainty about this Spanish asset remains, but the Canadian explorer has other projects in the country providing value and upside, noted a Research Capital Corp. report.
With inflation on the rise, investor attention has shifted to more tangible assets such as zinc-lead. With a positive relationship with locals and good ESG, Slave Lake Zinc Corp. may be one company you want to add to your radar.
Defense Metals Corp. has now released results from 10 of 18 holes in its 5,500m drill program this year.
Two recent events help the firm in its efforts to secure water and power access for a future mining operation there, noted a Haywood Securities report.
Accumulating a myriad of analyst coverage, Dolly Varden Silver Corp. has been on our radar for a while, and with its latest drill results, now may be the time to invest, according to a Haywood Capital report.
Shares of Anavex Life Sciences Corp. traded 36% higher Friday after the company reported that during a Phase 2b/3 clinical trial of patients diagnosed with early Alzheimer's disease, its ANAVEX®2-73 (blarcamesine) met both key primary and secondary endpoints and demonstrated significant reductions in clinical decline.
Expert Michael Ballanger of GGM Advisory Inc. reviews Andrew Ross Sorkin's decision to interview SBF in a global broadcast, Fed Chairman Jerome Powell's November 30th email alert, and the price of gold as it advances to tell you where he believes the market is heading and what you should look out for.
One hole at this British Columbia property returned 75.13 grams per ton gold and 2,337 grams per ton silver over 1.77 meters, noted a Research Capital Corp. report.
Results of drilling there returned downplunge high-grade silver and expanded the mineralized system downdip, noted a Haywood Securities report.
To achieve this end, the board of trustees is currently weighing various options, noted an Echelon Capital Markets report.
The divestment boosted the Canadian explorer's balance sheet and lowered its share dilution, noted a Stifel report.
Quebec Precious Metals Corp. is reviewing its heavy rare earth projects after its sale to an Australian company fell through.
MAG Silver Corp. is waiting for the OK to open its processing plant in Mexico, but is already generating a profit with the material it is mining.
Shares of Titan Machinery Inc. traded 26% higher yesterday to a new 52-week high after the company reported Q3/23 financial results, highlighting a 47.3% YOY increase in revenue. The firm additionally raised its full-year revenue and earnings estimates.
This company, undergoing a business model shift, is doing well and remains Buy rated despite a weaker-than-expected Q3/22, noted a Research Capital Corp. report.
These new data, from three zones at the property, bode well for growing the existing resource there, noted a Haywood Securities report.
HighGold Mining Inc. shares traded 14% higher after the company reported that it intersected 120m of 18.76 g/t gold at its Johnson Tract Deposit in Southcentral Alaska.
Recent share price weakness and a catalyst-rich next six months are good news for investors, noted a Research Capital Corp. report.
The newly reported drill results also extended the mineralization present at the primary exploration target, noted a Research Capital Corp. report.
Volatus Aerospace Corp. could be a company to watch in the fast-growing drone aviation market.
Since hitting the market on November 10, 2022, ASP Isotopes has been busy and has now announced a US$675 million-dollar contract. Expert Penny Queen shares this news and reviews why she still believes this company is worthwhile.
Today, expert Adrian Day sends a revised Current Positions table, updating dividends paid and current recommendations. Prices are as of early afternoon yesterday.
Expert Ron Struthers believes consumers are on an unsustainable path of wracking up credit card debt, and it is only a matter of when the economy buckles, meanwhile big profits are being made by tanker companies and oil and gas/energy transmission companies as supplies continue to tighten.
This company serving the oil and gas industry grew revenue 14% over the last 12 months and is expected to continue the trend, noted an Echelon Capital Markets report.
The Canadian company has already secured two contracts for three-quarters of the capacity of this new pipeline in Colombia, noted a Research Capital Corp. report.
A soil geochemical anomaly could significantly expand the footprint and potential size of the deposit at Libero Copper and Gold Corp.'s Mocoa project in Putumayo, Colombia.
With only 33 days left in the fiscal year 2022, expert Michael Ballanger reviews where he believes the markets are heading.
Technical analyst Clive Maund reviews the 1-year chart for Reliq Health Technologies to tell you whether he believes it is a Buy.
Shares of Axsome Therapeutics Inc. traded to a new 52-week high after the company reported its AXS-05 successfully met both the primary and key secondary endpoints
in the Phase 3 ACCORD Alzheimer's disease agitation trial.
BacTech Environmental Corp. is completing an engineering report needed to start construction of its bioleaching plant in Tenguel, Ecuador.
The company aims to achieve record production in Q4/22 to recover from the hit in Q3/22, noted an Echelon Capital Markets report.
The outlook for full-year 2022 production is positive, and growth is expected, noted a Haywood Securities report.
With the breakdown of the U.S. dollar, expert Clive Maund reviews charts for gold, copper, and palladium to tell you where he believes the metals are headed and which he thinks you should buy.
Shares of Japanese pharmaceutical firm Shionogi & Co. Ltd. traded nearly 13% higher yesterday after the company reported it received emergency regulatory approval from Japan's Ministry of Health, Labor, and Welfare for its Xocova® (ensitrelvir fumaric acid) tablets for use in treating SARS-CoV-2 infection.
Also, operating cash flow was a beat during this strong quarter for the Quebec-based firm, noted a Haywood Securities report.
During the quarter, the Canadian specialty biopharma performed well and maintained a healthy balance sheet, such that it raised revenue guidance for this year, noted a Research Capital Corp. report.
The year's final quarter is significant for this U.S.-based firm given the trio of significant clinical achievements in its sight, noted a Laidlaw & Co. report.
Imago BioSciences Inc. shares traded 104.5% higher yesterday to a new 52-week high after the company reported it entered into a definitive agreement to be acquired by Merck & Co. in an all-cash transaction for US$36.00 per share.
Global Compliance Applications Corp. signs an agreement with a South African insurance company to get into that country’s expanding cannabis industry.
Expert Clive Maund reviews silver's 4-month, 1-year, and 5-year charts to tell you where he believes the future is headed for this precious metal.
Expert Rick Mills explains the uses, geology, and market for zinc to tell you why he believes this is a transitional metal you should be paying close attention to.
Growth of net operating income and of net asset value is expected from this investment vehicle in the near and longer term, noted an Echelon Capital Markets report.
Volatus Aerospace Corp.'s acquisition of an Alberta aviation company puts it in a strong position to change the way oil and gas companies monitor their pipelines.
Iveric Bio Inc. shares traded 25% higher Friday after the company reported that the U.S. FDA has granted breakthrough therapy designation for its avacincaptad pegol for use in the treatment of geographic atrophy secondary to age-related macular degeneration.
Expert Adrian Day reviews quarterly financials from several resource companies. Most are doing well, though costs are rising. But given recent rallies in stock prices, Day suggests, for the most part, holding rather than buying more.
In light of the controversy with FTX Corp., expert Michael Ballanger shares his opinion on current news coverage and the state of the gold market and U.S. dollar to tell you his view on the precious metals and whether he believes we are headed toward a bear market rally.
An unusually warm October has helped natural gas inventories, but gas prices don't seem to believe it. Oil has seen three days of heavy selling volume ending with a hammer candle stick Monday. Birchcliff, Callon, and Earthstone should benefit.
Defense Metals Corp. is looking toward the preliminary feasibility study for its Wicheeda rare earth element deposit in British Columbia.
The explorer's ongoing exploration results at this project continue to be encouraging ahead of a mineral resource update expected next year, noted a Haywood Securities report.
The owner of this Quebec project will include these exploration results in the upcoming definitive feasibility study, noted a Laurentian Bank Securities report.
The U.S. Food and Drug Administration Advisory Panel denied the approval of this therapeutic for patients hospitalized with severe SARS-CoV-2, yet it is still a Buy, noted a Research Capital Corp. report.
The company takeover just closed, and consequently, an NI 43-101 report from the acquirer is expected soon, noted a Research Capital Corp. report.
World Copper's projects in Arizona and Chile are in the near-term development stage.
Shares of Alvopetro Energy Ltd. traded 13% higher yesterday after the company reported record Q3/22 sales, raised its quarterly dividend by 50%, and announced plans for a robust NCIB share buyback program.
Rover Metals Corp. has signed the definitive agreement to option a 100% ownership interest in a Nevada lithium project that puts it closer to its goal of pivoting from gold to lithium and critical elements.
CytomX Therapeutics Inc. shares traded 32% higher after the company reported it has formed a strategic research collaboration with Regeneron Pharmaceuticals Inc. to develop next-generation bispecific immunotherapies to treat multiple cancer tumor types.
The Australian firm warrants this change given its recent track record in growing revenue, noted a Bell Potter report.
Jericho Energy Ventures Inc., which is making the move to green energy, is selling some of its undeveloped acreage in the STACK oil region of Oklahoma.
4D Molecular Therapeutics Inc. shares traded 38.5% higher yesterday after the company reported interim data from its Phase 1/2 clinical trial of Intravitreal 4D-150 for use in the treatment of wet age-related macular degeneration.
This U.K. healthcare company revealed a compound that's 3.5x more effective in treating alcohol use disorder than the industry standard. Now, expansion is on the horizon.
New extraction technology is a game-changer for Spey Resources, which just signed a lithium offtake letter of intent.
This data set "highlights the potential of the southern starter pit and its ability to provide higher grade material for longer in the early years of the mine," noted a Research Capital Corp. report.
These early results of 2022 drilling at this Golden Triangle property highlight the presence of high silver grades and potential for future resource growth, noted a Haywood Securities report.
The acquisition is a 0.6% net smelter return royalty on production that is estimated to start at this copper-gold property in late 2029, noted a Haywood Securities report.
Expert Michael Ballanger of GGM Advisory Inc. reviews the newest dubbed "investment guru," the outlook of the precious metals sector, and the current state of the stock market to tell you where he believes we are all headed.
Since copper has just broken out of a multi-month Cup & Handle base, expert Clive Maund reviews four charts of a company he believes you should set your sights on.
Opiant Pharmaceuticals Inc. shares traded 111% higher after the company reported it entered into a definitive agreement to be acquired by Indivior Plc. for US$20.00 per share in cash. Opiant shareholders will also receive contingent value rights that are worth up to an additional US$8.00/share if certain product sales milestones are met.
With late-stage drug candidates and major near-term catalysts, undervalued Aldeyra Therapeutics warrants a Buy to Outperform rating and consideration by potential investors, according to various analysts.
ADMA Biologics Inc. shares traded 27.5% higher yesterday after the company reported Q3/22 financial results that included a 99% YOY revenue increase. The firm added that it is raising its FY/22 revenue estimates from US$130 million to US$145 million.
Nova Scotia-based nanotech company Meta Materials Inc. reports a major revenue increase just as it signs an agreement to help reduce the cost and weight of batteries for electric vehicles, extend their range, and improve their safety.
NevGold Corp. has released new assays from its inaugural 10,000-meter drill program at its flagship Limousine Butte project in Nevada.
As the prices of oil stocks are running ahead of oil prices, expert Clive Maund reviews the 7-month, 3-year, and 20-year charts of the oil index to tell you where he believes the commodity is headed.
Merrimack Pharmaceuticals Inc. shares traded 200% higher yesterday to a new 52-week high after the company advised that Ipsen SA reported that in a Phase 3 clinical trial, Onivyde® regimen was shown to significantly improve overall survival in previously untreated patients afflicted with metastatic pancreatic ductal adenocarcinoma.
Printing and marketing services company Data Communications Management Corp. continues to report impressive numbers with its third-quarter revenue.
Along with improving its numbers during the quarter, this firm sold its first ultrasound ablation machines in North America, noted a Research Capital Corp. report.
Silver X Mining Corp.'s mill at its flagship mine in Peru has seen eight consecutive months of increased processing on a three-month moving average from last January.
Expert Clive Maund reviews the 6-month charts of nine companies he believes are worth keeping an eye on.
With MedTech ASP Isotopes hitting NASDAQ tomorrow, expert Penny Queen reviews the company to tell you why she believes it is worth your attention.
In light of Infinitum Copper Corp.'s Phase 1 drill program at the La Adelita copper project being completed, expert Thibaut Lepouttre tells you his view of the results and where he sees the copper company is headed.
Expert Clive Maund reviews silver's 4-month and 1-year charts to tell you why he believes it is a good time to load up on this precious metal.
Several companies on expert Adrian Day's list have either reported quarterly earnings or had other news. In the case of the larger companies, most have already pre-announced production or sales.
Shares of Oyster Point Pharma Inc. traded 38.5% higher yesterday after the firm reported it agreed to be acquired by Viatris Inc. for US$11.00 per share along with a contingent value right for a potential additional payment of up to US$2.00 per share.
Volatus Aerospace Corp. has announced record third-quarter revenue, a 238% increase YOY.
Expert Dr. Jim Jones shares his extensive research on Emerita Resources Corp. to tell you why he believes this is only the tipping point for the company and what catalysts he sees up and coming.
Shares of Ocuphire Pharma Inc. traded 20% higher after the ophthalmology-focused biopharmaceutical firm reported it executed a global license agreement with FamyGen Life Sciences Inc. to develop and commercialize its Nyxol® Eye Drops for use in treating mydriasis, presbyopia, and night vision disturbances.
Expert Michael Ballanger believes markets are at a critical juncture, commonly referred to as a "fork in the road." In light of this, he reviews current Fed updates and movements in the gold and silver sectors to tell you where he believes the market is heading.
Expert Clive Maund takes a look at some movements in the precious metals sector with a focus on the gold market to tell you where he believes it is headed.
Expert Adrian Day believes the gold sector is picking up again and reviews two companies attempting to outbid Gold Fields in its proposed takeover of Yamana Gold.
Given the amount of drilling happening at this Spanish project and the new drill data so far, it is likely the new resource estimate will exceed the historical one, noted a Research Capital Corp. report.
Shares of medical technology firm TransMedics Group Inc. traded 24% higher to a new 52-week high after the company reported Q3/22 financial results highlighting a 378% YoY increase in net revenue and raised its FY/22 revenue estimates to US$80-85 million.
As internet-enabled health care becomes more accepted in the wake of the pandemic, telemedicine company Reliq Health Technologies Inc. is seeing its revenue soar.
The Fed's mandate is 2% inflation and maximum employment. Expert Ron Struthers believes they have lots of room to soften the job market. Struthers also sees promise with three stocks. Gilat Satellite is growing sales, Callon Petroleum is undervalued, and Zonte Metals has a unique situation.
Arcturus Therapeutics Holdings Inc. shares traded 19% higher yesterday after the firm reported it entered a global partnership with CSL Seqirus to develop and commercialize self-amplifying mRNA vaccines worldwide.
A Haywood Securities analyst initiates coverage on Dolly Varden Silver Corp., saying "now is the right time" for investing in the company.
Shares of turnkey residential solar firm Sunrun Inc. traded 19% higher after the company reported Q3/22 financial results that included a 44% YoY increase in revenue and a 21% gain in its installed customer base.
This firm, with both high-grade silver and gold assets in one project, already has a resource large enough for a mining-processing operation, noted a Haywood Securities report.
Rover Metals Corp., which is pivoting to critical metals and minerals, is looking to a peer’s feasibility study to help prove the viability of the resource at its new project.
Kiniksa Pharmaceuticals Ltd. shares traded 12% higher yesterday after the company reported Q3/22 financial results that included a 720% YoY increase in net revenue attributed to a combination of organic growth and increases in global licensing revenue.
Expert Michael Ballanger reviews recent updates in the stock market to tell you where he believes it is headed and why he thinks October was "The Bear Killer," with countless bear markets ending and bull markets possibly beginning today, November 1, 2022.
With this season's drilling behind it, the Canadian explorer plans to start, by year-end, the next step in advancing its project, noted a Noble Capital Markets report.
Actinium Pharmaceuticals Inc. shares traded 39% higher yesterday to a new 52-week high after the firm reported topline data from its Phase 3 SIERRA study of Iomab-B in patients with active relapsed or refractory acute myeloid leukemia. During the pivotal trial, Iomab-B met its primary pre-established endpoint of durable complete remission or dCR of six months post-initial remission following a bone marrow transplant.
The decline in gold prices will not last forever, and we just witnessed a double bottom and now heard Central Banks are buying at a record pace. Newmont mining is expert Ron Struthers' go-to stock when gold prices start to move, and he believes it currently offers great value with an over 5% dividend yield.
The high-grade and mineable widths of this zone will likely improve the economics of the future mining operation in Fiji, noted a ROTH Capital Partners report.
Expert Michael Ballanger reviews updates from some major junior mining companies, such as Getchell Gold Corp. and Norseman Silver, among others, to tell you his opinion on each company and where junior mining is heading as a sector.
Today expert Adrian Day discusses results from two core holdings, both doing well, according to him, despite cost inflation. Day believes you can use current weakness to accumulate a portfolio of blue chips.
With the possibility of a Fed pivot looming, expert Clive Maund touches on his views of the precious metals sector and why he believes you should invest in it sooner rather than later.
The results from the first two holes of a nine-hole drilling campaign at this company's Nevada flagship project have surpassed expectations.
Shares of Oceaneering International Inc. traded 16.5% higher yesterday after the diversified offshore engineering services and manufacturing firm reported Q3/22 financial results that included a 20% YoY increase in revenue and improved operating performance and profitability across all its business units.
Outcrop Silver & Gold Corp. is reporting its deepest high-grade mineralization to date at its Santa Ana project in Colombia.
Shares of Nuvalent Inc. traded 60% higher to a new 52-week intraday high after the company reported initial data from its Phase 1 ARROS-1 trial of NVL-520 demonstrating positive objective response rates in patients with ROS1-Positive non-small cell lung cancer.
This firm, with eight treatment candidates for mental health disorders in development, boasts a catalyst-rich next two months, noted a ROTH Capital Partners report.
Shares of Wingstop Inc. traded 15% higher yesterday after the company reported that during Q3/22, it opened 40 net new restaurants and increased its system-wide sales by 17.7%. In addition, the company raised its FY/22 earnings guidance.
With global interest and use of copper rising, copper may not be able to meet demand. Expert Rick Mills of Ahead of the Herd reviews the demand for copper, the push for more infrastructure, and what he believes the future holds for this metal.
Shares of full-service clinical contract research organization Medpace Holdings Inc. traded 37% higher yesterday after the company reported Q3/22 financial results that included a nearly 30% YoY increase in revenue.
Shares of Vaxcyte Inc. traded 61% higher yesterday to a new 52-week high after the company reported positive topline results from its Phase 1/2 study of VAX-24, its novel 24-valent pneumococcal conjugate vaccine candidate being developed to prevent invasive pneumococcal disease in adults 18 to 64 years of age.
Algernon Pharmaceuticals has entered into a clinical trial agreement with Yale and caught expert Clive Maund's attention. In light of this, Maund reviews the company's chart to tell you when he believes you should buy its stock.
Shares of PureCycle Technologies Inc. traded 8% higher Friday after the company reported that together with Milliken & Co. of Belgium it has created a new concentrate using recycled polypropylene (PP) resin that advances circularity and reduces GHG emissions by 35%. Thursday, PureCycle announced it formed a JV with SKGC of South Korea to build the first PP recycling plant in Asia.
Terra Balcanica's drill results demonstrate the potential of a high-grade silver-zinc-gold deposit.
Expert Clive Maund believes the Fed may pivot soon. Read to find out why he believes this is true and where he thinks the market is heading.
Several resource companies on expert Adrian Day's list have reported their production numbers for the third quarter, with some positive surprises, though costs are rising.
Palatin Technologies Inc.'s third-party clinical trial of Vyleesi in women with hypoactive sexual desire disorder was just published in the Journal of Clinical Investigation, and the biopharma offers investors significant potential return, noted an H.C. Wainwright & Co. report.
Rock Tech Lithium Inc. shares traded 30% higher yesterday after the company reported it executed a five-year supply contract with Mercedes-Benz AG of Germany. Under the terms of the agreement, Rock Tech will provide Mercedes with 10,000 tonnes of battery-grade lithium hydroxide yearly, which is expected to generate CA$2 billion in revenue for the company.
Seabridge Gold Inc. has received its permit and started drilling at its 3 Aces project in the Yukon. It plans to expand its exploration of the site in 2023.
In addition to this news, the Canadian company is trading at a discount to peers, noted a Stifel report.
Shares of Intuitive Surgical Inc. traded 9% higher yesterday after the robotic surgical device maker reported Q3/22 earnings that included an 11% YoY increase in revenue and a 13% YoY increase in its installed da Vinci Surgical System base.
More and more North American natural gas will end up as LNG to Europe in the coming years. Soon we will compete on price. Expert Ron Struthers believes Shell Plc. offers a compelling valuation compared to its peers and will benefit from this market transition.
Frontier Lithium Inc. announced the latest group of drill results from its Spark Deposit in northwestern Ontario. The firm reported it intersected 326.6m of pegmatite averaging 1.92% lithium oxide (Li2O), which included a 50m high-grade zone of 2.98% Li2O. Canaccord Genuity Corp. (Canada) advised in a research update that the positive results achieved in Frontier's Phase XII drill program once again demonstrate grades that are well above the current mineral resource estimate of 1.38% Li2O.
Industrial hemp is legal in all 50 states, and companies are working to get CBD, insulation, textiles, and biofuel made from it to the masses. These three companies hope their partnership will help connect the growers and buyers.
With 13 active drill rigs at its project in Spain, this Canadian mining firm should continue announcing results over the near term, noted a Research Capital Corp. report.
Jericho Energy Ventures is working to bring its zero-emission hydrogen boilers to companies for commercial heating, hot water, and industrial steam.
This Canadian critical metals firm with many "attractive attributes" is well-positioned to become a globally significant rare earth oxide producer, noted an Agentis Capital report.
Markets will remain in a bear market for some time, and it is best to look for short trades. Lumber stocks ran up in price with high lumber prices and a post-Covid-19 recovery in the economy. They are priced too high and not reflecting lower lumber prices and a softer housing market induced by a coming recession.
Expanded interim data from the Phase 2 trial of this biotech's lead asset PDS0101 in HPV16-associated cancers are consistent with previously reported results from the same study. Read more to discover why H.C Wainright & Co. believes this stock is a Buy with a target price over three times the current.
Shares of Gatos Silver Inc. traded 29% higher yesterday after the company reported it achieved record levels of production at its Cerro Los Gatos mine during Q3/22. The firm raised its FY/22 production guidance while lowering its operating cost estimates.
With this and other clinical studies, the U.S. company has a busy and, thus, catalyst-rich Q4/22 ahead, noted an H.C. Wainwright & Co. report.
Defense Metals Corp. is seeing more high-grade results from assays at its Wicheeda rare earth element deposit in British Columbia. Results from three holes, including one released on Thursday, are showing broad mineralization.
Shares of DICE Therapeutics Inc. traded 62% higher yesterday and established a new 52-week intraday high after the company reported positive topline data from its Phase 1 DC-806 Psoriasis study.
New results from the Ontario lithium deposit show high grades and significant widths, noted a Canaccord Genuity report.
Asset manager Chen Lin's picks for the home stretch of 2022 include several biotechs and some precious metals companies.
Expert Michael Ballanger of GGM Advisory reviews the current stock market, the outlook for gold, and how he believes everyone should move forward.
This nanotech company has been awarded US$4.3 million to develop anti-counterfeiting measures on currency for a confidential G10 central bank customer.
Provention Bio Inc.'s shares traded 25% higher yesterday after the company reported it is joining forces with Sanofi U.S. to support the potential upcoming U.S. launch of its teplizumab for use in delaying the onset of clinical type 1 diabetes in at-risk patients. The U.S. FDA is expected to rule on the firm's Biologics License Application in mid-November 2022.
Expert Ron Struthers believes TC Energy is a well-run pipeline company as it is yielding about 6.5% and has increased its dividend every year since the turn of the century. He also discusses how oil tanker rates are soaring as the market tightens more with the Ukraine war, but DHT Holdings is a laggard worth a look.
Vancouver mineral explorer Zacapa Resources Ltd. is preparing to close on a CA$3 million private placement and has proactively taken steps to separate and possibly spin out its copper assets from its core gold property holdings that include its cornerstone South Bullfrog project located near the rapidly emerging Beatty gold district in Nevada.
Friday, Emerita Resources Corp. announced drill results for its fully-permitted La Romanera deposit at its 100%-owned Iberian Belt West project. Read to discover the latest results and why President Joaquin Merino is continuing to accelerate its Romanera drill program.
Dolly Varden Silver Corp. is adding a new institutional investor to its stable of big-name backers that includes Hecla Mining Co. and mining financier Eric Sprott.
Read to learn why ROTH Capital Partners gave Atai Life Sciences NV a Buy rating and a target price 10 times its current.
With this upcoming analysis, the board will determine whether the Phase 2b/3 trial may continue to completion, noted a ROTH Capital Partners report.
The data suggest this treatment could be safer and more effective in treating proliferative vitreoretinopathy than compounded methotrexate, noted a Laidlaw & Co. report.
Deposit upside at this polymetallic project in Spain is indicated by the historical mineral resource and past and current drill results, noted a Research Capital Corp. report.
Drilling is underway at this company’s project in northern Nevada, where it hopes to expand its resources with help from a major.
Placer gold recovery at this project is expected to start in the coming months after mine stabilization is completed, noted a Research Capital Corp. report.
Expert Michael Ballanger takes a moment to review current updates in the stock market, including the position of gold, the current Fed mandate, the outlook of Getchell Gold Corp., and the Nord Stream Gas Pipelines.
Shares of Viasat Inc. traded 27% higher yesterday after the global communications firm reported it has agreed to sell its Link 16 Tactical Data Links Business to L3Harris Technologies for US$1.96 billion.
Now BacTech Environmental Corp. must pursue the community consultation phase before receiving final environmental permit for its Tenguel bioleaching plant.
In light of yesterday's lithium results from Argentina Lithium & Energy Corp., expert Clive Maund takes a look at the 10-year, 15-month, and 6-month charts for the natural resource company to tell you his outlook.
Infinitum Copper Corp. continues to get impressive results from its drilling campaign at its flagship project in Mexico, but another discovery is helping to point the way to future exploration.
Junior explorer Alpha Copper Corp. is trying to get ahead of the crush for more copper for the green revolution by doubling the number of its projects with a new purchase.
The firm plans to advance its alpha-1 antitrypsin deficiency program into the clinic next year, noted an H.C. Wainwright & Co. report.
Results of this program, expected to be done in November, could cause the company's stock to react upward, noted a Research Capital Corp. report.
Today, expert Adrian Day reviews the latest acquisition by Agnico Eagle Mines Ltd. and shares his thoughts on some of the resource companies on his list.
This company with early-stage exploration projects with blue sky potential just garnered analyst coverage by Red Cloud Securities, a firm report noted.
Data show the biotech's compound had a positive effect on several noninvasive measures, noted a ROTH Capital Partners report.
Ero Copper Corp. shares traded more than 7% higher on a down market yesterday after the company reported it discovered a new nickel sulfide system within Brazil's Curaçá Valley. In an area historically known for rich copper deposits, the firm reported that drill results from the system's VB zone returned 16.5m of 1.22% nickel which included 3.8m of 3.60% nickel.
Expert Clive Maund reviews Ecolomondo Corp.'s 6-month and 2-year charts to show you why he believes this stock may be strong no matter the market.
Shares of oncology-focused biopharmaceutical company Immuneering Corp. traded 9% higher after the firm reported it received U.S. FDA clearance for its IND Application for a Phase 1/2a clinical trial of IMM-1-104 for use in treatment of advanced solid tumors with RAS mutations. The company expects to enroll the first patient in the study in Q4/22.
Shares of Eisai Co. Ltd. traded 58% higher yesterday after the company reported topline data from its global Phase 3 clinical study demonstrating that its lecanemab significantly met the primary and key secondary endpoints in reducing mild cognitive impairment due to Alzheimer's disease.
After speaking with the president and CEO of Arizona Silver Exploration Inc., editor and publisher of The National Investor, Chris Temple, shares why he believes its Philadelphia Project is compelling.
Expert Clive Maund takes a look at the 6-month and 2-year charts for Spey Resources Corp., following the completion of a large base pattern, to tell you whether he believes it is a Buy.
The requested approval is specifically for critically ill patients, a population for which the U.S. Food and Drug Administration granted the therapeutic fast track status, noted an H.C. Wainwright & Co. report.
This mining firm with a robust project portfolio is exploring its newly acquired asset in Chile's Atacama region, from which results are expected soon, noted a Fundamental Research Corp. report.
This company warrants a favorable investment thesis and Buy recommendation based on many factors, noted a Bell Potter report.
Shares of clinical-stage immuno-oncology company LAVA Therapeutics NV traded nearly 100% higher yesterday after the firm reported that it has entered into a global licensing agreement with Seagen Inc. to advance its LAVA-1223, a preclinical gamma delta bispecific T cell engager designed for use in the treatment of EGFR-expressing solid tumors.
Treatment of alcohol use disorder with psychedelics plus therapy is effective, according to existing data, and the potential global market is large, noted an H.C. Wainwright & Co. report.
Altus Power Inc. shares traded 17% higher to a new 52-week high after the industrial, public and community solar firm reported it entered into definitive agreements to acquire 97 megawatts of operating solar assets.
Numerous positive influences on oil and gas prices are looking to converge this winter in North America and Europe. Expert Ron Struthers believes oil and gas stocks have been oversold and offer very good value, and he highlights two he thinks are worth your attention.
Revenue last quarter was strong, and management expects to increase revenue 20% this fiscal year, noted a ROTH Capital Partners report.
Quebec Precious Metals Corp. is selling all of its non-core assets so it can focus on its flagship Sakami gold project in the James Bay territory of Quebec.
Snow Lake Resources Ltd.'s shares traded 38% higher Friday after the company reported it signed an MOU with global lithium-ion battery manufacturer LG Energy Solution. Under the terms of the proposed agreement, the firms will collaborate to develop and build a lithium hydroxide processing plant in Winnipeg, Man. capable of supplying LG Energy with lithium over a 10-year period beginning in 2025.
Norseman Silver has just announced more high-grade assays of rock chip samples at its project in Argentina.
Michael Ballanger explains why he believes sample assays provide evidence "indicating the potential for world-class scale and value."
Expert Michael Ballanger takes a look at a few charts to tell you how he believes the US dollar is doing and where he thinks the market may be heading.
Bioleaching company BacTech Environmental Corp. has begun trading on the OTCQB Venture Market as it gets ready to open a plant in Ecuador and has opened a pilot facility in Ontario.
To fund continued development of its lead immunotherapy candidate, the U.S.-based biopharma recently completed a $35 million debt financing agreement, noted an H.C. Wainwright & Co. report.
Argenx SE has "several upcoming catalysts," noted a Wedbush report.
Shares of Electra Battery Materials Corp. traded 13% higher yesterday after the company reported it entered into a 3-year supply agreement with LG Energy Solution of South Korea to provide 7,000 tonnes of cobalt sulfate for use in manufacturing batteries for electric vehicles in North America.
With good news shown on Tuesday, Strikepoint Gold Inc. has piqued expert Clive Maund's interest. Today he reviews the gold company's 3-year and 6-month charts to tell you where he believes the stock is headed.
StrikePoint Gold Inc. is selling its Yukon Territory properties so it can better focus on its flagship Porter and Willoughby projects in the Golden Triangle.
Expert Clive Maund reviews the charts for the broad stock market to tell you when he believes the U.S. market will crash.
The pandemic changed the way many people get their basic healthcare, giving a big opening to telemedicine companies like Reliq Health Technologies Inc.
Expert Michael Ballanger reflects on his views of Norseman Silver last April to compare his opinion of the company then versus what he sees now.
Shares of Fennec Pharmaceuticals Inc. traded 14% higher after the company reported it received approval from the U.S. FDA for its PEDMARK® (sodium thiosulfate injection) for use in reducing the risk of ototoxicity in pediatric patients who are undergoing or completed chemotherapy for non-metastatic solid tumors.
The biopharma's strategic marketing campaign "should continue growing U.S. sales to current and new customers," noted a ROTH Capital Partners report.
The biopharma should announce initial clinical trial data on its lead small molecule candidate by year-end, noted a Wedbush report.
Rover Metals Inc. is moving quickly as it eyes the all-important critical metals and minerals sector with a district-scale claystone lithium project in Nevada.
Satsuma Pharmaceuticals Inc. shares traded 12% higher to a new 52-week high after the company reported positive results from its Phase 3 long-term study of STS101 for use in acute treatment of migraine attacks. The company expects to receive further efficacy data from its Phase 3 SUMMIT trial in Q4/22, which it believes will support submission of an NDA with the U.S. FDA in Q1/23.
Expert Clive Maund takes a look at charts from Infinitum Copper Corp., Reyna Gold Corp., and Reyna Silver Corp. to tell you where he thinks these three mining stocks are going.
"It certainly appears that Romanera could prove to be a significant precious metals deposit," noted a Research Capital Corp. report.
Coeur Mining Inc. shares traded 18% higher after the company reported it has agreed to sell its Southern Nevada Holdings to AngloGold Ashanti Ltd. for $150 million in cash. The purchase by AngloGold includes provisions for an additional payment of $50 million if the project is shown to host a total resource of 3.5 million ounces of gold or higher.
The purpose behind this complementary study is to potentially expand the treatment's target patient population, noted an H.C. Wainwright & Co. report.
Dolly Varden Silver Corp. is adding a fourth diamond drilling rig to its campaign at its Kitsault Valley project in British Columbia after seeing big returns.
Expert Clive Maund reviews Danavation Technologies Corp. after the completion of a large base pattern to see whether he believes it is a Buy.
Copper and other critical metals and minerals are the backbone of the world's switch to green energy, and Rover Metals Corp. hopes to supply some of them.
Shares of Mallinckrodt Plc. traded 28% higher yesterday after the company reported that the U.S. FDA has issued approval for its Terlivaz® (terlipressin) for injection for use in treating hepatorenal syndrome, a serious and life-threatening condition that is accompanied by rapid reduction in kidney function.
Shares of bowling center operator Bowlero Corp. traded 7.5% higher and rolled to a new 52-week high after the company reported Q4/22 and FY/22 financial results that included a 130.7% YoY increase in annual revenue.
The increase came after positive clinical trial results on one of its lead drug candidates differentiating it from a competitor, noted a BTIG report.
This oral gamma-secretase inhibitor met the primary and secondary endpoints in a Phase 3 clinical trial, noted a Wedbush report.
The explorer recently hit upon the main deposit's feeder zone, discovered a new vein nearby and keeps drilling high-grade gold intercepts, noted a ROTH Capital Partners report.
After a relatively big buyer appeared a week ago and bought a lot of stock from Legible Inc., expert Clive Maund believes something may be on the horizon for the publishing company.
This and the biopharma's other treatment candidates for ocular diseases are underappreciated, which translates to an investment opportunity, noted an Oppenheimer report.
Positive topline data could boost the share price of this Swiss medical device firm, noted an H.C. Wainwright & Co. report.
The company has numerous elements working in its favor, including a fully permitted gold project only 12 months away from initial production, noted an Eight Capital report.
Infinitum Copper Corp. hopes to help close a coming copper shortage with the red metal coming out of its La Adelita project in Mexico.
Shares of Evolution Petroleum Corp. traded 19% higher after the U.S. onshore oil and gas producer reported that during FY/22 it increased production by 145% YoY and achieved a 233% increase in annual revenue. The company advised that it is raising its quarterly cash dividend by 20% and is initiating a $25 million share buyback program.
This developer of C1q-targeting therapeutics, with a catalyst-rich 18 months ahead, warrants analyst coverage, noted a BTIG report.
The explorer agreed to work together with a local First Nations community as it advances its critical elements project in British Columbia, noted a Noble Capital Markets report.
One Phase 2 clinical trial showing LSD reduced symptoms of anxiety bodes well for other studies of LSD in this indication. In light of this, Oppenheimer & Co. gave this biotech company a target price that is over six times its current share price.
Expert Clive Maund reviews the 6-month and 15-month charts for Awakn Life Sciences Corp. to explain why he thinks this company's technical setup is exceptionally positive.
Shares of Hycroft Mining Holding Corp. traded 12% higher after the Nevada gold and silver mining firm reported initial drill results from its Hycroft Mine. The company commented that it has encountered multiple zones of continuous higher-grade silver that extend further than prior interpretations.
One biopharma co. is teaming with a much larger pharmaceutical company to develop a fast-dissolving oral tablet to deliver MDMA to patients with Alcohol Use Disorder. Find out why developing an oral tablet could benefit the company in the long run.
Trial results are expected later this month, but anecdotal data available now suggest the findings should be positive, noted a ROTH Capital Partners report.
Emerita Resources Corp. reported drill results from five new holes at its Iberian Belt West Project in Spain. Research Capital Corp. commented in a research note that Emerita is proceeding with its aggressive 2022 drill program and expects to resume around-the-clock drilling within the next two weeks. The research firm stated it is maintaining its Speculative Buy rating on the company.
Defense Metals Corp., which hopes to compete with China in the production of vital rare earth elements, has entered into an agreement with the McLeod Lake Indian Band in British Columbia.
This "uniquely positioned" junior explorer has a large land package in a prolific, historical South Dakota mining district and top-tier management and board members, Canaccord Genuity noted.
Expert Adrian Day looks at recent comments from central bankers and comments on the little news this week from Osisko Gold Royalties Ltd.
Pure Gold Mining Inc. shares traded 30% higher after the company reported that during August 2022, it produced 4,595 ounces of gold at its Red Lake Greenstone Belt property. The firm additionally reaffirmed its Q3/22 estimates calling for production of 8,700-12,300 ounces of gold.
Expert Clive Maund reviews three metal stocks he believes are worth your while.
One silver explorer in Bosnia and Herzegovina hopes its first drill result is a sign of things to come as it continues to drill test its 90%-owned silver-lead-zinc project.
Expert Clive Maund reviews the latest updates in Silver X Mining Corp.'s stock to tell you where he believes the company is headed.
Shares of Zscaler Inc. traded 22% higher after the cloud-security platform provider reported Q4/22 financial results that included a 61% YoY increase in total revenue.
The company's Zero Trust Exchange platform utilizes what the firm claims is "the largest security cloud on the planet" to make doing business easier, faster, and more productive.
This is set to happen because the biopharma's commercialization partner recently terminated its agreement over the product, noted an H.C. Wainwright & Co. report.
Expert Clive Maund reviews the 6-month chart for Dakota Gold Corp. in light of its retreat in recent weeks.
Glaukos Corp.'s shares traded 18% higher yesterday after the company reported that in two separate Phase 3 trials, its iDose TR met its primary efficacy endpoints by lowering intraocular pressure in glaucoma patients.
Read the article below to find out what led to the jump in Reyna Gold Corp.'s stock.
BacTech Environmental Corp. realized much of the land for its Ecuador bioleaching plant isn't needed yet, so it is letting local workers continue to farm thousands of cocoa trees.
In light of this weekend's rejection of a new constitution by the Chilean government, expert Clive Maund shares his view on how he believes this will impact companies within the region.
The discovery of a gold vein can dramatically change the outlook for a gold project. So when an un-drilled gold vein is discovered outcropping at surface at a gold project with a defined resource, it certainly warrants further investigation.
Amylyx Pharmaceuticals Inc.'s shares traded 51% higher after the company reported that a U.S. FDA advisory committee has voted to support approval of the firm's AMX0035 for use in treating amyotrophic lateral sclerosis. Although the committee's recommendation is not binding, it is expected that the decision will provide staunch support for approval of the firm's pending NDA for AMX0035, which has a target action date of September 29, 2022.
This Israeli firm recently attracted the attention of the US-based financial institution, H.C. Wainwright & Co., which launched analyst coverage of it.
Expert Clive Maund shares his view on Awakn Life Sciences Corp. as its stock continues to strengthen.
One analyst says the work Seabridge Gold Inc. is putting in to get a permanent environmental certification could help it attract a large-tier partner in British Columbia’s Golden Triangle.
With the latest drop in the silver market, expert Clive Maund reviews his opinion on where he thinks silver stocks are going and why investors should play close attention to this precious metal.
Expert Adrian Day takes a look at Federal Reserve policy after Jackson Hole and what it might mean for the markets, plus updates developments at some companies on his list.
This firm is undervalued, has a near-producing oil asset in Alberta with large resource potential and upside, and is pursuing an opportunity to expand in Thailand, noted Research Capital Corp., which initiated coverage on it.
The upcoming discussions pertain to a biopharma's clinical stage T-cell therapy as a treatment for solid tumors, noted a ROTH Capital Partners report.
Japan Gold Corp. shares traded 18% higher after the company reported its development partner and industry major Barrick Gold Corp. has chosen six of its gold projects in Japan to be moved forward to the second evaluation phase for advancement.
New results from this area between two deposits show greater widths and consistent grades when compared to previously reported intercepts from there, noted a National Bank of Canada report.
One small-cap pharma co. just published more good news on a possible treatment for patients suffering from idiopathic pulmonary fibrosis, a lung disease that's usually terminal. Find out why the company has more near-term catalysts and may continue to build on an 84% gain since a private placement in mid-August.
New drill results from this Idaho project also showed there is at-surface mineralization of higher grades than the average of the current resource, noted a Desjardins report.
Drill results from Liberty Gold Corp.’s flagship Black Pine project in Idaho show that the site’s largest areas of concentrated gold are connected.
Forma Therapeutics Holdings Inc. shares traded 51% higher yesterday after the company reported it agreed to be acquired by Denmark's Novo Nordisk A/S in an all-cash deal for $20.00 per share. With the acquisition, Novo Nordisk aims to expand its global presence in the treatment of rare blood disorders and sickle cell disease.
The company is in the process of meeting its obligations to earn 100% of a Vancouver Island property that is prospective for precious and base minerals . . . and sasquatches.
Shares of Trillion Energy International Inc. traded 14% higher to a new 52-week high after the company reported it has increased the price it receives for natural gas by 47% to US$31/Mcf.
New drill results highlight intra-pit continuity of mineralization and resource expansion potential, noted a Haywood Securities report.
Expert Chris Temple gives his view on Algernon Pharmaceuticals stock in light of its positive results for its Phase 2a study for the treatment of idiopathic pulmonary fibrosis and chronic cough.
This Canadian explorer is working toward a preliminary feasibility study at its Wicheeda rare earth element deposit in British Columbia.
Hannam & Partners launched coverage on this near-term producing company set to add proven helium assets in Alberta to its large helium property portfolio in Saskatchewan.
Despite the increase in cost assumptions for the company's joint venture project in Mexico, this mining company is positioned for "robust cash flow," noted a Stifel report.
In light of the world moving away from fossil fuels, expert Clive Maund reviews Azincourt Energy Corp.'s six-month, three-year, and 12-month charts to tell you whether he believes it is a Buy.
ChargePoint Holdings Inc. shares traded 14% higher after the company reported Q2/23 financial results that included a 93% YoY increase in revenue. The firm posted the first $100 million sales quarter in its history and affirmed its FY/23 revenue guidance for total revenues of $450-$500 million.
At least nine analysts continue to rate MAG Silver Corp. a Buy after positive second-quarter financials, even as it continues to wait for its electricity hookup at its new plant in Mexico.
With a 340% year-over-year increase in the price of lithium, raising cash for exploration is easier than it once was. One lithium junior just raised more than CA$3.3 million to bolster its lithium portfolio with another project in Argentina and continues exploration on a nearby project that borders a lithium project being developed by Rio Tinto.
Now with clearance, the firm plans to commence a Phase 1 study of its lead candidate in patients with lymphoma by the end of this year, noted an H.C. Wainwright & Co. report.
Expert Clive Maund reviews the most recent news with Royal Helium Ltd., which has just signed a new supply agreement with a major space launch company.
A project site visit revealed the explorer is working to achieve this goal, necessary for an environmental certificate extension, Cantor Fitzgerald noted in a report.
The developer of genetic medicines is taking six more months to conduct longer preclinical safety studies involving its lead therapeutic, noted an Oppenheimer report.
This same medicine is currently being evaluated in a global clinical trial from which topline results are expected in Q1/23, noted an H.C. Wainwright & Co. report.
One helium company in western Canada slated to launch helium production in Q1/23 just signed a helium offtake agreement with a 'space launch company.' Find out the name of the helium company and why its helium operations have a low carbon footprint.
Chimerix Inc. shares traded 8% higher after the company reported it has entered into a 10-year, $680 million contract with a U.S. Government health agency to deliver up to 1.7 million treatment courses of its TEMBEXA for use as a medical countermeasure for smallpox.
With this first such agreement and derisking milestone for the energy company, it "is expected to realize near-term cash flows," noted an Eight Capital report.
Expert Clive Maund reviews the five-year and six-month charts for TraceSafe Inc. as well as its recent partnership with Solutions by stc.
In light of Silver X Mining Corp.'s significant rise in the price of its stock, expert Clive Maund reviews whether he believes the company is a good Buy.
These new data bode well for the upcoming resource update and prefeasibility study, expected by year-end, noted a Canaccord Genuity report.
A small biotech has taken further steps to deepen the intellectual property moat for its potentially revolutionary treatment for alcohol addiction. Find out which company it is and why one analyst has given it a CA$8 target price.
Shares of Nevada Copper Corp. traded 10% higher after the company reported it has lined up the necessary financing to restart production at its Pumpkin Hollow underground copper mine in Q2/23. The firm's plan calls for production hoisting rates to ramp up to 3,000 tpd in Q3/23 growing to 5,000 tpd in Q4/23.
Outcrop Silver & Gold Corp. sees unusually high surface sampling assays as it explores a new trend at its Santa Ana project in Colombia.
In light of Infinity Stone Ventures Corp.'s completion of its first tranche of financing, expert Clive Maund reviews the company to determine whether or not he would rate it a Buy.
PetroTal Corp. shares traded 11% higher after the company reported Q2/22 financial results highlighting seven consecutive quarters of production growth and reaffirmed its FY/22 guidance for average production of 15,000 bbl/d.
Bion Environmental Technologies Inc. is transforming cattle manure into natural gas, organic fertilizer, and clean water, and helping ranchers grow sustainable organic beef.
Management's ongoing execution is raising the biopharma's profile among investors, noted an Oppenheimer report.
New data thus far from drilling the deposit suggest the future resource grade will exceed the historical one, noted a Research Capital Corp. report.
These results confirm the owner of this Athabasca Basin project identified a shallow uranium deposit with economic potential there, noted a Research Capital Corp. report.
The U.S. Food and Drug Administration's follow-up to the new drug application for this potential treatment suggests a possible green light based on unmet medical need, noted a BTIG report.
Historically, dividends make up about 50% of stock market returns, so they are important. Not often can you find a solid, growing gold company with stellar management that is also offering over a 5% dividend yield. Expert Ron Struthers reviews the latest updates in gold stocks as well as GCM Mining Corp.
Shares of Snowline Gold Corp. traded to a new 52-week intraday high after the company posted initial assay results from its Rogue Project's Valley Zone. Starting from just below bedrock, the firm reported that it intersected 2.3 g/t gold over 282.9 meters.
Three newly encountered high-grade areas indicate considerable upside at this precious metals mining project, noted a Research Capital Corp. report.
Expert Clive Maund looks at the six-month chart of TraceSafe Inc. to show how this stock can be both cheap and effective for its buyers.
A Canadian hedge fund doubled its stake in a tiny biotech that demonstrated promising results in a study that used a former Sanofi drug called Ifenprodil to treat idiopathic pulmonary fibrosis and chronic cough. Find out the name of the company and why one analyst has given it a 12-month CA$25 target price — a 560% increase from the unit price in its recent placement.
Expert Clive Maund reviews the latest news with Algernon Pharmaceuticals Inc., including the recent successful closing of its financing.
Expert Adrian Day reviews the quarterly earnings reports from the remaining precious metals companies on his list, including Wheaton Precious Metals and Franco Nevada, among others.
Shares of AbraSilver Resource Corp. traded 13% higher after the company reported assay results from four recently completed holes during this year's Phase 2 drill program at the company's Diablillos silver-gold deposit in Argentina. The firm highlighted results from hole DDH-22-037, which returned 155m of 289 g/t Ag eq, including 30m of 609 g/t Ag eq.
This developer of immunotherapies has a robust pipeline, several active clinical programs and, thus, numerous catalysts, noted an Oppenheimer report.
The price target was increased by 66% to reflect the full potential opportunity of the biopharma's drug candidate for hepatocellular carcinoma, a key driver going forward, noted an H.C. Wainwright & Co. report.
Shares of Belite Bio Inc. traded 19% higher after the company reported it has initiated a pivotal Phase 3 clinical study in the U.S. for its LBS-008 for use in treating Stargardt disease.
A Vancouver-based firm just announced a partnership with the biggest publicly traded IT company in Saudi Arabia as it looks to provide hardware-assisted software solutions for the multi-billion-dollar new Smart City buildout happening in the Middle East.
Analyst coverage was initiated on this Canadian mining explorer, which has significant land packages and multimillion ounces of gold in metals-rich areas of Papua New Guinea, noted a Jemini Capital report.
Shares of Canadian Solar Inc. traded 15% higher yesterday to a new 52-week high after the company reported Q2/22 financial results that highlighted a 62% YoY increase in revenue and raised the ranges of its FY/22 revenue estimates by $500 million.
Drill results Troilus Gold Corp. generated in the last four months at this property will be incorporated into the upcoming mineral resource update and prefeasibility study, noted a Haywood Securities report.
Shares of Axsome Therapeutics Inc. traded 39% higher after the company reported that the U.S. FDA granted approval for its AUVELITY™ making it the first oral N-methyl D-aspartate (NMDA) receptor antagonist authorized for treating major depressive disorder in adults.
One healthcare company in the U.K. is bringing its proprietary Ketamine-assisted treatment for Alcohol Use Disorder to Canada. It's the second deal the company has made with a North American clinic operator this week. Find out why this won't be the last one.
The government in Ecuador is on track to grant an environmental permit for BacTech Environmental Corp.'s new bioleaching plant in September, the company says.
Expert Clive Maund reviews the latest update with Awakn Life Sciences Corp., including its recent rise in stock volume and the announcement that the company is to receive 66% funding support from the UK government for the development of its ketamine-assisted therapy treatment for alcohol use disorders.
The new figure takes into account recently determined economics and upside of the world's largest undeveloped gold project along with future precious metals prices, noted a ROTH Capital Partners report.
Shares of Touchstone Exploration Inc. traded 16% higher after the company reported it received environmental approval for construction of a two hundred million cubic feet multi-well surface production facility in Trinidad.
Expert Chris Temple of The National Investor reviews the latest updates with Enterprise Group Inc., including the announcement of its second-quarter results.
This sale indicates the firm is continuing to forge a pathway into one of its large target markets, noted a Noble Capital Markets report.
B2B communications and marketing solutions firm DATA Communications Management Corp. has implemented a five-year, 14-point strategic plan aimed at transitioning clients from print to digital services. eResearch Corp. stated in a research update that the plan is expected to generate both top-line growth and robust EBITDA margin expansion and mentioned that during Q1/22 the company posted its largest quarterly YoY revenue growth in four years. eResearch stated that it is maintaining its Buy rating on the company with a 12-month price target of CA$4.00.
Rover Metals Corp. is not getting out of its gold projects but has an eye on the future with a critical minerals and metals project in the Northwest Territories.
In landing this first licensing deal, the life sciences firm "shows good progress towards a potentially high-margin business," noted a Stifel report.
Silver One Resources Inc. shares traded 14% higher after the silver mining firm reported that it intersected 48.77m of 332 g/t Ag and 0.39 g/t Au, which included 10.67m of 1,339 g/t Ag and 1.21 g/t Au and its Candelaria Project in west central Nevada.
Nuvectis Pharma Inc recently announced quarterly financial results and is continuing to advance its precision oncology programs. H.C. Wainwright & Co. LLC advised in an earnings update that the firm offers significant upside potential as it is rapidly advancing its drug candidates through clinical development and is looking for ways to expand to markets outside of the U.S. H.C. Wainwright stated that it is reiterating its Buy rating and $21 price target for Nuvectis Pharma.
Hematopoietic stem cell transplantation (HSCT) and gene therapy firm Magenta Therapeutics Inc. recently announced updates related to two of its leading clinical programs. BTIG LLC advised in a research update that it expects Magenta to release updated clinical data from its MGTA-117 and MGTA-145 programs in Q4/22, which will serve as key catalysts for the company. BTIG stated it is reiterating its "Buy" rating and $6/share price target on Magenta Therapeutics.
Arbutus Biopharma Corp. presented clinical data to an international liver disease conference showing that its AB-729 continues to deliver strong reductions in HBsAg. The company is now conducting three separate combination therapy studies of its AB-729 and expects to achieve important milestones when the initial data readouts are released in H2/22. H.C. Wainwright & Co. affirmed its Buy rating for Arbutus Biopharma and adjusted its price target to $7.50.
One analyst says this healthcare co. has the opportunity to generate attractive CAPEX-light, high margin SaaS-like recurring revenues, which investors are currently getting for free, after the biotech firm entered the US market for alcohol addiction treatment through off-label licensing deals with a network of treatment clinics.
Avivagen is an early-stage life sciences company with a patented product for immune support that causes dramatic and profitable improvements in livestock. They have been increasing their sales and market penetration at a dramatic rate, and I believe them to be at an inflection point. Research coverage is expecting a 7x return.
These funds, including US$30M from a strategic investor, should see Vital Metals Ltd. through extraction facility commissioning, now underway, noted an MST Access report.
Recent orders from Avivagen Inc. are helping the developer of this product build a recurring revenue stream, noted a Noble Capital Markets report.
Accelerate Diagnostics Inc. shares traded 25% higher after the company reported Q2/22 earnings and announced it entered into a commercial agreement with Becton, Dickinson and Co. that will allow it to deliver rapid antimicrobial identification and susceptibility diagnostics to clinicians and patients worldwide.
The CEO of a junior silver explorer operating in Mexico’s Parral region believes its drill campaign revealed more than just promising gold-silver grades – he thinks his company is onto something much bigger. And that perhaps the entire camp is open to re-evaluation.
One analyst believes a 10-year extension of a mining lease at a high-grade gold project in Fiji could put a junior gold play in the crosshairs of companies looking to add ounces.
Dolly Varden Silver Corp. releases results from the first hole in its 30,000-meter drilling campaign at its sprawling Kitsault Valley project in British Columbia.
This means the pads could be leached again, and cyanide solubility test results indicate the process could be done economically, noted a PI Financial report.
There is significant potential to expand Defense Metals Corp.'s current resource and extend the mine life, noted a Noble Capital Markets report.
With Enterprise Group Inc.'s stocks steadily improving, expert Clive Maund reviews the latest updates with the company, including news with its wholly owned subsidiary Evolution Power Projects Inc.
Energy services and specialty equipment rental supplier Enterprise Group Inc. reported earnings for Q2/22, which included a 64% YoY increase in revenue along with substantial growth in gross margins and adjusted EBITDA. The company is now heading into the busy peak winter drilling season with a new arsenal of natural gas fueled generators that enable oil and gas drillers and natural resource firms to greatly reduce on-site CO2 emissions, meet and exceed mandated ESG requirements, and in the process, save thousands of dollars per day by eliminating the need for diesel-powered generators.
Shares of Twin Vee PowerCats Co. traded 77% higher and reached a new 52-week high after the high horse-power sport and commercial watercraft manufacturer reported Q2/22 financial results highlighting a 158% YoY increase in revenue from its Gas-Powered Division.
The widespread use of antibiotics in animal feeds, as well as over-prescription by physicians for therapeutic treatment of human infections, is leading to a growing resistance to antibiotics that is killing close to 1 million people each year. One company believes it has developed at least part of the solution through a beta carotene food additive that boosts immunity and contributes to better overall health.
The significant growth potential of the project also enhances its profile as a takeout target, noted a ROTH Capital Partners report.
Big earnings results posted by Data Communications Management Corp. have led an analyst to raise his target and estimates for the company.
Expert Clive Maund reviews the latest updates in copper stocks and how he thinks this turnaround will effect copper company Infinitum Copper.
More resource companies released quarterly earnings, but since in all cases production and other items had been pre-released, there were few surprises for expert Adrian Day.
One of Canada’s largest printing and marketing services company is growing its coffers by expanding its digital footprint.
Biotech ProMIS Neurosciences Inc.'s monoclonal antibody in development for Alzheimer's disease boasts a "unique" binding profile that could be "important to its clinical success," noted a Leede Jones Gable report.
Expert Clive Maund reviews the most recent updates from digital printing company Data Communications Management Corp. to tell you whether or not he believes it is a Buy.
With consumers moving away from artificial meat products and other preservatives, Avivagen Inc.'s antibiotic free animal feed seems to be just what they're looking for. With orders coming in and demand raising, expert Clive Maund shares his view on the potential of this life science company.
Jericho Energy Ventures Inc.'s hydrogen boiler technology creates high-temperature water and steam with no greenhouse gases. The only by-product is water.
The latest data from Emerita Resources Corp. may support growth of the company's overall project resource, noted a Clarus Securities report.
Aided by the burgeoning drone industry, this company is expected to grow its revenue enough in the next 12 months to move into the black, noted a ThinkEquity report.
Expert Clive Maund reviews the most recent updates with tech co. DroneShield Ltd., a company he believes is at the start of a major uptrend.
Shares of Shockwave Medical Inc. traded 17% higher to a new 52-week high after the company advised that it posted a 116% YoY increase in revenue during Q2/22 and raised the midpoint for its FY/22 revenue guidance by $25 million to $465-475 million.
This junior explorer is analyzing samples, conducting fieldwork and geophysical surveys, and mapping its British Columbia site with drones. But it can’t wait to drill and find out what’s underneath.
Expert Adrian Day reviews recent quarterlies and other developments at some more of his favorite gold and silver companies.
W&T Offshore Inc.'s shares traded 17% higher after the oil and gas producer reported Q2/22 financial results featuring a 106% YoY increase in revenue. The company noted it has been successful in increasing its proven reserves, reducing net debt levels, and is continuing to focus on generating free cash flow for shareholders.
A look at recent economic and market indicators that allude to more stagflation and not the outlook mainstream analysts are expecting. In other news, Greenbriar Capital Corp. is negotiating the purchase of a real estate franchise network to compliment its Sage Ranch 995 unit housing development.
Governments all over the world are more concerned than ever about the growing risk from drones that can carry weapons, engage in chemical warfare, and disrupt flights. One Australian company is using technology to mitigate the threat — without ever firing a bullet.
Awakn Life Sciences Corp.'s rating went to an Immediate Speculative Buy after it received substantial funding from the UK government. Expert Clive Maund shares his thoughts on the development.
Sarepta Therapeutics Inc. recently announced that it intends to submit a BLA to the U.S. FDA for its SRP-9001, a gene therapy to treat Duchenne muscular dystrophy. Equity research firm BTIG LLC advised in a research update that SRP-9001 seems to have met the necessary criteria for receiving accelerated approval and it expects an AdCom will be established shortly. BTIG stated that it rates Sarepta Therapeutics as a "Buy" and has a $125 price target for the company's shares.
Sensus Healthcare Inc.'s shares traded 30% higher after the company reported it achieved a 124% YoY increase in revenue in Q2/22. The company advised that demand continues to remain strong for its superficial radiation therapy (SRT) devices which provide minimally invasive and non-surgical alternatives for non-melanoma skin cancer & keloid removal.
Expert Adrian Day reviews results and developments from some of his favorite non-resource companies. He believes all three are solid dividend payers, and for investors seeking income attractive buys.
After a few weeks of observation, expert Clive Maund believes Bion Environmental Technologies Inc. may be due for a major uptrend and is building up to a major bull market.
This junior releases a preliminary economic assessment focusing on new copper-rich deposits on its massive KSM site in the Golden Triangle.
Shares of Senseonics Holdings Inc. traded 31.5% higher yesterday after the company reported that Elevance Health (formerly Anthem) has approved coverage of its Eversense® E3 implantable continuous glucose monitor to its forty-five million covered members.
Shares of ChemoCentryx Inc. traded 110% higher after the company reported it agreed to be acquired by Amgen Inc. for $52.00 per share in an all-cash deal valued at $4 billion. With the purchase, Amgen aims to cement its leadership position in inflammation and nephrology with the addition of ChemoCentryx's TAVNEOS® (avacopan) which the U.S. FDA approved late last year to treat ANCA-associated vasculitis, a serious autoimmune disease.
Seabridge Gold Inc.'s copper-rich expansion at its KSM project in the Golden Triangle gets one analyst to raise his target price for the company.
IRadimed Corp. reported Q2/22 financial results that were modestly higher than expected. ROTH Capital Partners LLC advised in a research update that based on the company's higher revenues, improved margins and disciplined cost control measures it is maintaining its Buy rating on IRadimed and raising its price target to $42/share (up from $40).
Expert Clive Maund reviews his opinion on gold and silver junior Western Exploration Inc. after it had what he calls "an impressive rally" in June.
New patents could help Meta Materials Inc. improve safety and reduce the cost of lithium-ion batteries needed for the electric vehicle industry.
MAG Silver Corp.'s Juanicipio project continues to deliver silver as the company waits for local officials to give the go-ahead to power up its own plant.
Expert Clive Maund shares the recent drop in Getchell Gold Corp.'s stock price and his rating of the company in light of the news.
Expert Clive Maund gives his assessment of biotech Algernon Pharmaceuticals Inc. after its Phase 2 study of Ifenprodil.
Expert Clive Maund shares his assessment of Omineca Mining and Metals Ltd. since its stock is currently inexpensive, and tells you whether he believes this stock is a Buy or a "goodbye."
Expert Clive Maund touches on the latest news with Bloom Health Partners Inc. from the enthusiastic buying toward the end of June to whether he believes the health company is still bullish.
BioLargo Inc. seemed to be very close to breaking out of its tight trading range on July 20, 2022, after remaining in the same place for a month. Expert Clive Maund goes over this update and his assessment of the company after this news.
SunPower Corp. shares traded over 9% higher after the company reported Q2/22 financial results highlighting a 63% YoY increase in revenue. The firm confirmed its previous guidance indicating that it expects to add 73,000 to 80,000 net new customers in FY/2022.
Shares of lithium-ion battery manufacturer Romeo Power Inc. traded 26% higher after the company reported it entered into a definitive agreement to be acquired by commercial EV truck maker Nikola Corp. in an all-stock transaction valued at $144 million.
After Algernon Pharmaceuticals Inc.'s Ifenprodil treatment for chronic cough was reviewed in a Phase 2 analysis, analysts at Research Capital Corp. noted that it is maintaining its Speculative Buy rating on the company.
The Critical Investor takes a look at one junior lithium play in Argentina that just had some success with the drill bit and is building its prospective land package — real estate that should only increase in value as lithium carbonate prices hover around US$75,000 per tonne.
Shares of NervGen Pharma Corp. traded 28% higher yesterday after the company reported that, in a landmark pre-clinical animal study, its NVG-291-R demonstrated significant functional repair to damage from ischemic stroke seven days following the event.
Energy industry service company Mammoth Energy Services Inc.'s shares traded 22% higher after the company reported Q2/22 financial results that included significant increases in quarterly revenue, net income, and adjusted EBITDA.
Geophysical surveys often reveal secrets just below the surface. One junior explorer operating in Quebec’s prolific Val d’Or mining camp has found a few of those secrets and it’s ready to drill them to see if a secret or two could become something much more valuable.
This junior is trying new ways to involve the local population in its project, hoping to take “environmental, social, and governance” considerations to a new level.
Outcrop Silver & Gold Corp., on its way to a maiden resource estimate at its Colombian flagship project, says it has returned its thickest and highest-grade intercepts yet.
A scientist at a junior biotech company recently conducted an additional review of the top line data from a Phase 2a study that used NP-120 to treat idiopathic pulmonary fibrosis (IPF) and chronic cough — only to learn that it treated chronic cough far better than first thought.
Shares of Northern Dynasty Minerals Ltd. traded more than 22% higher after the Vancouver mining firm reported it entered into a life-of-mine royalty agreement for non-core metals which may provide up to $60 million in proceeds.
Shares of Soligenix Inc. traded 8% higher after the company reported it formed a strategic global partnership to supply SERB Pharmaceuticals with its novel ricin antigen for use in developing a therapeutic treatment against ricin poisoning.
Shares of Zymergen Inc. traded 16% higher after the company reported it agreed to be acquired by Ginkgo Bioworks Inc. in an all-stock transaction valued at $300 million.
Expert Adrian Day discusses recent purchases from two royalty companies, as well as preliminary quarterly reports from several gold companies that he considers top buys right now.
Shares of SANUWAVE Health Inc. traded 12% higher after the company reported it successfully treated legendary football player Jim McMahon Jr. with its ENERGY FIRST system.
Shares of One Medical traded nearly 70% higher after the company reported it agreed to be acquired by Amazon Inc. for $18.00 per share in an all-cash deal valued at $3.9 billion.
A revenue-generating junior biotech company based in the U.K. has become the first public company to be approved for a government grant to fund most of a Phase 3 study exploring the use of psychedelics to treat alcohol use disorder. It could be a catalyst for the share price.
Expert Michael Ballanger reviews the current market cycle, Elon Musk's impact on the stock market, and reveals the stock he says has a positive outlook amidst the chaotic backdrop of summer 2022.
PolyMet Mining Corp. shares traded nearly 8% higher after the company reported it entered into a joint-venture deal with Teck Resources Ltd. to develop copper, nickel, cobalt, and platinum group metals resources at the NorthMet and Mesaba properties in Minnesota.
These study data from Aldeyra Therapeutics Inc. solidified the therapeutic's path to filing a new drug application, potentially in Q3/22, noted an H.C. Wainwright & Co. report.
Shares of Vimy Resources Ltd. traded 19% higher after the company reported positive results from the first two diamond drill holes at its Alligator River Project in Australia's Northern Territory. The company said it plans to prepare a mineral resource update for its Angularli Deposit in late 2022.
The Critical Investor explains why major shareholders like Crescat Capital "are stepping up once again ... but this time increasing their ownership in Tectonic even more" as everyone eagerly awaits the results from Seventymile.
Shares of Sidus Space Inc. traded 37% higher after the satellite technology company reported it has expanded the scope of its working relationship and increased deliverables to Teledyne Technologies Inc. Sidus stated that revenues registered under its contracts with Teledyne in Q2/22 were the highest amounts earned over the course of its four-year relationship with that company.
Lithium carbonate prices are up 340% year-over-year and one lithium junior explorer operating in Argentina just drilled some healthy lithium grades in a salar that extends beyond its property boundary and onto the junior's concessions.
Fundamental Research Corp. mentioned in a research note that this company is on a clear path to a potential new discovery in Argentina. The firm stated that it expects that a maiden resource estimate for its properties will be completed next year and is initiating coverage with a "Buy" rating.
Expert Clive Maund examines the confluence of increasing debt and the precious metals sector and speculates on how the European Central Bank's plan to engage in "unlimited bond buying" will impact the market.
StrikePoint Gold Inc. is "laser-focused" on its Porter Idaho and Willoughby properties in British Columbia's Golden Triangle.
Psychedelic-assisted therapy has shown in a clinical trial that it can help patients with alcohol use disorder (AUD) or alcoholism. One company hopes to bring its treatments to clinics throughout Europe and become the go-to standard of care for AUD.
Shares of Clene Inc. traded 38% higher yesterday after the company reported that its CNM-Au8 was shown to significantly decrease mortality in its RESCUE-ALS long-term extension trial.
Vertical Aerospace Ltd.'s shares traded 70% higher after the eVTOL aircraft designer and manufacturer reported it secured a pre-delivery payment commitment from American Airlines Group for the first 50 units of its VX4 eVTOL aircraft. The firm also advised it received a separate order for 50 VX4s from a business jet operator in Belgium.
One healthcare co. is currently rated a Buy and is making a push for a share of the $17.5-billion addiction treatment industry after a recent study showed its psychedelic-assisted psychotherapy treatment showed a significant decrease in alcohol use, noted a Maxim Group equity research report.
This green tech company will use its rock-eating bugs to process gold from mining production in Ecuador—and possibly somewhere near you.
Shares of Rhythm Pharmaceuticals Inc. rose by over 30% after the company posted positive interim results from its Phase 2 clinical study of setmelanotide in hypothalamic obesity. The data shows that after 16 weeks of treatment with setmelanotide, patients experienced a 17.2% mean reduction in BMI and a mean weight loss of 15.8%.
Technical Analyst Clive Maund explains why this junior gold explorer in Papua New Guinea that is gearing up to go far is a Buy in his book.
One healthcare company with upcoming catalysts wants to take a share of the CA$6-billion alcoholism treatment market with its proprietary psychedelic-assisted psychotherapy treatments.
A simpler open-pit only mine plan for Seabridge Gold’s massive KSM copper-gold project in northern B.C. could attract a joint-venture partner. But it might not be the company you think.
Shares of Canoo Inc. traded 57% higher after the company reported that Walmart has contracted to purchase 4,500 of its electric Lifestyle Delivery Vehicles for use in its growing e-commerce business. The agreement includes an option for 5,500 additional units.
It is difficult to get three people to agree on anything, let alone three investment analysts. But that is precisely the case with one junior biotech company that has shown in a clinical trial that its ketamine-assisted therapy for alcohol use disorder (AUD) is three times more effective than the current standard of care.
Can a psychedelic compound help you heal after a stroke? This biopharmaceutical company hopes it can and plans to start Phase 1 trials this September.
Shares of Volcon Inc. traded 47% after the all-electric powersports company reported that over the course of just 14 days it received thousands of pre-orders for its class-leading 125 hp Stag EV. The orders are expected to provide the firm with an additional $70 million in revenue.
Expert Maurice Jackson sits down with the CEO of Goldshore Resources Inc., Brett Richards to go over the latest updates with the company. With just one year under its belt, Goldshore Resources is already positioning itself to become the next tier one asset in Ontario. The flagship Moss Lake Property has a historical resource with significant expansion potential and is currently undergoing a 100,000-meter drill program, with impressive initial assay results.
Expert Adrian Day reviews updates at some of his favorite companies, including most recently the news between Altius Minerals Corp. and Lara Exploration Ltd.'s relationship.
Expert Michael Ballanger reviews this week's updates in the oil and gas sector, specifically his view on the U.S. government's handling of sanctions against Russia and how that will impact the economy.
Independent financial analyst Matt Badiali reviews the current bear market in junior mining stocks, profiling Vizsla Silver, Arizona Sonoran Copper Company, and Cross River Ventures Corp. to tell you which stock's risks are worth the reward.
This morning, newsletter writer Bob Moriarty, after not writing about a junior mining stock since early June, published an opinion piece on KRL Resources — and came out with a Buy recommendation on the junior.
Taseko Mines Ltd.'s shares traded 10% higher after the mine developer and operator reported that last month prior to the recent downturn in raw copper prices it had secured contracts for H1/23 for an additional 30Mlb Cu at prices ranging from $3.75-4.20/lb
As money dries up for a lot of mineral exploration, it seems that investors will still write checks for lithium plays. One junior with two lithium projects in Chile recently raised over $3 million — and the investors approached the company.
The leftist president-elect of Colombia has promised to halt new gas and oil development. But the government has highlighted the importance of finding new forms of energy for the green transition, and one analyst says copper will play a big role in that future.
The Critical Investor discusses the first results of deep drilling aimed at the Campbell Shear with CEO Gerald Panneton.
Shares of Ozop Energy Solutions Inc. traded 23% higher after the company reported that H1/22 revenues are expected to be 285% higher versus the same period last year. The firm advised that it anticipates further sequential growth in H2/22.
Expert Michael Ballanger reviews recent movements in the mining and precious metals market and what moves he plans on making as we wait and see whether the Fed will pivot.
Expert Adrian Day looks at the state of the market after this year’s 23% decline and discusses the risk of more possible downturn. Find out which companies he thinks are a buy — and which ones need to fly off your radar.
Ra Medical Systems Inc. shares traded 36% higher after the firm reported it received U.S. FDA 510(k) clearance for its DABRA 2.0 Catheter. The DABRA 2.0 is incorporated into the company's DABRA Excimer Laser System which is used by vascular surgeons in procedures to treat lower extremity and peripheral vascular disease.
You've seen placer gold being mined on Gold Rush, Discovery's gold mining TV show. But one junior explorer just announced that it's started to commercially mine placer gold in south-central British Columbia from a pay channel underneath Lightning Creek. At least one analyst thinks that makes this junior a Speculative Buy.
In the environment we are now in, the best thing investors can do is find stocks that are impervious to declines in the market indices. Even though they can be hard to find, there are some around, like the one in this story.
Shares of personalized, member-focused healthcare solutions company Accolade Inc. traded 29% higher after the company reported financial results for Q1/23 highlighting a 44% YoY increase in revenue and significant improvements in adjusted gross margin.
Junior explorer Quebec Precious Metals Corp. is focusing on gold in its project in the James Bay territory of Quebec and selling off its non-core properties. It hopes to complete a mineral resource estimate by the end of the third quarter.
Need to know where to go in these turbulent times? Asset manager Chen Lin has some ideas with his top picks for the third quarter.
Shares of BioNTech SE traded 5% higher after the company together with its partner Pfizer Inc. reported that the two firms have agreed to provide 105 million 30 µg, 10 µg and 3 µg new doses of the SARS-Co-V2 vaccine to the U.S. government in a contract valued at $3.2 billion. The agreement includes a provision allowing the U.S. government to purchase up to an additional 195 million doses, which if exercised would increase the grand total to 300 million doses.
Red Cat Holdings, a hardware and software provider to the drone industry, continues to innovate, and this industry observer calls it a "strong player to keep an eye on."
The Russell 3000 is home to the top 3,000 U.S.-traded equities. One junior gold explorer with a significant land package in the Black Hills of South Dakota — where the Homestake gold mine once produced more than 40 million oz gold — has joined the Russell 3000 and the VanEck Junior Gold Miners ETF, better known as the GDXJ. Heady days for a company that started trading on the NYSE American exchange in April.
Shares of Patterson Companies Inc. traded 11% higher after the dental supply and animal health products distributor reported Q4/22 and FY/22 financial results highlighting a 9.9% increase in annual sales and an expansion in operating margins.
Shares of Sutro Biopharma Inc. traded 21% higher after the company announced it entered into a global collaboration agreement with Japan's Astellas Pharma to advance three novel immunostimulatory antibody-drug conjugates.
Epizyme Inc. shares traded 55% higher today after the company reported that it agreed to be acquired by Ipsen S.A. of France for $1.45 per share along with a contingent value right of $1.00 per share.
The Critical Investor looks into the latest drill results of this junior miner at its Regnault target, which could be very close to 1 Moz gold now.
Shares of USA Truck Inc. traded 111% higher after the trucking and logistics firm reported it agreed to be acquired by DB Schenker of Germany in an all-cash transaction for $31.72 per share.
Expert Michael Ballanger goes over the latest news with Getchell Gold Corp. The gold-copper exploration company has announced that they will be working with Apex Geoscience Ltd. to conduct a resource estimate for their Fondaway Canyon gold project in Nevada. Ballanger reviews the highlights of the move and recent results, as well as information on Getchell Gold Corp.'s upcoming webinar.
Shares of uniQure N.V. traded 26% higher after the company released 12-month treatment data from the low-dose cohort in its Phase 1/2 Huntington's disease clinical trial.
Shares of healthcare technology and services firm Convey Health Solutions Holdings Inc. traded 138% higher after the company reported it received a proposal from majority shareholder TPG Inc. to take the company private. TPG has offered to buy all outstanding shares in Convey that it does not already own for $10.50 per share in cash.
Maurice Jackson sits down with Ari Sussman of Collective Mining, Colombia’s newest exploration company. Sussman says the company "expects strong news flow with lots of drilling activity. We are a discovery-based company with already significant results under our belt, and I hope everyone either tries to participate by buying shares, or at least watches us continue to put out news."
Shares of Biomea Fusion Inc. traded 14% higher after the company reported it dosed the first Multiple Myeloma patient in its Phase 1 COVALENT-101 r/r acute leukemia trial.
Dolly Varden Silver Corp. has started its 99-hole drilling campaign at one of the largest high-grade and undeveloped precious metal assets in the Golden Triangle.
This junior explorer is starting its summer surface fieldwork campaign at its copper project while it continues to wait on drilling permits.
With Bitcoin going bonkers and the market in turmoil, Adrian Day says gold is a safe haven. Here are a few of his favorite companies that have throttled through the turbulence to top his list as Buys.
The best place to look for a new mine is near an existing mine. One company exploring for silver, gold, and base metals deposits on three different projects in southeastern Europe, is employing that strategy to its advantage as it lists on the Canadian Securities Exchange.
Shares of Global Blood Therapeutics Inc. traded 12% higher after the company reported it has teamed up with New York Jets running back Tevin Coleman and his family to promote education and to offer hope and support to families affected by sickle cell disease.
Expert Michael Ballanger reviews this week's market updates from Wednesday's FOMC meeting to his outlook on Getchell Gold Corp., which he maintains is a "pound-the-table Buy."
Algoma Steel Group Inc. shares traded 18% higher after the North American light gauge rolled steel sheet and plate products producer reported financial results for Q4/22 and FY/22 that featured a 112% YoY increase in consolidated revenue.
Advent Technologies Holdings Inc.'s shares traded 245% higher after the fuel cell systems developer and components manufacturer advised it received official notification from the Greek State for the IPCEI Green HiPo Project. The firm is scheduled to receive an investment totaling €782.1 million ($829M) over a period of six years for a new hydrogen fuel facility to be constructed in Western Macedonia.
The tiny world of metamaterials could do everything from helping to deice your car’s windows to helping you see clearly into your microwave. And the industry could be worth billions.
Some big names in the industry invested during this company's recent financing, which will fund a new drill program. Drill targets are already defined and derisked, leading one expert to conclude this "could be very successful for the company."
Continental Resources Inc. shares traded 15% higher to a new 52-week high after the oil and gas company announced it received a non-binding buyout proposal for $70 per share in cash from the firm's largest shareholder Chairman Harold G. Hamm and the Hamm Family Trust.
Santa Ana was once the biggest colonial silver mine in Colombia. Today one junior explorer is looking to return Santa Ana to its previous glory, and some recent bonanza-grade drill results show the old mining district has plenty left to give.
Gold Terra Resource Corp. has some ambitious plans as they continue to drill their 30,000m program, and the most recently announced results 'continue to impress.'
One junior explorer just added a project in Idaho to a healthy stable of assets. Management believes the deal creates a lot of upside for shareholders, as the focus now turns toward extracting that value.
Today expert Adrian Day runs over the latest updates in deals and exploration from Midland Exploration, Orogen Royalties, and Fortuna Silver to tell you which ones he believes are a Buy.
Optinose Inc. shares traded 40% higher after the company reported positive top-line data from its Phase 3 ReOpen2 Trial of XHANCE for use in treating chronic sinusitis without nasal polyps.
Expert Michael Ballanger shares his thoughts on the Fed's actions to combat interest rates, the "angst" gold investors may be feeling at the present moment, and what he believes we should do next.
Could this aspiring junior have the next company-maker IOCG deposit on its hands? One junior explorer operating in Chile recently acquired 18,000 hectares between one giant copper mine and another massive development-stage project. Management thinks this could be another success story for a company with a history of turning little into lots.
Mining along the Iberian Peninsula has occurred for thousands of years. Today, one company is again exploring the Iberian Pyrite Belt as part of an effort to quickly build a resource and join the ranks of Spain’s metals producers.
Cogent Biosciences Inc. shares traded 70% higher after the firm reported positive clinical data from Part 1 of its ongoing Phase 2 APEX trial evaluating bezuclastinib in patients with advanced systemic mastocytosis (AdvSM), a severe hematologic disorder.
This company is getting drills turning and renewing its search for rare earth elements in Canada, hoping to reduce the West’s dependence on resources from China.
Signet Jewelers Ltd. shares traded 9% higher after the company reported Q1/23 financial results and reaffirmed its FY/23 estimates for total revenue and non-GAAP operating income.
This North American natural resource explorer is advancing the potential of its key gold projects at the 60th parallel of Canada’s Northwest Territories.
After weathering some major setbacks, PetVivo Holdings Inc. is stepping it up. With their new product for osteoarthritis and the team's perseverance, they may soon show themselves as a diamond in the rough.
MediciNova Inc. shares traded 9% higher after the company released top-line data from its Phase 2 study of MN-166 (ibudilast) in hospitalized COVID-19 patients deemed to be at elevated risk for acute respiratory distress syndrome. In the study, MN-166 demonstrated significant decreases in respiratory failure.
A Canadian junior explorer has attracted the attention of strategic metals and mining investor Michael Gentile, as he is expected to take part in the financing.
Augusta Gold Corp. has been on an upward swing, even after facing hurdles in mid-April/May this year. While buying in mid-May would have been ideal, analyst Clive Maund says it still looks like it's 'a good time to buy ahead of a more vigorous advance.'
Shares of AeroClean Technologies Inc. traded 150% higher after the company reported it received 510k clearance from the U.S. FDA for its Pūrgo™ medical-grade indoor air purification technology that uses UV-C LEDs to eradicate airborne bacteria, fungi, and viruses, including COVID-19.
This Canadian junior's processing plant is on track to open mid-year in Mexico. The mine feeding it is already producing and beating analysts' estimates.
Expert Adrian Day looks at likely outcomes for the Federal Reserve’s new, possibly hawkish, policy and reviews one of his favorite income investments. He also takes a moment to wish Her Majesty the Queen a happy Jubilee.
One junior operating in Fiji is well on its way to building a gold mine, but now it’s hit a long high-grade gold intercept that might alter those plans — and change the story altogether.
The Critical Investor marvels at the ongoing CA$3 million PP by Tectonic Metals, and explains why he believes in low downside risk, as does for example Tectonic's strategic partner Crescat Capital.
Shares of Canadian gold explorer Lion One Metals Ltd. traded 17% higher after the company reported it discovered a major new gold structure at its Tuvatu Alkaline Gold Project on the island of Viti Levu in Fiji.
Turning Point Therapeutics Inc. shares traded 116% higher after the company reported it entered into a definitive agreement to be acquired by Bristol Myers Squibb Co. in an all-cash transaction for $76.00 per share.
It's still in the early stages but one junior gold explorer in Nevada's Carlin Trend has outlined an oxide gold system that looks similar to others being mined nearby in America's most prolific gold-mining state.
As Omai Gold Mines is busy drilling their project in Guyana, the Critical Investor catches up with CEO Ellingham to discuss the latest results.
Repare Therapeutics Inc. shares traded more than 50% higher after the company reported it entered into a worldwide license and collaboration agreement with Roche AG for its anti-tumor drug camonsertib (RP-3500). The agreement includes an upfront payment of $125 million and up to an additional $1.2 billion in development, sales and royalties if certain milestones are achieved.
You want copper? You go to Chile. One junior explorer operating near the coast there just published its first drill results and they're above 1% copper. Now the hunt is on to find an iron-oxide-copper deposit like the ones others have found in the same copper belt — that's the ultimate goal.
Everything in the future seems like it will run on batteries. Here are some smart picks to grow your money along with the industry, according to one analyst.
Land position is often the key to not only finding an economic deposit but also ensuring that when you do, it’s all yours. One uranium explorer in the Athabasca Basin just added 732 sq. kilometers to its land package and is looking to dust off some old drill targets and expand its resource base.
As month five of this bear market comes to an end, expert Michael Ballanger goes over some bear market stories that left him with battle scars and provides some insight on what to expect in the months ahead.
FenixOro's Colombian gold project is just 15km from a world-class, high-grade gold mine that the team's COO helped discover and develop before it was sold for CA$1.4 billion. FenixOro believes it has a similar mine in the making with possibly 6 to 10 million ounces of medium or high-grade gold, yet the market values the company at CA$14 million.
View Inc. shares traded 33% higher after the company reported FY/21 financial results highlighting a 125% YoY increase in revenue along with expectations for even higher growth in FY/22.
With the backing of some heavy hitters in the industry, this company is looking to crack the 120-year mystery of where the major gold deposits are in the Yukon.
Outcrop Silver & Gold has a growing high-grade discovery in Colombia and just identified a new, 3.5-meter-wide vein that extends its system to 12 kilometers. The company aims to publish a maiden compliant resource in 2022.
Altius Minerals appears to have numerous growth opportunities under its belt. Expert Adrian Day goes over the latest updates and some news in other promising resource companies.
CatchMark Timber Trust Inc.'s shares rose 42% after the company reported it agreed to be acquired by PotlatchDeltic Corp. in an all-stock transaction for $12.88 per share.
Don't be asleep at the switch. Chris Temple of The National Investor explains why you should look at this helium company now.
Mexico is known for "la plata", and silver has been mined there since Spanish colonial times. One aggressive junior explorer just pulled the trigger on a deal to acquire a past-producing mine that management knows intimately (maybe even more than the previous operators). The acquisition just needs to be approved by regulators and shareholders.
Shares of Red Robin Gourmet Burgers Inc. traded 24% higher after the company reported Q1/22 financial results highlighting a 19.7% YoY increase in comparable restaurant revenue.
With battery metals in short supply and prices for some platinum group metals approaching record highs, one junior is developing a unique project in Montana that would bring these metals and others to market. It would also provide America with many of the critical minerals necessary in an unstable world.
A junior explorer in BC is one of a kind. It is not only exploring for gold in a historic gold mining camp, but it is looking to supplement exploration with potential gold sales from a joint-venture, underground paleoplacer mining operation. Now the company has added some much-coveted claims to its land package.
Analyst Clive Maund reviews Astra Exploration's newest updates, sharing his rating of the company after promising drill results.
Apyx Medical Corp. shares traded 50% higher after the company reported it received U.S. FDA 510(k) clearance for its Renuvion Dermal Handpiece for use in specific cosmetic dermal resurfacing procedures.
Chile produces more copper than any country in the world. But what about gold? One Vancouver-based junior explorer is seeking Chile's next company-maker gold deposit, and it's already finding similarities with another long-time gold and silver producing mine.
Shares of Nano One Materials Corp. traded 46% higher after the company reported it has agreed to acquire 100% of the shares of Québec lithium iron phosphate cathode material manufacturer Johnson Matthey Battery Materials Ltd. for CA$10.25 million.
Adrian Day recaps the recent news at some of his favorite resource companies, noting several good buys that emerged after the recent sector pullback.
Red Metal is fitting together the puzzle pieces of a promising copper project in Chile.
America's Car-Mart Inc. shares traded 26% higher after the multi-state used automotive retailer reported that it achieved record revenues of $352 million in Q4/22.
With this strategic decision, the company hopes to increase the chances its dry eye disease drug gets greenlighted, noted a BTIG report.
One junior gold explorer in Mexico is finding not only gold but also silver, copper, zinc and lead values in its first drill results at its district-scale project in Sonora state. The polymetallic nature of these early drill results adds promise to some high-grade gold intercepts found elsewhere on the property.
Shares of Entasis Therapeutics traded 21% higher after the company reported it entered into a definitive merger agreement with Innoviva Inc., whereby Innoviva will acquire all outstanding shares of Entasis that it does not already own for $2.20 per share.
SIGA Technologies Inc. shares traded 30% higher after the company reported that the U.S. FDA has granted approval for an intravenous (IV) formulation of its TPOXX® (tecovirimat) for use in treating smallpox.
Aztec Minerals goes from strength to strength it seems; after a myriad of excellent drill results at Cervantes, mid-tier producer Alamos Gold, operating the Mulatos Gold mine nearby got interested and is working on a CA$3M strategic investment at the moment.
Analyst Clive Maund reviews Trailbreaker Resources' latest rating with the acquisition of their Eagle Lake property.
The Critical Investor reviews the latest updates with Alianza Minerals Ltd., including their closing of a CA$750K private placement.
On a day when the DJIA dropped more than 1,200 points, shares of TJX Companies Inc. traded 6.5% higher after the company reported financial results for Q1/23 that highlighted a 3% YoY growth in same store sales at its T.J. Maxx and Marshalls stores.
With their newest project of building a commanding land position in New South Wales, Australia, expert Maurice Jackson believes Roo Gold is on track to become the New Dominant Player in the region.
Shares of Danish vaccine company Bavarian Nordic A/S traded 70% higher after the company advised that it had secured a contract for its IMVANEX® smallpox vaccine from an undisclosed country in Europe for use in addressing newly confirmed cases of monkeypox.
Sometimes the pieces all come together at the right time. One B.C.-based junior explorer just secured a long-held asset from a major producer in a low-cost, all-equity deal. Now the junior plans to develop and de-risk that copper-gold property into something that rivals its neighbor to the north and others in the district.
Every once upon a time comes a new, groundbreaking technology that becomes the new industry standard. In 2007, Steve jobs brought us the iPhone, now SQL Technologies has pioneered the safe-smart SkyPlug.
Millions of tonnes of mining waste could be converted to usable minerals with a new bioleaching process at a plant expected to open this summer in Ontario.
With Europe going through a major energy crisis, Rystad Energy, a respected energy consulting group, has predicted that European gas prices could triple again. Expert Kerry Lutz reviews how Trillion Energy could be the one to fill that void.
Across lithium, copper, nickel, and gold, Usha Resources’ CEO offers insights into how the company plans to capitalize on market forces and advanced technology to succeed.
Shares of EV Li-ion battery manufacturer Microvast Holdings Inc. traded 16% higher after the company reported Q1/22 financial results highlighting a 145% YoY revenue increase.
Lithium demand is expected to increase by at least 300% between now and 2030 as the desire for electric vehicles, smartphones, and other portable technology puts unprecedented pressure on global lithium production. Here are five ideas to add lithium to your life — and your portfolio.
While investors may have been betting on a Fed pivot, expert Michael Ballanger analyzes where we may find ourselves if they don't.
Maurice Jackson of Proven and Probable sits down with the CEO of Provenance Gold Corp, Rauno Perttu, to go over their historical data analysis and summer drilling plans.
Rattler Midstream LP shares rose 15% after the company reported it entered into an all-stock merger agreement with Diamondback Energy Inc.
As new results continue to come in, this company is adding rigs to complete its 100,000-meter drilling program and push its Ontario project to the next level.
Cullinan Oncology Inc. shares traded 23% higher yesterday after the company reported it entered into a strategic investment, development, and licensing agreement with Taiho Pharmaceutical Co. Ltd. of Japan for its CLN-081/TAS6417 for use in treatment of non-small cell lung cancer.
Filo Mining Corp. shares traded 30% higher today after the Canadian Explorer reported drill results from its Filo del Sol project in South America that extended its high-grade Breccia 41 copper-silver-gold zone by 175m to the North.
Aztec Minerals has already successfully delineated a considerable mineralized envelope at the California Zone, part of its Cervantes project in Sonora state, Mexico. But now Aztec appears to finding more mineralization at the California North target, too.
Partnership on a water pipeline will serve World Copper’s project, investors, and local communities making it an interesting investment to review. Streetwise Reports is here with the updates.
This energy company is pivoting to hydrogen, but it still has some interests in the oil and gas sector.
Can Collective Mining follow in the footsteps of its larger predecessor Continental Gold? Clive Maund examines the latest data from its one-year chart to see if it's rising to the challenge.
Michael Ballanger digs deep to uncover the connection between secular bear markets and gold in a credit-tightening cycle, mining out what he believes the Fed will do in this current bear market.
Endeavour Silver Corp.'s shares traded 9% higher after the Vancouver-based precious metals company reported Q1/22 financial results highlighting a 25% YoY increase in silver production.
With today's college students scrambling to save money, technology firm Mijem is using $5k crypto scholarships to drive followers to its buy-and-sell marketplace. Here's how it all works.
In today’s Bulletin, analyst Adrian Day reviews the recent results from the big three royalty companies, all strong, with rock-solid balance sheets, but with a shortage of large projects in which to invest.
Shares of Biohaven Pharmaceutical Holding Co. Ltd. traded almost 70% higher after the company reported it agreed to be acquired by Pfizer Inc. for $148.50 per share in cash plus future royalty opportunities.
This junior explorer has found more resources than it expected on its Mexican property and is looking for more surprises as it gets set to break ground in 2022.
Hemisphere Media Group Inc. shares traded nearly 80% higher today after the Spanish language media streaming company reported that it agreed to be acquired by Gato Investments L.P. in an all-cash transaction for $7.00 per share.
One Vancouver-based junior exploration company just went from one to two flagship projects with the release of the maiden resource estimate on a copper-silver project in Colorado. Could this be a game-changer for shareholders?
James Dines, financial analyst, author, and editor of The Dines Letter, died in April at the age of 90.
Rick Rule of Rule Investment Media and David Cole of EMX Royalty Corp. outline the history and benefits of mineral royalties for financial growth.
Shares of RxSight Inc. traded 7% higher after the company reported Q1/22 financial results which highlighted a 157% YoY increase in revenue and a 208% increase in unit sales of its Light Delivery Devices (LDD™s) utilized in cataract surgery procedures to implant its RxSight Light Adjustable Lens® (LAL), which it says is "the world's first and only adjustable intraocular lens (IOL) that is customized after cataract surgery."
With Avivagen's breakthrough product relishing in its success, Analyst Clive Maund reviews if he believes it is now a formidable contender as a Buy.
Intercept Pharmaceuticals Inc. shares traded 20% higher after the company reported it entered into a $450 million licensing agreement with Advanz Pharma in markets outside of the U.S. for Ocaliva® for use in treatment of primary biliary cholangitis, a progressive and chronic autoimmune disease which affects the liver.
Shares of Livent Corp. traded 23% higher after the company reported a 56% YoY increase in Q1/22 revenue driven by strong demand and higher prices and significantly increased its FY/22 adjusted EBITDA forecast.
Copper prices have more than doubled since early 2020 as demand continues to outstrip supply. One junior explorer has changed its tack to drill off brownfield exploration targets in an existing copper camp as part of a strategy to get these assets to production in time to capitalize on the forecast highs in copper prices.
Michael J. Ballanger reviews the current market and tells you how to not only make it through, but also rise above the "secular bear."
Shares of Chemours Co. traded 16% higher after the company reported Q1/22 financial results and raised its FY/22 adjusted EBITDA estimates by 12% over previous guidance.
The explorer, which completed its geophysical surveys at the Rincon West lithium project, will use the data to target drilling.
Trading is halted when the Ecuadorian government jumps the gun on announcing an Investment Protection Agreement.
Silk Road Medical Inc. shares traded 12% higher after the company reported that the U.S. FDA granted expanded authorization for its ENROUTE® transcarotid stent system for use in preventing stroke in patients deemed to be at standard risk for adverse events from carotid endarterectomy.
The Critical Investor catches up with the CEO of this gold explorer and discusses its latest financing and plans.
A research report from Peloton Capital says this anti-drone company is having a "transformative year" in 2022.
After recovering from a short "character assassination," Reliq Health Technologies may be on the up-and-up. Clive Maund examines the latest data from the company to see if it would make a good 'buy'.
Clearwater Paper Corp. shares traded 22.5% higher after the company reported Q1/22 financial results that included a 15% increase in YoY net sales. The firm said it sees continued strength in its paperboard business along with improvements in its parent roll tissue business and has been able to command higher prices to offset higher raw materials and transportation costs.
This junior mining explorer hopes drilling will confirm the high-grade copper it has found in fieldwork at its project in British Columbia.
The Moss Lake Property, located in Ontario, has a historical resource. The Moss Lake Property offers year-round exploration in a highly prospective area in Ontario with significant upside resource potential.
Does Australian-born DroneShield Ltd. show promise for stockholders? Clive Maund reviews the newest updates with the company.
PTC Inc. shares traded 18% higher after the software and services firm reported Q2/22 earnings and raised its FY/22 estimates for ARR, revenue and free cash flow.
In this article Clive Maund takes a long view of this Canadian silver explorer, flashing back to three years ago to review its trajectory.
Peru is home to some of the world's most prolific silver mines. One small-scale silver producer in a past-producing district is cleaning up its balance sheet and drilling off further resources—all while looking at M&A opportunities. It's all part of the plan to achieve long-term growth.
Alkermes Plc. shares traded 12% higher after the Ireland-based company reported Q1/22 financial results and reiterated its FY/22 business outlook.
This explorer's drill results out of its flagship project in Colombia are turning heads and leading to comparisons with another recent copper success story.
One Quebec-based junior is breathing life into an old gold camp and is poised for a re-rating in the coming months as it calculates a new resource estimate as part of its prefeasibility study — slated for mid-2022.
Gold rush or gold bust? Editor of Adrian Day’s Global Analyst, Adrian Day reviews rising opportunities and developments in gold stock.
Shares of Arch Resources Inc. traded 21% higher after the metallurgical and thermal coal producer reported Q1/22 financial results and announced an $8.11 per share dividend as part of its recently formed program to increase return of capital to shareholders.
Bonzana-grade copper in a hot copper market? Samples found by one Vancouver-based explorer have returned copper grades as high as 9.63% in a region of Argentina known for its world-class discoveries.
Nkarta Inc. shares traded over 120% higher after the company reported positive dosing data from two separate Phase 1 clinical trials evaluating the use of natural killer cell therapies to target r/r acute myeloid leukemia and myelodysplastic syndrome and r/r B cell malignancies.
Kimberly-Clark shares traded 9% higher on a down market day after the company reported Q1/22 financial results that highlighted a 7% YoY increase in net sales.
Shares of steel wire manufacturer Insteel Industries Inc. traded 10.5% higher after the company reported Q2/22 financial results that highlighted a 53% YoY increase in revenue and a 65.4% increase in average selling prices.
The upgrading of resources from Inferred to Measured and Indicated "should allow the company to demonstrate improved economics compared to [its] previous prefeasibility study," noted a ROTH Capital Partners report.
Editor of Adrian Day’s Global Analyst, Adrian Day takes a look at the first quarter results of three gold companies they think are worth watching.
One Québec-based junior is exploring mineralized structures in and around the past-producing Belleterre gold mine. The Critical Investor discusses the company's first drill results with management.
Shares of AlloVir Inc. traded 18% higher after the firm reported that the U.S. FDA awarded Regenerative Medicine Advanced Therapy designation to its posoleucel for use in preventing life-threatening infections from six viruses in allogeneic hematopoietic cell transplant patients.
Streetwise Reports recently spoke to renowned biotech expert John Vandermosten (CFA) about three of his favorite healthcare companies that are addressing as-of-yet unmet market needs.
Clive Massey, CEO of Canada's Universal Copper, explains the company's approach to creating shareholder value in a rising copper market.
Shares of Checkmate Pharmaceuticals Inc. traded 330% higher to a new 52-week high after the company reported it agreed to be acquired by Regeneron Pharmaceuticals Inc. for $10.50 per share in cash.
The electric vehicle industry is poised to grow to $823 billion by 2028. Companies that scale up production and transition successfully to profitability may eventually overtake the EV giant.
Some properties pass through different hands on their way to production. One Vancouver-based junior gold and copper explorer plans to be the one that succeeds where others have failed in southeastern Alaska.
"Contained metal on a gold equivalent basis increased by 8.4% over the previous 2020 resource estimate," noted a Cantor Fitzgerald report.
Editor and Publisher of The GGM Advisory Service, Michael Ballanger, explains his current bearish stance on gold.
Shares of Natus Medical Inc. traded 29% higher after the company reported it agreed to be acquired by ArchiMed Group, a France-based private equity firm, for $33.50 per share in cash.
Editor of Adrian Day’s Global Analyst, Adrian Day shares his recommendation to sell this stock that is up nearly 60% this year.
This junior miner appears to be proving up 1 Moz heap leachable gold with ease, as further step-outs from the northern center part of its Cervantes project have returned a few excellent results.
Shares of Valneva SE traded 8.5% higher after the company reported that the U.K.'s MHRA has granted Conditional Marketing Authorization for its inactivated whole-virus COVID-19 vaccine candidate called VLA2001 for primary immunization in adults between 18 and 50 years old.
If you’re looking for epic gold deposits in America, you probably want to start in Nevada – home to the Carlin and Cortez trends and the country’s top gold mines. One junior explorer is hitting long intercepts of oxide gold mineralization at its flagship gold project in Nevada and it is becoming a real Butte.
Shares of Sierra Oncology Inc. traded 38% higher after the company reported it agreed to be acquired by GlaxoSmithKline Plc. for $55 per share in cash.
"Tokens.com provides public investors an easy and secure way to get exposure to the most exciting and fastest growing sectors in crypto," noted a Noble Capital Markets report.
This technology solutions company plans to put an end to the $3-trillion-a-year counterfeiting market. With an easy-to-use QR tool on their smartphone, consumers can confirm instantly if a product is authentic.
Shares of Actinium Pharmaceuticals Inc. traded 24% higher after the company reported it entered into a licensing and supply agreement for its antibody radiation conjugate, Iomab-B, with Sweden's Immedica Pharma AB for sales in Europe, the Middle East and North Africa.
With geopolitical tensions rising, the US recently banned defense contractors from purchasing REE metals from China and will consequently attempt to revive its domestic rare earths industry. However, the US has just one rare earth mine and no processing technology, which highlights the need for a new wave of investment, writes McAlinden Research Partners.
The Critical Investor discusses 2022 exploration plans and projects with Alianza Minerals CEO Jason Weber.
With the global helium market forecasted to reach $18.18 billion by 2025, this Canadian helium explorer is now planning an aggressive advance toward commercial production.
One junior explorer has defined a gold resource along the "Rim of Fire," a rift between tectonic plates in the South Pacific. Recent drilling has shown there is even more gold at depth. Maybe a lot more.
Editor of Adrian Day’s Global Analyst, Adrian Day explains what he sees in the future for two gold companies and reveals his pick that had an $11.8m market value increase.
Shares of Veru Inc. traded 180% higher after company reported interim data from a Phase 3 clinical study of its COVID-19 drug candidate sabizabulin which was shown to reduce deaths in hospitalized patients by 55%.
The Critical Investor sits down with Kenorland Minerals CEO Zach Flood to discuss the company's latest exploration results from its Regnault gold project in Québec.
Nurix Therapeutics Inc. shares traded 13% higher after the company reported Q1/22 financial results and released an outline for two poster presentations that will be submitted at the American Association for Cancer Research Annual Meeting this weekend.
The Critical Investor looks at a junior miner that has been raising cash and acquiring additional claims for its Ontario projects.
With the next batch of drill results from the Ivana deposit coming back from the labs including a few high-grade results, the Critical Investor discusses recent developments with Blue Sky CEO Niko Cacos.
This company wants to patent a process using bacteria to recover iron and other ores from millions of tonnes of mining waste.
The spot price for uranium has almost doubled in less than a year and the long-term price outlook looks almost as promising. One junior explorer is developing a significant uranium-vanadium project in Argentina, a country with established atomic energy infrastructure and no domestic production — yet.
Shares of AngioDynamics Inc. traded higher after the company reported Q3/22 financial results highlighting a 28.6% YoY increase in net Med Tech sales.
Kainantu Resources' properties surround K92's mine, a massive project with a 4.8 million ounce gold resource in Papua New Guinea. The deal opens the door for large miner Harmony Gold to take a strategic position in the explorer.
BioXcel Therapeutics Inc. reported that the U.S. FDA has approved its IGALMI™ (dexmedetomidine) Sublingual Film for use in acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
Technical analyst Clive Maund charted this drone company and believes that it has a very strong chart and looks to be on the verge of breaking out into a major bull market.
In January 1879, entrepreneur George Hearst took Homestake Mining public on the NYSE — the first mining stock ever listed. Now, 123 years later, some intrepid mining men are bringing the Homestake gold camp back to the NYSE in a new offering backed by $50M in exploration and development cash.
Red Cloud Securities just initiated coverage on this Canadian copper exploration and development firm with a compelling project portfolio.
Shares of Nano-X Imaging Ltd. traded 9% higher after the company reported it opened a new semiconductor chip fabrication plant in South Korea. The 12,000 sq. meter facility was commissioned to produce the firm's Nanox.SOURCE semiconductor chips for its novel digital Nanox.ARC 3D x-ray system.
The miner is developing the historical Homestake Mining properties in South Dakota.
A quarter of the way into the year, this global healthcare technology company is experiencing “phenomenal growth,” with “a lot of growth ahead of us” for the rest of this year.
Vision and Value discusses the state of the virus and big pharma's race to slow the death rate as well as the spread of the pandemic — and what it means for investors.
The number of Q4/21-produced gold equivalent ounces attributable to the Canadian company exceeded expectations, noted a Haywood Securities report.
With funds from the sale, this energy company will be able to advance its new entity to the development phase and grow, noted a Haywood Securities report.
Chris Temple of The National Investor ranks this drone industry products and services co. a BUY, citing that its "value proposition is mind-blowing."
Adrian Day sees a significant lack of new discoveries in the mining business and says it's "good to see some majors making investments in exploration companies."
The sector fared well during Q1/22, but a repeat performance in Q2/22 is not a guarantee due to the uncertainty regarding several macroeconomic factors, noted a Noble Capital Markets report.
Shares of Array Technologies Inc. traded 9.0% higher after the company reported it entered into an agreement to provide advanced tracker technology for the 1.4 GWh Gemini solar project, the largest solar plus storage project in the U.S.
Wearables company that aims to promote better sleep "looks ready to start a new bull market after a long decline."
This sustainable housing and renewable energy company has two solar projects, but its 995-unit sustainable housing development in California is going to give a near-term reward.
Technical analyst Clive Maund explains why he rates this company a strong speculative buy.
In this update, technical analyst Clive Maund rates this community and commercial solar generation and storage company an 'immediate strong speculative buy.'
A company that uses naturally occurring bacteria to separate precious and base metals from difficult to treat ores, concentrates and tailings has caught the attention of this technical analyst.
The Critical Investor looks into a junior that is trading at all-time lows at the moment and could be an interesting opportunity.
Michael Ballanger goes bearish on silver and breaks down why a "heretofore uninteresting" junior developer has recently caught his eye.
Frequent contributor Bob Moriarty is no stranger to reading the Daily Sentiment Index. In this article, he uses it to assess today's silver market — and to show how he finds the best times to buy.
Technical analyst Clive Maund charts White Gold and explains why the bullish volume on this junior suggests it will probably reverse to the upside soon.
This junior explorer with mining projects in Papua New Guinea's stock is in a steady uptrend that is in its early stages, analyst Clive Maund says.
NGM Biopharmaceuticals Inc. shares rose 14.75% after the company reported it dosed the first group of patients in its Phase 1/1b clinical trial of NGM831 for use in treating advanced solid tumors.
In this update, Clive Maund explains why he thinks this stock is attractive with its world-class Wicheeda deposit.
Asset manager and contributing writer Chen Lin looks to the biotechnology and mining sectors for his top second quarter picks.
One junior silver explorer has almost ideal backing. When it needs capital, it turns to the likes of mining financiers Eric Sprott, Jeff Zicherman, as well as institutional investor Crescat Capital. Hecla Mining is also a major shareholder. That kind of support is rare. Find out why they just added to their positions.
An emerging junior developer is banking on its sprawling northwest Ontario property having what it takes to reach Tier 1 status and attract the attention of a major.
Clovis Oncology Inc. shares traded 36% higher after the company reported that in the Phase 3 ATHENA-MONO clinical study its Rubraca® (Rucaparib) was shown to significantly improve progression-free survival in women diagnosed with ovarian cancer.
In its promotional deck, one junior explorer with two projects in Nayarit state, Mexico, bills itself as building a ‘superior junior.’ With a chairman and CEO who have transformed junior explorer companies into prized acquisitions for larger players, Sierra Madre is well on its way to achieving its goal.
Shares of national furniture retailer Arhaus Inc. traded 21% higher after the company reported Q4/21 and FY/21 financial results that included a 57% increase in FY/21 revenues.
Cellular infrastructure is big business, and start-ups in this space come around about as often as unicorns. Until now. One company is seeking to leverage its clout as a public company and grab an even bigger slice of the 5G wireless buildout.
Adrian Day's Global Analyst discusses recent developments at some companies on their list, including a new agreement Barrick has reached with the government of Pakistan to allow it to proceed with a giant mine in that country. Also, there's a growing trend for brokerage firms to decide what you can and cannot buy.
Micro-cap tech names are underperforming the broad market, but one of such plays continues to put together deals and build on its fundamentals in anticipation of the day when investors return en masse to the space.
Bob Moriarty shares his thoughts on York Harbour Metals, which has been simmering for a decade — until recently when they made a deal on a former mine.
Shares of IGM Biosciences Inc. traded 97% higher after the company reported FY/21 financial results and announced it entered into a collaborative partnership with Sanofi SA to develop six separate IgM antibody agonists for three oncology and three autoimmune/inflammation targets.
This company that specializes in bioleaching technology expects its new plant to open in Ecuador in Q1 2023.
This exploration and development company is expanding its opportunities with the acquisition of an Ontario property with three connected, high-grade gold deposits.
STAAR Surgical Co. shares traded higher after the company reported that the U.S. FDA approved its EVO Visian® Implantable Collamer® Lenses to correct myopia (nearsightedness) and myopia with astigmatism.
Michael Ballanger is never shy on opinion and in this submission he reveals a high-leverage copper play in Colombia that is in the early stages of exploration. He's convinced you should take a closer look.
This junior miner, after repeatedly reporting strong drill results, could be well on its way to delineating an estimated 800-1,100koz Au oxide gold resource near surface at its project in Sonora, Mexico.
Shares of Texas-based LNG terminal operator NextDecade Corp. traded 31% higher after the company reported it executed a binding long-term, 20-year supply agreement with Guangdong Energy Group Natural Gas Co. Ltd.
Quadrupling the two million ounces of gold it inherited from a previous miner is just one way Troilus Gold is moving ahead with de-risking and building a “generational asset” in Québec, Canada.
The Critical Investor checks in with a junior explorer after it intersects visible gold and completes a CA$5.6 million raise.
Shares of Atlantic Lithium Ltd. rose 17% after the company reported the lithium resource at its Ewoyaa Project in Ghana has increased by 42% to 30.1Mt @ 1.26% Li2O.
David Lucatch, CEO and president of Liquid Avatar, spoke to Streetwise Reports about what’s ahead in 2022 for the company as well as the future of digital identity.
A junior mining explorer releases a batch of surface fieldwork data and images from its copper project in British Columbia and prepares for a drilling campaign.
Shares of 4D Pharma Plc. traded 28% higher after the company reported positive interim results from its Phase 1/2 study of its MRx0518 in combination with Merck & Co.'s KEYTRUDA® (pembrolizumab) for use in treating renal cell carcinoma.
With copper flirting with $5/lb, it’s a good time to publish an expanded high-grade copper resource on a project you own outright in a mining-friendly jurisdiction with solid infrastructure and proven route to a deep-water port. It looks even better when metals recoveries from oxide and sulphide ore are higher than 85%.
Shares of SQZ Biotechnologies Co. traded 17% higher after the company reported that it has been awarded a $2 million grant from the NIH to develop a new cell replacement therapy for use in treating Parkinson's disease.
Michael Ballanger submits that steps should be taken to end central banking, and to remove the function known as "control of the currency" from its powers.
Adrian Day — editor of Adrian Day's Global Analyst — discusses six companies, several of which are Buys, and looks to the SEC's latest plans for emissions control.
Shares of Aris Gold Corp. traded 30% higher after the company reported it entered into an agreement to become operator of the Soto Norte Gold Project in Colombia and has taken a 20% ownership interest in the operation with an option to increase its investment to 50%.
Shares of Marinus Pharmaceuticals Inc. jumped 16.4% higher near the end of trading today after the company reported that the U.S. FDA granted approval for its ZTALMY® (ganaxolone) in treating a rare type of genetic epilepsy called CDKL5 deficiency disorder.
The James Bay territory in northern Quebec is rich in metals, especially gold. One large mine and a few smaller ones are in production and now the race is on to drill off enough ounces to determine where the next mines will be.
A green tech company that has developed technology to transform hydrocarbon waste such as tires into renewable commodity products is at another very good buy spot, analyst Clive Maund says.
This pharmaceutical company is trading well below its cash value and is on the cusp of a potentially significant catalyst, one analyst says.
This nanotech company says it is hitting an inflection point in the commercialization of its science and technology.
Copper prices are at record levels due to supply constraints and surging demand. And quite possibly the best place to look for copper is Chile, home to the largest copper deposits in the world. However, one junior is eschewing the country’s typical large porphyry deposits in the Andes for a shot at high grade near the coast.
The Critical Investor looks into Omai Gold Mines, which is proving up as many left behind ounces of gold as they can at the historic Omai Gold Mine in Guyana.
Shares of Marrone Bio Innovations Inc. traded 47% higher after the company agreed to merge with Bioceres Crop Solutions Corp. in an all-stock transaction valued at $236 million.
This mental health company is pioneering a unique, new treatment for mental health issues such as depression and PTSD in which psychedelics are administered by medical professionals in specialized clinics.
Helium gas is one of the hottest commodities on the planet, but few investors are tracking its price because prices are quite opaque. But by first quarter 2023, margins should be very high and run-rate annual revenue could exceed CA$100M.
Shares of cyber security firm SentinelOne Inc. traded 12% higher after the company reported a 120% increase in FY/22 sales and announced it is acquiring ITDR firm Attivo Networks for $616.5 million.
A Canadian clean tech company specializes in recycling technology that converts tires, plastics, and other hydrocarbon waste into marketable commodity end products.
Go to any mining conference and you’re likely to hear this adage: the best place to find a new mine is near an old mine. It’s true. It’s even more likely when metals prices are healthy and trending higher. One junior is seeking to outline resources in two former mining camps. The odds — and metals prices — just might be on its side.
One analyst says commodity prices are soaring as tensions between superpowers escalate, setting up the U.S. dollar to continue to dominate the world as a reserve currency.
Adrian Day discusses financials from three resource companies that released earnings last week; all reported record years.
Bob Moriarty of 321 Gold recommends this "low-cost, high-opportunity" Mexican explorer to today's investor.
Hycroft Mining Holding Corp. shares traded 14% higher after the silver and gold mining company reported it received a $56 million equity investment from famed precious metals investor Eric Sprott and movie chain operator AMC Entertainment.
As the dust settles after an intense proxy battle, the Critical Investor looks into this junior explorer's new direction and a rare opportunity.
Uranium is a cyclical commodity, but unlike most commodities, it is more of a feast or famine situation. Penny Queen says the table is set, and she can smell the food.
Shares of this pharmaceuticals co. traded 22% higher after the company reported Q4/21 and FY/21 financial results that included a 17% sequential gain in net revenue from sales of its FOTIVDA® (tivozanib), which has been approved by the U.S. FDA for treating adults with relapsed or refractory advanced renal cell carcinoma (RCC).
Analyst Clive Maund says this maker of sophisticated drones looks ready to reverse to the upside as the industry gets a massive boost from Russia's invasion of Ukraine.
Shares of Clearside Biomedical Inc. traded 42% higher after the company reported Q4/21 and FY/21 financial results and provided an update regarding positive developments at the company including the receipt of over $20 million in milestone payments from its commercial development partner.
One of the hottest regions for gold exploration in Canada is the James Bay Lowlands, where several significant gold discoveries have already been made and one has become one of the country’s largest primary gold mines. One junior seeks to take its discovery to the next level, and recent drilling suggests it is on the right path.
Uranium explorers in Saskatchewan's Athabasca Basin have delivered a lot of shareholder value over the years with one simple formula for success: make a high-grade discovery during a period of robust uranium prices. With global energy supplies in question and uranium prices soaring, one junior is leveraging this formula to add pounds to an earlier discovery.
Shares of ethically farmed egg producer Vital Farms Inc. traded 9% higher after the company reported Q4/21 and FY/21 financial results that included a 43.4% YoY increase in Q4/21 net revenue.
Stars align for the helium market and for an Alberta-focused development company with proven helium resources, multiple drilled wells, and forecast production in 2023.
Adrian Day discusses recent results and developments at several of his favorite resource companies, with some still good buys despite the recent rallies.
Technical analyst Clive Maund charts Kainantu Resources and explains why he has a Buy recommendation on the explorer with projects in Papua New Guinea.
Shares of C4 Therapeutics Inc. traded 16% higher after the biopharma company reported that the U.S. FDA granted Orphan Drug approval status for its CFT8634 for use in treating soft tissue sarcoma.
After its recent project acquisition, this Canadian mining company boasts one of the Golden Triangle's largest undeveloped precious metals properties, a significant total mineral resource, and compelling exploration upside.
Shares of Intertape Polymer Group Inc. traded 76% higher after the company reported it agreed to be acquired by Clearlake Capital Group L.P. for CA$40.50 per share in cash.
Rare earth elements are in high demand, and newly released drilling results in Canada could point to a way to help loosen China's stranglehold on the sector.
It has been a wild week for crude oil. Technical analyst Clive Maund reviews the trends.
Technical analyst Clive Maund takes a look at Barsele Minerals' chart and explains why he finds it attractive.
Shares of two leading independent exploration and production companies traded higher after they reported they entered into an agreement to combine operations in what was referred to as a "merger of equals," creating a new entity with a total enterprise value of around $6.0 billion.
Multiple factors are pushing fertilizer (and critical component phosphate rock) prices higher and higher. One need look no further than grain prices like wheat, corn, and soybeans.
Technical analyst Clive Maund charts a uranium company with projects in Canada and explains why he believes it will benefit from higher energy prices.
The Critical Investor takes a deep dive into Quebec-focused gold explorer Vior Inc. and concludes that he likes "the odds for Vior, as Belleterre is an impressive brownfield project with lots of indications for mineralized potential."
A junior is nearing the major catalysts of maiden resource estimates for two of its prospective silver projects where it continues exploration work, noted a Couloir Capital report.
Given current geopolitical conflicts and rising inflation, investors should put their capital in precious and base metals as they are excellent stores of value during times like this, Ross Beaty said at a March 2022 mining industry event.
With a recent agreement for greener electricity, this company has abandoned its previous plan to use diesel-generated power for its mining project, noted a Red Cloud Securities report.
A Vancouver-based tech startup decides to protect its shareholders versus following through on an acquisition that would have ultimately created company-threatening dilution.
Adrian Day has been promising a few sells among the stocks on his list for some months now, to offset recent new buys and make room for new buys. Today, we have the first of those.
Against this backdrop of uncertainty, many uranium explorers and developers continue to advance their North American projects.
Shares of new concept fast casual restaurant chain Sweetgreen Inc. (SG:NYSE) traded 23% higher after the company reported Q4/21 and FY/21 financial results highlighting a 63% YoY revenue increase in Q4/21.
At very high zinc and copper prices, and with a pretty impressive (60.4m @ 2.25% CuEq) drill result at the Sesmarias target, part of the Alvalade project in Portugal, it was easier for Avrupa Minerals to raise almost a third of their market cap, being CA$1.25M. The Critical Investor does a quick update.
Shares of The Kroger Co. traded 11.6% higher after the company reported Q4/21 and FY/21 financial results that included a two-year stack growth rate of 113% in Digital Sales.
Spain’s Andalusia region is known for its seafood, olive oil, and Moorish architecture. It’s also known for having one of the world’s most prolific mining belts — the Iberian Pyrite Belt. One junior explorer has some of the most prospective mining concessions in that belt, with Spain’s courts about to give it yet one more — and it comes with a big historical resource.
Copper prices are rising quickly and the number of junior exploration companies seeking to ride the copper price wave grows by the day. One such company has strong land positions in four mining friendly states, an experienced exploration team, an enviable share structure, and is already delivering results for shareholders.
Shares of a Medicare-focused and AARP endorsed primary care facility operator traded 27% higher after the company reported FY/21 financial results that included a 64% YoY increase in capitated revenue.
Vancouver-based silver and gold co. is exploring a very high-grade and robust silver ore discovery at its Santa Ana project in Colombia.
Streetwise recently sat down with a veteran miner to learn more about his quest for the red metal that is being used for everything from electric vehicles to wireless communication and energy storage systems.
This biotech company is commercializing its lead drug candidate, Kimmtrak, has a catalyst-rich 2022, and has various clinical-stage drugs for cancers and autoimmune and infectious diseases.
In light of news events of the past week, Michael Ballanger sat in disbelief as gold traded from $1,976.20 to under $1,890 in one single trading session.
Shares of Renewable Energy Group Inc. traded 40% higher after the biofuel producer reported it agreed to be acquired by Chevron Corp. for $61.50 per share in cash.
Adrian Day reviews two of his global investments, "one with a rock-solid dividend the other with an attractive if less certain yield."
Fiji might be known for its bottled water, but gold production keeps the lights on. Fiji is located on an active tectonic boundary between the Pacific and Indo-Australian Plate, known as the “Ring of Fire.” This rift hosts several world-class copper-gold porphyry and epithermal gold deposits. One Vancouver-based junior is tracking at least one more.
A promising biotech company is finding new ways to treat neurodegenerative diseases by focusing on misfolded proteins.
This company has announced more excellent drill results from its project in Mexico, and the Critical Investor believes it is well on its way to prove 1Moz of heap leachable gold.
Aerie Pharmaceuticals Inc. shares traded 30% higher after the ophthalmology-focused pharmaceutical company reported Q4/21 and FY/21 financial results and announced the appointment of a new Chief Medical Officer.
Lantheus Holdings Inc. shares traded to a new 52-week high after the firm reported Q4/21 and FY/21 financial results that included a 25.3% increase in annual revenue. The firm also advised that the FDA approved the sNDA for its isolator-based drug manufacturing facility for diagnostic ultrasound enhancing agent DEFINITY® for patients in the U.S. with suboptimal echocardiograms.
Analyst Clive Maund says this hydrogen stock is ready for a significant rally after news of agreements with two North American food companies.
Shares of this green technology company have bottomed out, making it a good time to buy back any positions sold or add to existing ones, analyst Clive Maund says.
Currently China has a virtual stranglehold on rare earth elements, but this Canadian company is getting ready to capitalize on the downstream value of processing the REEs it’s mining.
Shares of Beauty Health Co. traded 32% higher after the company that is credited with creating the category of hydradermabrasion reported Q4/21 and FY/21 financial results outlining significant improvements in sales, margins and adjusted earnings.
Asia Pacific has the world's highest concentration of gamers but internet speeds that lag far behind the US and Europe. Now, cutting-edge technology is leveling the playing field and connecting developers, service providers, and players with profit — and reduced latency — for all. Consider this the missing link between investors and the gaming industry.
A miner reports better earnings than expected and meets its guidance for the third year in a row, Adrian Day of Global Analyst reports.
Shares of Meritor Inc. traded 45% higher after the company reported it entered into an agreement to be acquired by Cummins Inc. for $36.50 per share in cash.
Clive Maund reviews a range of copper stocks that are believed to be at good entry points.
QC Copper & Gold is a well-capitalized junior expanding its Quebec based resource and has recently found extensive additional mineralization on its property.
With robust economics projected for it, the project is likely to attract prospective financing or joint venture partners, noted a Fundamental Research Corp. report.
Shares of a health care professional staffing and services company traded 12% higher after the company reported Q4/21 financial results that included a 116% YoY increase in revenue and a 1,149% YoY increase in net income.
A Canadian explorer encounters oxide gold mineralization at all four holes drilled at its Nevada property, with more drill results expected within the next few weeks.
A Canadian exploration and development company reports that initial assays from its inaugural 10,000 meter drill program at a site in Nevada indicate extremely positive results.
Whereas U.S. multistate cannabis operators are expected to do well in 2022, federal legalization of cannabis would give a jolt to companies of all sizes, noted a ROTH Capital Partners report.
Shares of this pharmaceutical company traded 16% higher after it reported positive interim data from its long-term extension study of a treatment for obesity and hyperphagia in patients with Bardet-Biedl Syndrome (BBS).
An Asia Pacific-focused junior explorer breaks out of a bull pennant and marks the start of the next upleg in its stock, analyst Clive Maund says.
A Preliminary Economic Assessment has confirmed the viability of this company's flagship copper asset in Chile.
Adrian Day reviews two of the high-yielding stocks on his list; he notes that both are boosting distributions and are good long-term holdings for income-oriented investors.
Shares of a wireless mobile dialysis equipment maker traded 15% higher after the company reported FY/21 financial results highlighting a 105% YoY increase in revenue to $102.6 million.
The supply-demand characteristics for copper are very bullish and prices are in a strong up trend. There has been over a decade of underinvestment in the mining sector and as a result it will be many years to bring on any significant new production. Element 29 has two advanced projects in Peru and Midnight Sum Mining has a new discovery in Zambia that has attracted Rio Tinto as a partner.
Chris Temple of The National Investor explains why he has issued a speculative buy recommendation for BioLargo, a small-cap company with a flagship product that removes certain contaminants from water.
Generac Holdings shares traded 14% higher after the firm reported Q4/21 and FY/21 financial results featuring a 40% YoY increase in net sales and advised that it estimates FY/22 sales will rise further by 32-36%.
Technical analyst Clive Maund takes a look at this alt energy co.'s charts and rates it an immediate speculative buy.
Technical analyst Clive Maund charts this mineral exploration company and explains why he sees the stock as a strong speculative buy.
Streetwise Reports talks to Legible.com founder and CEO Kaleeg Hainsworth about the company's innovative browser-first and device-agnostic book entertainment platform for readers and publishers. As Hainsworth told Streetwise in a recent interview, "We allow people to read when, where, and how they want."
In a recent interview with Streetwise Reports, Cybin Inc.'s General and IP Counsel Robert Mino explained the company's position at the forefront of mental health treatment via psychedelics. "This sector has the potential to improve the human condition on a massive scale."
Jericho Energy Ventures branches out to support two North American-based food companies reduce their energy footprints with the company's groundbreaking zero-emission DCC hydrogen boiler solution.
Adrian Day of Global Analyst looks at Vista Gold's long-awaited feasibility study on its Australian gold project, and provides updates on a couple of other companies on his list.
Headed into a gold bull market, one should consider swinging for the fences with high risk / high reward junior miners like St. Anthony Gold with two projects in Ontario. Its flagship project could comfortably host 1M+ ounces of gold, perhaps at a grade of 4-6 g/t — yet the market cap is under CA$3M.
Michael Ballanger looks at the recent rise in the gold price in light of what is happening in the broader markets and geopolitical activity.
It wasn't all that long ago that BacTech Environmental Corp. found it an ordeal to raise money, but Chris Temple of The National Investor says those times have changed.
Shares of Tower Semiconductor Ltd. traded 42% higher after the company reported it entered into a definitive agreement to be acquired by Intel Corp. in an all-cash transaction for $53.00 per share.
Cabral Gold Inc., in the midst of a 25,000 meter drill program at its Cuiú Cuiú gold project in Brazil, continues to release outstanding drill results almost weekly.
Minable gold deposits are often found near where other discoveries have been made. It’s just a matter of time, money, and opportunity. One junior explorer has checked off all those boxes and already has a significant discovery in an old camp.
A Canadian company is hoping that its bugs that eat rocks can help clean up the mining industry. BacTech Environmental Corp.'s bioleaching technology could make it possible to work with lower-grade ores.
In the Feb. 10 episode of Streetwise Live!, Host Cyndi Edwards interviews two medical experts who discuss the need for a new stroke treatment, explain why today's stroke treatments are so limited and express their excitement around what Algernon Pharmaceuticals is testing with DMT.
White Gold Corp. released positive assay results from follow-up diamond drilling at its Ulli's Ridge target located at its 420,000 ha property in Yukon, Canada. The firm highlighted that drill hole WHTULR21D004 intersected 19.5 m of 6.5 g/t Au, which included 1.5 m of 39.1 g/t Au. Stifel Nicolaus Canada Inc. commented in a research note that the company is significantly undervalued and that this latest set of drill results may have a positive impact on the company's share price.
NevGold is excited by the first intercepts returned from its maiden drill program at Limousine Butte in Nevada's Carlin Trend.
Fabled Silver Gold Corp. expected to find more silver resources drilling on its Santa Maria property in Mexico. But one hole gave the company results it didn't expect.
Ecolomondo Corp. has developed proprietary technologies for transforming hydrocarbon waste such as tires, rubber, and plastics into renewable commodity products.
Bloom Energy Corp. shares traded 8% higher after the company reported Q4/21 and FY/21 financial results that included a 37.3% YoY increase in Q4/21 revenue. The company expects that revenue will continue to grow by 30-35% annually over the next 10 years.
Peter Epstein of Epstein Research shares his thoughts on why "cashed-up" Allied Copper is a Cu company to watch.
Adrian Day of Global Analyst looks at the mostly favorable developments at some of the companies on his list, but also at the farce playing out in Mexico.
Shares of Peabody Energy Corp. rose by 10% after the leading U.S. coal producer reported Q4/21 and FY/21 financial results that included a 72% YoY increase in Q4/21 revenue.
AlphaNorth Asset Management was recently recognized with multiple performance awards at the 2021 Alternative IQ Canadian Hedge Fund Awards. The AlphaNorth Partners Fund won first place for its five-year annualized return gaining 40.35% for the period. The fund also placed second for its three-year return and third for its one-year return. Streetwise Reports sat down with CIO Steven Palmer to discuss some of the firm's recent investments and emerging opportunities for 2022.
Streetwise sat down with Michael Wood, CEO of Reyna Gold, to learn more about its sampling program at La Gloria, which returned 93.9 grams/tonne and 36.2 grams/tonne gold samples.
White Gold Corp. has put together an impressive portfolio of over 21,000 quartz claims and now owns claims encompassing more than 40% of the Yukon White Gold District. The company has already succeeded in verifying gold resources of nearly two million ounces and is heavily backed by two major gold producers. In the coming weeks, the firm is expected to announce additional assay results from diamond drilling conducted during Q4/21 at two of its newest promising targets.
Allied Copper, in line with its mission to acquire and develop scalable copper assets in the Western U.S., successfully obtained the option to acquire the prospective Klondike copper-silver property in Colorado.
In Citi's Jan. 25, 2022 Psychedelic Call Series broadcast, Novamind CEO Yaron Conforti and Chief Medical Officer Dr. Reid Robison discussed how the company is increasing people's access to psychedelic therapies for mental health disorders.
Analyst Clive Maund says the outlook on White Gold Corp. remains very positive after a dip in recent weeks.
Doximity Inc. shares traded 25% higher after the digital medical platform provider used by 80% of all physicians in the U.S. reported Q3/22 financial results that included a 67% YoY increase in revenue.
After raising $4 million, Heliostar Metals is now drilling 5,000 meters in Mexico with the first results anticipated in late February.
In a phase 2 clinical study, Todos Medical's oral antiviral Tollovir showed a 100% reduction in mortality from COVID-19.
The Critical Investor discusses the first assays being reported by Blue Sky Uranium regarding the Ivana Main target, part of their district scale Amarillo Grande uranium/vanadium project in Argentina.
Every time a podcaster with the most internet views comes out with a new narrative on the Fed's current predicament, 800 clones descend upon the YouTube galaxy and that narrative suddenly goes viral, Michael Ballanger says.
Shares of Tritium Dcfc Ltd. traded 35% higher after the company reported it plans to open a new electric vehicle fast charger manufacturing facility in Tennessee.
Algernon Pharmaceuticals plans to be the world's first company to test the psychedelic drug DMT in stroke patients, and it's close to achieving its goal.
Over the past decade, Red Lake, Ontario didn’t get the recognition it deserves for its gold production and exploration. That’s changing thanks to several new discoveries and a high-profile acquisition.
Tyson Foods Inc. shares traded to a new 52-week high after the refrigerated and frozen meat products company reported Q1/22 financial results that included a nearly 20% increase total revenue.
Desert Mountain Energy expects to be in helium production within six months and be robustly cash flow positive from 2023 on.
Bob Moriarty of 321 Gold discusses the "one game in town" which is gold, silver and resource stocks. Pluck them from the tree while they are still low hanging.
Bob Moriarty of 321 Gold discusses Secova Metals' interesting business model for reprocessing tailing piles from past production mines.
Shares of Snap Inc. traded 62% higher after the camera and social media company reported FY/21 financial results that included a 64% YoY increase in revenue.
Drug re-purposing co. Algernon Pharmaceuticals Inc. is actively reinventing itself. The firm's leading therapeutic candidate NP-120 (Ifenprodil) is currently being evaluated in a Phase 2 trial for IPF and chronic cough, and the company is now moving forward with a revolutionary new use for DMT to treat ischemic stroke.
As the January Barometer registers a definitive “sell,” Michael Ballanger discusses his ”Trade of the Year 2022.”
Shares of Modine Manufacturing Co. traded 16% higher after the company reported Q3/22 financial results and reaffirmed its full-year sales and adjusted EBITDA outlook for FY/22.
Allegheny Technologies Inc. shares traded 17% higher after the company reported Q4/21 financial results that included a 16% YoY increase in sales to $765.4 million.
Technical Analyst Clive Maund examines the charts for the Market Vectors Gold Miners ETF, code GDX, and sees good cause to be positive about gold's future outlook.
Puma Exploration's acquisition of 30 claims over 662 hectares increases its foothold in an emerging gold district in New Brunswick.
With this work, Allied Copper is exploring the north and south portions of its SK copper-gold project in Nevada in advance of drilling.
Arianne Phosphate has a globally-significant, advanced-stage phosphate rock project in Quebec, Canada, that's very undervalued, with huge catalysts coming in 2022, Peter Epstein of Epstein Research writes.
New drill results from Goldshore Resources' Moss Lake Project confirm the Main and QES zones encompass wide zones of 1-plus grams per ton gold mineralization.
It seems Avrupa Minerals has finally hit at its Sesmarias North target. The Critical Investor discusses the results with CEO Paul Kuhn.
In an article for Streetwise Reports, Penny Queen explains how environmental engineering company, BioLargo Inc., is on track to "make shareholders' portfolios better."
Shares of United Parcel Service Inc. traded 13.5% higher establishing a new 52-week high after the company reported Q4/21 financial results that included a 15% YoY increase in consolidated revenue and raised its quarterly dividend by 49% to $1.52/share.
Adrian Day looks at companies that have made recent acquisitions and whether you should add them to your portfolio.
With its new processing plant at the Juanicipio project in Mexico, MAG Silver is moving toward being a producer. But its president and CEO says it won't forget its explorer DNA.
Provenance Gold has two potential multimillion ounce bulk tonnage gold projects in Nevada and Oregon.
Shares of Provention Bio Inc. traded 29% higher after the company reported that following its Type B meeting and conversations with the U.S. FDA, it is now planning to resubmit a Biologics License Application for delay of clinical type 1 diabetes in at-risk individuals.
Bob Moriarty of 321 Gold explains why he is a believer in Scottie Resources, which owns 52,000 ha of prime ground in British Columbia's Golden Triangle.
ProMIS Neurosciences appointed to its science advisory board Canada-based Dr. Cheryl Wellington, professor, neuroscientist and head of a globally recognized neuro research program.
During Streetwise Live! on Jan. 27, 2022, representatives of Algernon Pharmaceuticals discussed the use of the psychedelic DMT in stroke sufferers. On the broadcast were Algernon CEO Christopher Moreau and consultants to the firm, Dr. David Nutt and Dr. Rick Strassman.
Todos Medical has closed a Phase 2 trial of its antiviral 3CL protease inhibitor Tollovir after getting positive interim data.
Shares of Insulet Corp. traded 15% higher after the company reported its Omnipod® 5 automated insulin delivery system has received clearance from the U.S. FDA. The Omnipod® 5 is the first tubeless system to be monitored and controlled remotely using a smartphone.
The Critical Investor is looking into Aztec Minerals, which is aiming to delineate two oxide deposits in Mexico and Arizona, both with large scale porphyry/CRD potential at depth.
Shares of hard drive storage maker Seagate Technology Holdings Plc. traded 8% higher after the company reported Q2/22 financial results that featured 39% YoY increase in free cash flow.
Forward Water Technologies Corp. is exploring applications for its forward osmosis water technology in the lithium extraction industry.
Corning Inc. shares traded 11% higher after the company reported Q4/21 and FY/21 financial results highlighting a 23% YoY increase in core sales.
Lion One Metals' infill drilling at its Tuvatu gold project in Fiji, in an area earmarked for early production, has defined "exceptionally high-grade mineralization."
Vancouver-based junior Barsele Minerals Corp. is taking the rare step of trying to buy out its major partner, Agnico Eagle Mines Ltd.
Technical Analyst Clive Maund dissects Lion One's stock chart and explains why he sees this to be a "great buy spot" for the company's stock.
Algernon Pharmaceuticals Inc. has included novel salt forms of a psychedelic drug being investigated to combat strokes in its intellectual property applications.
Michael Ballanger discusses whether gold and silver (and their equities) will decouple from correlation with the broad stock market.
Zacapa Resources will complete its initial public offering and be listed on the TSX Venture Exchange on Jan. 26.
With this impending program, Newrange Gold will drill test priority targets at its North Birch and Argosy projects northeast of Ontario's Red Lake.
Shares of Sierra Oncology Inc. traded 48% higher after the company reported that topline data obtained during its Pivotal Phase 3 MOMENTUM Myelofibrosis Study showed that its momelotinib produced statistically significant improvements in anemia and splenic size.
Bob Moriarty of 321 Gold explains why he is an investor in Reyna Gold, an explorer with projects in northern Mexico that began publicly trading earlier this month.
OOOOO Entertainment Commerce and QVC Italia debut likeQ, their new interactive livestream shopping app in Italy.
Red Metal Resources plans a 2,000 meter diamond drill plan, testing two sets of targets shown, via previous exploration efforts, to be prospective.
Todos Medical is set to take on the dominant players in oral antivirals for mild to moderate COVID-19, Pfizer Inc. and Merck & Co. Inc., with "strong data" expected to be released soon for its drug Tollovir.
Shares of full-service oil & gas solutions provider Exterran Corp. traded 60% higher after the company reported it agreed to be acquired by Enerflex Ltd. of Canada in an all-stock transaction for US$735 million.
Adrian Day reviews updates from several resource companies and discusses whether this is the time to load up.
Shares of Limelight Networks Inc. traded nearly 14% higher last Friday after the digital media content platform operator reported record Q4/21 financial results and advised that it expects the strong upward momentum to continue in FY/22.
Solar is back. A 10-year chart of the Invesco Solar ETF (TAN) of solar-based stocks shows the surge in price and volume. This pull-back in the sector provides a buying opportunity.
Several events slated to happen this year could boost Algernon Pharmaceuticals' share price, noted an AlphaNorth Partners Fund performance report.
After acquiring the W2 Copper-Nickel-PGE project in Ontario, Platinex adopted a new dual strategy by going back to its roots, which involved platinum group elements (PGE), but is also in the process of revitalizing its large and prospective Shining Tree gold exploration project in the Abitibi Greenstone Belt, also in Ontario, writes The Critical Investor.
Bob Moriarty of 321gold discusses the high-grade drill results Eskay Mining just released from its summer exploration program at its project in British Columbia's Golden Triangle.
Shares of Luminar Technologies Inc. traded 11.5% higher after the company reported it formed a collaborative partnership to integrate its enhanced safety and autonomy technology in the production of Mercedes-Benz passenger vehicles.
Michael Ballanger delves into inflation, the Fed's actions, and how they affect precious metals investing.
PennyQueen explains why you should care about Jericho Energy Ventures Inc.'s announcement that it has led the investment into a company developing a new class of hydrogen electrolyzer.
Adrian Day of Global Analyst takes a look at the macro picture in light of Fed Chairman Jerome Powell's more hawkish comments last week and also reviews recent developments at some companies on his list.
Jericho Energy Ventures' latest foray into the burgeoning hydrogen energy market is as the lead seed capital investor in a company with disruptive electrolyzer technology.
Shares of Zogenix Inc. rose by 66% after the company reported it entered into an agreement to be acquired by UCB. S.A. of Belgium for $26.00 per share in cash. The offer includes the potential for an additional $2.00 per share if a specific drug approval milestone is met.
PennyQueen explains why she thinks this uranium explorer is a great pick and why the metal should have an especially auspicious season.
Shares of Activision Blizzard Inc. traded 26% higher after the developer and publisher of World of Warcraft® and Call of Duty® reported it agreed to be acquired by Microsoft Inc. for $95 per share in cash.
Political unrest in Kazakhstan and a buildup of stockpiles is leading to tightened demand and opportunities for growth in uranium, according to an industry report.
With two strong projects in a Tier One jurisdiction and experienced management and geological teams, Metals Creek Resources Ltd. could be ready for a breakout.
Algernon Pharmaceuticals is a clinical-stage, small biotech that boasts a massive pipeline of lower risk and efficient drugs. Catalysts abound with this genius repurposing company.
Following a severe downtrend, charts show Jericho Energy Ventures Inc. could be about to take off, analyst Clive Maund says.
The Critical Investor discusses the latest developments for Blue Sky Uranium with CEO Niko Cacos, as a new drill program at Ivana has commenced, and the company has won a lawsuit.
If your neighbors sell their house, the sale price will tell you a lot about the value of your home. In British Columbia’s Golden Triangle, companies with mines and well-defined resource development plans are getting taken out and the remaining players — and their investors — can see the favorable writing on the wall.
After semiconductor sales shattered records in 2021 amid an ongoing supply shortage, chip manufacturers are forecasting another year of growth in 2022. An overwhelming digital transformation is expected to ramp up this year across multiple industries, which could subsequently bring over half a trillion dollars to the semiconductor industry, writes McAlinden Research Partners.
The Critical Investor provides a quick update about Argentina Lithium, after they announced the acquisition of more lithium projects, on the back of a C$6M raise. All this when lithium product prices are breaking record after record.
After Kenorland Minerals announced its latest batch of drill results, the Critical Investor took the opportunity to do an extensive interview with CEO Zach Flood to discuss results, programs, strategy, and projects for 2022.
Shares of leading homebuilder KB Home rose 16% after the company reported Q4/21 and FY/21 financial results that included substantial increases in revenues and margins fueled by rising sales prices and demand for new homes nationwide.
Michael Sheikh explains what makes Guanajuato Silver Co. a unique opportunity and takes a look at five other companies that caught his eye.
Sector expert Michael Ballanger finds himself at an investing crossroads. Find out what his top picks are for 2022.
Bob Moriarty of 321Gold shares his thoughts on Goliath Resources' outstanding drill results, which they just announced on Tuesday.
In this update, Adrian Day discusses some recent developments that occurred over the holidays, or otherwise got lost in the shuffle.
Shares of new class synthetic vaccine developer Vaxxinity Inc. traded 23% higher after the company reported it has dosed the first patient in its Phase 1b UB-312 Parkinson's disease study.
Newrange Gold Corp. is expanding its search for precious minerals from one project to three in 2022 and looking at the big picture at its flagship operation in Nevada.
Mijem Newcomm Tech is going public to capitalize on the cryptocurrencies trend, given it now rewards users of its marketplace app with Bitcoin SV.
With the accelerating involvement of government in the day-to-day behavior of all markets, it's a near-impossibility to forecast what will happen in 2022, Michael Ballanger says.
Reyna Gold, approved for listing on Toronto's Venture Exchange, finds high-grade gold in samples from La Gloria that highlight the project's potential.
Accolade Inc. shares rose 27% after the company reported Q3/22 financial results that included a 117% increase in YoY revenue. The firm highlighted that in calendar year 2021, its membership increased four-fold from 2 million to 10 million.
Social gamer Zynga traded 40% higher after the company agreed to be acquired by Take-Two Interactive Inc. in a combination stock and cash transaction for $9.861 per share.
The Critical Investor was asked again by Streetwise Reports to provide his top 7 picks for the new year — at a point where the COVID-19 pandemic is playing out the Omicron variant, inflation is reaching levels not seen in decades, the Fed surprising the markets with a more hawkish stance than anticipated, with metal prices at very high levels although gold and silver seem to be consolidating and setting up for a breakout.
Shares of Absci Corp. rose 18% after the company reported it is collaborating with Merck & Co. to create enzymes using its deep-learning Integrated Drug Creation™ platform and Bionic Protein™ technologies.
E-commerce customer acquisition solutions company Logiq Inc. plans to separate into two publicly traded companies this month, President and Executive Chairman Brent Suen says.
Shares of Vocera Communications Inc. traded nearly 27% higher after the company reported it entered into a definitive agreement to be acquired by Stryker Corp. for $79.25 per share in cash.
Analyst Clive Maund says Kainantu Resources Ltd.'s stock could take off if it makes a discovery at its properties in Papua New Guinea.
In a recent interview with Streetwise Reports, family assets manager and contributing writer, Chen Lin, shared the six (mostly mid-cap) companies that are his top investment picks for 2022.
Edgewise Therapeutics shares traded 24% higher after the company reported its EDG-5506 significantly lowered muscle damage biomarkers in adults after just two weeks of dosing in its Becker muscular dystrophy trial.
Shares of land-focused oil services firm NexTier Oilfield Solutions Inc. traded 27% higher after the company reported it expects Q4/21 revenues will be in the range of $500-510 million and advised that its 32-unit fracking rig fleet will be fully deployed in Q1/22.
Skyharbour Resources Ltd. has staked six new prospective uranium exploration properties within and near the Athabasca Basin of northern Saskatchewan, which contains the world’s highest-grade uranium deposits.
Imperial Helium’s second, future-producing helium well was spud on Dec. 6, 2021, amidst constrained global helium supply. The outlook is good for 2022.
Shares of Genprex Inc. traded 165% higher after the company reported the U.S. FDA has awarded Fast Track Designation for its REQORSA™ Immunogene Therapy for use in combination with Merck & Co.'s Keytruda® for non-small cell lung cancer treatment.
Sitka Gold Corp's recently released new drill results at its RC Gold Project in the Yukon have grabbed investors' attention.
Canadian company Algernon Pharmaceuticals Inc. has applied to uplist to the Nasdaq in hopes of attracting U.S. investors to its mission to repurpose drugs.
Although Gerald Panneton was already guiding Gold Terra as an Executive Chairman, it seems likely after this restructuring he will have full control being a Chairman and CEO effective January 1st, 2022. As he was used to be thinking big at Detour, the Critical Investor expects more of the same here.
On any given business day, results from a drill hole can turn a Wednesday into Christmas Day for shareholders. We take a look at what experts think are the best drill holes of 2021.
In a year-end bulletin, Adrian Day gives a brief reminder of the fundamental reason for each stock in his portfolio, as well as to note the largest downside or risk for each.
After a year of slow progress for Avrupa Minerals, management decided to create more opportunities by acquiring four exploration properties in Finland.
In the Dec. 22 episode of Streetwise Live!, influential uranium investor Terry Papineau tells why he believes now is the right time to invest in the uranium sector and, specifically, in Baselode Energy. Its CEO James Sykes discusses the company's new high-grade discovery and its work plan for 2022.
Bob Moriarty of 321Gold says that for astute investors, Silver Dollar Resources Inc. is a good bet into February regardless of what the rest of the market does.
What differentiates NaturalShrimp is its proprietary technology that allows it to "produce recirculating aquaculture system-raised shrimp at a sufficient density for mass production," noted a ROTH Capital Partners report.
Chris Temple, editor and publisher of The National Investor, explains Omineca Mining & Metals' almost 50% increase and why his rationale for his initial recommendation of Omineca remains unchanged.
Nikola Corp. shares traded higher after the firm reported that Heniff Transportation Systems LLC signed a letter of intent to purchase 100 zero-emission trucks from Thompson Truck Center and Nikola.
Near Quesnel, B.C., a small Canadian company is about to take placer gold mining public. It’s been a long road, but it looks like British Columbia’s Cariboo region could see another gold rush more than 160 years after the first.
Industry observer Michael Ballanger explains why he has Western Uranium and Vanadium Corp. on his buy list.
Micron Technology Inc. shares traded 11% higher after the company reported Q1/22 financial results and stated that it was on a path toward record revenue and solid profitability in FY/22.
Precious metals expert Michael Ballanger remembers lessons learned years ago from a three-year course in "Stocks and Bonds 101," and how those principles still apply today.
Intra-Cellular Therapies Inc. shares traded 19% higher to a new 52-week high after the company reported the U.S. FDA has approved the use of its CAPLYTA® (lumateperone) for treatment of adults with bipolar depression.
After Dolly Varden Silver announced the transaction with Fury Gold Mines regarding the Homestake Ridge Project, the Critical Investor looked into future potential coming from combining Homestake with the Dolly Varden Project, and exploration potential.
Shares of Bottomline Technologies Inc. traded 15% higher after the company reported it agreed to be acquired by private equity firm Thoma Bravo for $57.00 per share in cash.
Alico "offers a compelling opportunity" given expectations for increased production and pricing and continued dividends paid to shareholders, noted a ROTH Capital Partners report.
In this Dec. 15 episode of Streetwise Live! viewers learned about Datable Technology, what it does, why it is a compelling story and why two former Disney executives invested in it. They, Mike Ridgewell and Marc Reintjes, were on the panel along with Datable Chairman Kim Oishi and eResearch analyst Chris Thompson.
Just in time for Christmas, one junior explorer drilling off concessions in a historic silver camp in Mexico is spinning its copper assets into a red metal play in northern British Columbia; and it just announced positive new drill results at its Mexico project.
The Critical Investor catches up with CEO Jason Weber of Alianza Minerals about the company's latest endeavors with Cloudbreak Discovery and the status of their other projects.
Shares of Calliditas Therapeutics AB traded higher after the company reported the U.S. FDA granted accelerated approval for its TARPEYO™ (budesonide) to reduce proteinuria in IgA nephropathy.
With the recently earned-in ownership of 51% in the Independence Gold project, the PEA coming up and potentially a much more important catalyst in Q1 2022, the Critical Investor felt it was time to conduct an interview with CEO Christos Doulis.
CMC Materials Inc. shares traded 33% higher after the semiconductor materials company reported it agreed to be acquired by Entegris Inc. in a combination cash and stock deal valued at approximately $6.5 billion.
Critical and precious metals explorer Aurania Resources Ltd. is methodically moving forward with is exploration program at its Lost Cities-Cutucu Project which has been shown to host significant amounts of zinc, copper, silver and other elements. Noble Capital Markets advised that the firm plans to begin exploration work at its Awacha target site in mid-December and is building momentum as it moves into 2022.
Nevada Exploration Inc. is looking to another local company to help shoulder the risk of gold exploration in the Silver State.
Terminix Global Holdings Inc. shares traded 18% higher after the company reported it has entered into a definitive agreement to be acquired by Rentokil Initial Plc. in a cash and stock transaction valued at US$6.7 billion, or about US$55/share.
Omineca Mining and Metals will focus on the placer gold component of the Wingdam project throughout 2021 then next year also take on exploring the newly identified hardrock gold targets there, a Research Capital Corporation report noted.
Vancouver-based software and technology company Datable Technology Corp. is helping consumer packaged goods companies collect data from consumers who opt-in to their apps, promotions, contests, and loyalty programs. eResearch Corp. indicated that it is initiating coverage of the company with a "Speculative Buy" rating as it is now in the midst of a rapid revenue growth cycle.
Adrian Day, in the Global Analyst newsletter, updates recent results and developments at several companies, large and small, with some current buys among them.
Arena Pharmaceuticals shares traded 80% higher after the company reported it agreed to be acquired by Pfizer Inc. for $100.00 per share in cash in a deal valued at $6.7 billion.
Bob Moriarty of 321Gold shares his thoughts on Thesis Gold Inc.'s latest promising drill results at its Ranch Gold property in British Columbia.
Shares of global cloud infrastructure and enterprise software firm Oracle Corp. traded 16% higher after the company reported Q2/22 financial results that exceeded prior revenue guidance and non-GAAP earnings estimates.
In part two of a two-part series, Streetwise shares more insight from White Gold CEO and Director David D'Onofrio about the company's new and exciting discoveries that include the Betty property, which intercepted 3.46 g/t Au over 50m on its maiden diamond drilling program this year, and the Ryan’s Surprise/Ulli’s Ridge district.
As Metallic Minerals wraps up its exciting programs in the Keno Hill silver district, CEO and Chairman Greg Johnson explains why the future looks bright for silver.
Checkpoint Therapeutics' "cosibelimab represents a competitive asset on both efficacy and safety with an expected added advantage of lower net price," an H.C. Wainwright & Co. report noted.
The market may need time to account for Kinross Gold's acquisition given Dixie's early, preresource stage despite the asset's seemingly large size potential, a Stifel GMP report noted.
"Silver X marks the spot in the junior silver producer sector with the Nueva Recuperada project," noted an Echelon Capital Markets report. "We see the current valuation as a potentially rewarding risk-return proposition."
A recent Haywood Securities industry report highlights the value proposition helium offers and discusses several helium pure plays that are positioned to take advantage of strong demand growth for the gas.
White Gold Corp. continues to deliver a steady flow of highly positive drill results and new discoveries at its 420,000 ha White Gold District property near Dawson City, Yukon. The Company has teamed up with two renowned gold producers that see vast potential in the district scale property and have made significant equity investments in the company. Analysts who cover the company believe that the firm is greatly undervalued and have issued "Buy" ratings and price targets that are far above the firm's current share price. Read part one of our two-part series.
Digital Prime Technologies reported that an affiliate of Cowen Inc. has completed a strategic investment in the company. Cowen plans to use Digital Prime's software to expand its prime brokerage capabilities in the digital asset sector to meet the rising demand from institutional clients.
PennyQueen, an investor and stock market social media community builder who focuses mostly on clean tech, explains why she has invested in this energy company and recommends it to her social media following.
Dolly Varden Silver Corp. is positioning shareholders to have a commanding position on the southern tip of the Golden Triangle by acquiring the Homestake Ridge from Fury Gold Mines, along the Kitsault Valley Trend. The proposed amalgamation will position Dolly Varden Silver second to none in terms of size meets grade in precious metals.
Shares of Great Bear Resources Ltd. traded 24% higher after the company reported it entered into a definitive agreement to be acquired by Kinross Gold for CA$1.8 billion. Existing Great Bear shareholders will be given the option of receiving CA$29.00 per share in cash, shares in Kinross or a pro-rata combination of both, plus a contingent value right.
Bob Moriarty of 321Gold shares his thoughts on his 18 years of experience with Pacific Ridge Exploration Ltd. and its current projects in British Colombia, Canada.
Humanigen has applications for lenzilumab in the works with U.S., United Kingdom and European drug regulatory agencies, noted a ROTH Capital Partners report.
Shares of contract research organization Inotiv Inc. traded higher after the company reported select preliminary unaudited financial results for Q4/21 and FY/21 which included a 90.7% YoY increase in revenue and a 123.0% increase in gross profit.
More than 80% of the supply of rare earth elements needed to make phones, laptops, laser-guided drones, and tech-heavy weapons is controlled by China. One North American-based explorer could challenge that dominance, according to a recently published preliminary economic assessment.
Harmony Biosciences Holdings intends to conduct a Phase Three trial next year to evaluate Wakix as a treatment for idiopathic hypersomnia, according to an Oppenheimer report.
"Silver X is one of the best positioned emerging junior silver producers in the market, with tremendous growth potential," noted a Red Cloud Securities report.
Shares of pet healthcare insurer Trupanion Inc. reached a new 52-week high after the company reported it is teaming up with Chewy Inc. to offer an exclusive line of pet wellness and health insurance products to Chewy's 20,000,000 customers.
Bob Moriarty of 321 Gold shares his thoughts on Dolly Varden Silver Corp.'s Dec. 6 news of its planned acquisition of the Homestake Ridge gold/silver project from Fury Gold Mines Ltd.
In a Streetwise Live! Broadcast on Dec. 6, 2021, Stifel analyst Stephen Soock noted why now is a good time to invest in gold and, specifically, in White Gold Corp. Two of the companies' executives, David D'Onofrio, CEO, and Shawn Ryan, co-founder and technical adviser, shared what differentiates this exploration company from others and what it offers investors.
White Gold Corp. will use an investment of CA$9 million through strategic partner and investor Agnico Eagle Mines Ltd. for working capital and general corporate purposes. But the transaction has another benefit: It gives White Gold access to a tremendous level of expertise across all areas of mining.
Sensus Healthcare's "needle-free treatment presents a clear competitive advantage in the aesthetic dermatology space," an H.C. Wainwright & Co. report noted.
New clinical trials for G1 Therapeutics’ Cosela are “central to our investment thesis,” H.C. Wainright & Co. noted in a new research report.
"Solid tumors offers a substantial opportunity for Karyopharm Therapeutics' Xpovio (selinexor) that perhaps investors have not yet realized," noted an H.C. Wainwright & Co. report.
Adicet Bio Inc. shares traded 37% higher after the company reported positive interim data from its Phase 1 GLEAN Study of ADI-001, which the firm noted is the first-ever allogeneic, off-the-shelf, gamma delta CAR T investigational cell therapy.
Adrian Day, in the Global Analyst newsletter, reviews developments at several companies, three of his favorite large miners and one favorite junior, all of which he says are at very compelling levels to buy.
Precious metals expert Michael Ballanger discusses Fed actions and how they affect precious metals.
Shares of Marvell Technology established a new 52-week high after the infrastructure semiconductor solutions firm reported Q3/22 financial results than included a 61% increase in YoY revenue.
Gaming is an estimated $192 billion market, and it is forecasted to grow to almost $400 billion by 2026. Sophic Capital makes the case that telcos need to evolve from being utilities to offering gaming services to attract and keep Gen-Z subscribers.
Legible Inc. began trading on the Canadian Stock Exchange under the ticker symbol READ after a three-way amalgamation closed.
Golden Sky Minerals Corp.'s stock rose almost 20% on volume exceeding 43,000 shares in intraday trading on the strength of drill reports on a Yukon property.
The Critical Investor discusses the benefits of the recently acquired Con Mine with Gold Terra Executive Chairman Gerald Panneton.
Ambarella Inc. shares traded nearly 20% higher after the company reported Q3/22 financial results that included a 64% increase in YoY revenue together with higher gross margins.
ImmunoGen Inc. shares traded 30% higher after the company announced positive topline data from its pivotal Phase 3 SORAYA Trial of mirvetuximab soravtansine in platinum-resistant ovarian cancer.
PennyQueen, an investor and stock market social media community builder who focuses mostly on clean tech, explains why she has invested in this uranium company and recommended it to her social media following.
Bob Moriarty of 321 Gold profiles Aurania Resources and explains why he believes its stock is attractively priced right now.
Oramed Pharmaceuticals' oral vaccine offers "convenience and safety advantages as well as coverage of emergent variant strains," noted a Nov. 29, 2021 H.C. Wainwright & Co. report.
Just a few days after the WHO deemed the COVID-19 Omicron variant a serious global health concern, leading mRNA-based vaccine developers BioNTech and Pfizer, along with rival Moderna, advised that if needed, the companies would be capable of developing a vaccine for the new mutating strains within roughly 100 days. H.C. Wainwright & Co. commented in a research note that it reiterates its "Buy" rating for BioNTech SE.
Argentina Lithium seems to be making the most of the ongoing lithium frenzy by battery producers, raising sufficient capital to fund exploration for their Argentinian lithium projects, scheduled for next quarter.
Vox Royalty is completing a banner year on its royalty portfolio, executing its royalty acquisition strategy, as the company now is on the cusp of having five producing royalty assets.
Metallic Minerals has just completed its most expansive drill program on the flagship ultra high-grade Keno Silver Project, located in the prolific Keno Silver District. In addition, the company has updates on the La Plata gold-silver-copper project, and the Klondike Alluvial Gold Projects.
Shares of NRx Pharmaceuticals Inc. traded 50% higher after the company commented on new data released by the Israel Institute for Biological Research regarding the effectiveness of its BriLife® COVID-19 Vaccine against the SARS-CoV-2 "Delta" variant.
Phenom Resources' new drill results at its Carlin asset showed features of a Carlin-type system, but the grades were low, a Red Cloud Securities report noted.
Shares of Krystal Biotech Inc. reached a new 52-week high after the company reported it met both primary and secondary endpoints in its pivotal GEM-3 trial of VYJUVEK™ in patients diagnosed with Dystrophic Epidermolysis Bullosa, a rare and severe skin disease.
Standard Lithium had a remarkable week, as it got struck by a short selling report on November 18, and announced a US$100M investment by Koch Strategic Platforms on November 24. At the same time, lithium product prices don't seem to be slowing down anytime soon and set another record.
Bob Moriarty of 321Gold discusses Defense Metals' recent PEA and explains why this company is important for the Western EV market.
The Consortium just received government funding for a pilot project in a Scottish Distillery, enabling the switch from fuel oil to sustainable hydrogen energy technology. Jericho Energy Venture’s revolutionary, clean-tech hydrogen boiler is critical to the project.
Standard Lithium Ltd.'s shares rose 22% after the firm reported that a Koch Investments Group subsidiary has agreed to make a strategic investment in the company of CA$127.07 million via a direct private placement.
BioResearchAlert looks at Usha Resources as it looks to begin drilling at the Lost Basin Gold-Copper Project.
Adrian Day, in the Global Analyst newsletter, discusses Franco-Nevada's diversification of royalty assets, as well as providing updates on other precious metals companies he follows, including one strong buy.
Precious metals expert Michael Ballanger takes a look at the markets and homes in on one company in particular.
With most of the easy to find mineral deposits already uncovered, KoBold, Azincourt Energy, and Fobi are turning to artificial intelligence to guide exploration. While KoBold is privately held — by the likes of Bill Gates and Jeff Bezos — Azincourt Energy and Fobi offer investors with more modest portfolios access to AI-based exploration.
Streetwise recently caught up with Peter Flindell, Vice President of Exploration, to discuss the pending offering and Goldshore's plans for the funds.
Vonage Holdings Corp. shares traded 27% higher after the company reported it entered into an agreement to be acquired by L.M. Ericsson in an all-cash deal for $21.00 per share.
Argentina Lithium & Energy’s V.P of Exploration Miles Rideout has a plan to meet surging global demand from the battery sector.
Silver Wolf Exploration will be conducting the first modern exploration program on the project.
Shares of Longeveron Inc. traded 50% higher after the company reported that the U.S. FDA approved its Lomecel-B for Rare Pediatric Disease Designation to treat a rare and life-threatening defect in infants called Hypoplastic Left Heart Syndrome.
Streetwise spoke with Raymond Pomroy, CEO of SoLVBL, and investor and advisor to SoLVBL, Rahim Allani, to learn more about the company's new security technology "Q by SoLVBL."
Emerita Resources Corp. recently announced encouraging step-out drilling results from its Iberia Belt West property in Spain. The firm is now activating three new diamond drilling rigs to accelerate exploration work. Clarus Securities Inc. commented in a research note that it is maintaining its "Speculative Buy" rating for the company and due to higher commodity market prices is raising its price target for the firm's shares to CA$5.00.
U.S. Global Investors, which has historically focused on resource and precious metals investing prior to launching its global airlines ETF in 2015, is now branching out to a new sector. Streetwise Reports speaks to Frank Holmes, CEO and Chief Investment Officer, who discusses the path ahead for gold as well as the new investment area for the firm that he believes global economic imbalances have primed for profits.
Microcap gold stocks offer investors exposure to gold’s upside in an inflationary environment while providing a bit of fun as your position rides the waves of investor confidence. An expert analyst has made Inomin Mines Inc. his latest pick. As long as you can stomach the risk, the ride could pay off with much more than what you put into it.
"Today's results from Liberty Gold show the growth potential inherent in the providence of the gold mineralized system on the project area," noted a Haywood Securities report.
Shares of Dicerna Pharmaceuticals Inc. traded 78% higher after the company reported it entered into a definitive agreement to be acquired by Novo Nordisk A/S of Denmark for $38.25 per share in cash.
"This first stream represents an important milestone in terms of opportunities originated by Nomad Royalty Company since inception," noted a BMO Capital Markets report.
Michael Ballanger dissects last week's price gains in gold and silver.
According to Bob Moriarty of 321Gold, West Wits Mining Limited is worth a buy ... if you can get your hands on it that is.
Shares of Novavax Inc. traded 10% higher after the firm confirmed that the European Medicines Agency is now reviewing its COVID-19 vaccine filing for conditional marketing authorization. The firm advised that an opinion from the agency is expected within a few weeks.
White Gold encountered two types of mineralization in a newly identified breccia unit at Betty Ford, a Stifel report noted.
Expert analyst Ron Struthers — founder and editor of Struthers' Resource Stock Report — breaks it all down, in a November 15 report, about what makes Inomin Mines Inc. his latest pick.
"A joint venture partnership would arguably be the single largest and most important derisking event in Seabridge Gold's history and as such, the upside ahead of a partnering event is potentially massive," noted a Cantor Fitzgerald report.
Adrian Day of Global Analyst delves into what the denial of the renewal of a mining permit in Mexico means for Fortuna Silver.
Shares of Kezar Life Sciences Inc. rose to a new 52-week high after the company reported promising interim results from its Phase 2 trial of KZR-616 in patients with lupus nephritis.
"Higher commodity prices are providing Gran Tierra Energy with additional financial flexibility to service debt and to fund growth in 2022," noted a Research Capital Corporation report.
Shares of EyePoint Pharmaceuticals Inc. reached a new 52-week intraday high after the company reported positive data from its Phase 1 DAVIO study of EYP-1901 in Wet AMD and announced plans to move forward to additional Phase 2 clinical trials in 2022.
"We believe this data begins to form the basis of an approvable program for Compass Pathways' COMP360" in this indication, noted a BTIG report.
In a recent conversation with Streetwise Reports, David Lucatch, CEO and president of Liquid Avatar, talked about the company's multifaceted approach to bringing blockchain technology to people's everyday experiences and transactions.
Small tech company Mineworx has partnered with a Tennessee recycling company to extract platinum and palladium from diesel catalytic converters in a ground-breaking method that bypasses smelting, a major polluter.
Quebec Precious Metals CEO Normand Champigny discusses how his company's sale of non-core assets is funding its gold exploration programs in the James Bay region of Quebec.
Contakt World plans to build a diversified health technology SaaS platform and address inequity of health access through technology.
Invitae Corp. reported Q3/21 financial results that highlighted an 89% YoY increase in billable volume to 296,000 tests. Ladenburg Thalmann & Co. Inc. stated in a research note that it has a "Buy" rating for the company with a $55.00/share price target.
It seems drilling at Regnault is going well for Kenorland Minerals, as JV Partner Sumitomo recently completed a C$5.2M strategic investment, something you don't see very often. As the summer program is now several months underway, the first results are expected in a few weeks. The Critical Investor discusses this and exploration at other projects with CEO Zach Flood.
Diamond drilling results from White Gold Corp.'s Ryan's Surprise and Ulli's Ridge targets demonstrate significant potential to increase the global resource from 1.5 Moz Au to over 2 Moz Au at the company's Golden Saddle/Arc property. Stifel Nicolaus Canada Inc. commented in a research note that it has a "Buy" rating for White Gold and that a re-rating for the firm's shares is likely should it reach the 2 Moz mark.
"Magna Gold should be trading at a premium to the peer group, and a rerating is imminent," an M Partners report noted.
HudBay Minerals is in full execution mode in terms of exploration, project advancement and landing new opportunities, according to a BMO Capital Markets report.
Quebec Precious Metals, formed by a merger of two mining companies, may be sitting on as much as 2 million ounces of gold at its Quebec properties.
Precious metals expert Michael Ballanger explains why he believes the precious metals are breaking free of the gravitational pull of the last 15 months and are in the early stages of escape velocity.
Stereotaxis Inc. shares traded higher after the company reported Q3/21 financial results and confirmed its FY/21 revenue guidance. The company added that it is sufficiently funded and is on pace towards doubling its system revenue in FY/22.
Chart analyst Clive Maund explains in a quick update why he has also put E2Gold on his list as a great buy.
MAG Silver Corp. is now engaged in the pre-commissioning phases of its new 4,000 tpd mill at the Juanicipio JV Project in Fresnillo, Mexico that when finished is expected to provide the company with 9,000,000 ounces of pre-payable silver production each year.
MAG Silver Corp.'s Fresnillo joint venture project is on track heading towards annual production of 27 Moz Ag eq. Stifel Canada has issued a "Buy" rating for the company and recently added the company to its list of Top Picks for Q4/21.
Emerita Resources Corp. issued an update regarding the status of two ongoing independent court cases in Spain and its prospects for winning the tender for the Aznalcóllar project. Research Capital Corp. commented in a research note that it believes the company has at least an 80% probability of being successful in the cases and is maintaining a "Speculative Buy" rating for the company.
Shares of Seres Therapeutics Inc. traded 20% higher after the company reported Q3/21 financial results and announced it is partnering with Bacthera in Switzerland to manufacture medicine for use in c.Diff treatment.
Shares of Pretium Resources Inc. traded 17% higher after the company reported it entered into a binding agreement to be acquired by Newcrest Mining Ltd. of Australia for CA$18.50 in cash and shares. The transaction is valued at CA$3.5 billion and allows shareholders the choice of receiving all cash, shares in Newcrest or a 50% split of each.
Clinics that deliver novel psychiatric treatment and host clinical trials of psychedelic medicine have positioned Novamind for breakthroughs in mental health treatment.
This cost mitigation will derisk Juanicipio plant commissioning and ramp-up expected by year-end 2021, noted an H.C. Wainwright & Co. report.
Sector expert Clive Maund says that White Gold Corp.'s fundamentals 'look impressive' and that 'fresh purchases are in order.'
"The fact that White Gold's drilling hit fairly wide zones of high grade at shallow depth bodes well for both the mineral endowment and mineability of the emerging zone," noted a Stifel report.
All that needs to be done beforehand is connecting to the Mexico power grid then no-load and water testing, noted a Cormark report.
Results expected are for trials of Jounce Therapeutics' two lead product candidates, vopratelimab and pimivalimab, both monoclonal antibodies, noted a ROTH Capital Partners report.
Autolus Therapeutics Plc. shares traded 28% higher after the company reported that Blackstone Life Sciences is investing up to $250 million in the firm to develop obe-cel in treatment of adult Acute Lymphoblastic Leukemia and advance its broader targeted T- Cell technology platform.
The Critical Investor discusses the status of the projects of Standard Lithium, one of the major lithium developers in the Americas, and lithium product pricing in this quick update.
McAlinden Research Partners explains that while climate related disruptions have become standard in the agricultural industry, a new catalyst has recently emerged that could keep futures contracts climbing next year.
As the world adopts Cleantech as a means to curb environmental pollution, U.S.-based Mineworx Technologies Ltd. (MWX:TSX.V) has found a technological replacement for the traditional mining of precious metals. Mineworx uses its unique cleantech to economically and cleanly extract platinum and palladium from spent diesel catalysts.
Shares of brand, generic and injectable drug maker Endo International traded 25% higher after the company reported Q3/21 financial results and raised its FY/21 revenue and EPS guidance.
Chris Temple of The National Investor profiles 10 companies in a variety of sectors on his recommended list. "I very much am of the view that a great many resource-oriented stories and the best companies have incredible futures ahead of them," he writes.
Has the Klondike Gold Rush 2.0 quietly begun? Modern technologies and a century of accumulated know-how are catalyzing new discoveries in the Yukon, and one company at the center of the action is White Gold Corp. CEO David D'Onofrio was bullish in an interview with Streetwise Reports: "From a risk/reward perspective, I can't think of a better opportunity."
As Meridian Mining has been pretty busy at its Cabaçal VMS Copper-Gold Project in Brazil lately, raising an oversubscribed C$10.38M, drilling world class gold intercepts (8m @ 71.3g/t Au), other visible gold and long copper intercepts, defining new targets and gold structures, and is increasing strike length of mineralized zones, the Critical Investor catches up with management to discuss ongoing developments in a rather extensive update.
Shares of robotic performance-guided surgery device maker Asensus Surgical Inc. traded 21% higher after the company reported Q3/21 financial results that included a 215% increase in YoY revenue.
In an Oct. 8, 2021, broadcast, Crescat Capital Geologic and Technical Director, Dr. Quinton Hennigh, discussed the cycles in the gold market since the 1970s and posited that the U.S. is on the verge of a bull run in the gold price and another "age of discovery."
Surgery Partners shares traded 18% higher after the company reported Q3/21 financial results that included a 12.7% increase in YoY revenue and a 6.2% increase in the number of same-facility procedures performed.
Wedbush Securities Inc. advised that global precision therapy company Blueprint Medicines Corp.'s therapeutic AYVAKIT is gaining traction in patients diagnosed with advanced systemic mastocytosis and gastrointestinal stromal tumors. Wedbush reiterated its Outperform rating for the company and raised its 12-month price target by $4.00 to $136.00 per share.
Chris Temple of The National Investor explains why he has put E2Gold on his buy list and why he believes E2Gold has the potential to multiply its resource base, and geologic expert Dr. Quentin Hennigh agrees. In a statement made today, Hennigh told Streetwise why E2 is a buying opportunity for long-term investors right now.
McAlinden Research Partners estimates it may be only a matter of time before psychedelics become part of a biotech boom.
With the three-sided amalgamation completed, trading in Allied Copper shares is set to resume on the TSX Venture Exchange on Thursday, Nov. 4.
Bob Moriarty of 321gold highlights recent assay results for an explorer that he believes is one of the best stories in the past 20 years.
Kerry Lutz, the founder of the Financial Survival Network, delves into some of the factors that may be behind inflation.
According to Bob Moriarty of 321Gold, Granite Creek Copper "has to be one of the lowest market cap copper stories with a real asset."
In a recent conversation with the Westhaven Gold management team, they briefed Streetwise Reports on the latest findings at the Shovelnose gold project.
During Crescat Capital's Oct. 1, 2021, broadcast, the firm's geologic and technical director, Quinton Hennigh, provided an overview of a company Crescat recently invested in, highlighting why he is excited about it. He also gave updates on six other companies in Crescat's mining exploration portfolio and explained how laboratories assay core samples.
In an Oct. 8, 2021 broadcast, Crescat Capital's Portfolio Manager, Tavi Costa, and Chief Investment Officer, Kevin Smith, addressed stagflation in the U.S., the Federal Reserve's conundrum and the near-term expectations for precious metals prices.
Liberty Gold's "upcoming preliminary economic assessment on Black Pine, along with ongoing drilling updates, may represent meaningful catalysts to spur a rerate opportunity," noted a Haywood Securities report.
BTIG commented in a research report that Sigilon Therapeutics is developing a powerful and widely applicable "cell replacement in a bottle" as a potential functional cure for genetic diseases. BTIG advised it is initiating coverage on the company with a "Buy" rating and $14/share price target.
Shares of Rogers Corp. traded 30% higher after the company reported it entered into a definitive agreement to be acquired by DuPont in an all-cash transaction for $277.00 per share.
In an Oct. 1, 2021, broadcast, Crescat Capital's Portfolio Manager, Tavi Costa, and Chief Investment Officer, Kevin Smith, argued that precious metals offer investors incredible value, protection, and growth during periods of economic toil like what we are experiencing globally today and that gold and silver prices are poised to take off from their current lows.
Research Capital Corp. advised that Canadian oil and gas explorer and producer Pan Orient Energy Corp. may be "getting out while the getting is good," and is exploring opportunities to exit from its assets in Thailand and Canada.
With rising inflation, the gold price is a coiled spring. Senior and junior miners as shown in the TSX Venture index have begun to rally with anticipation. Inomin Mines has advanced stage projects in favorable jurisdictions and a very low valuation, writes Ron Struthers of Struthers Resource Stock Report.
Bob Moriarty of 321gold profiles South Star Battery Metals' graphite project and explains why he believes this is the best company he has written about in 20 years.
Shares of ANI Pharmaceuticals Inc. traded 50% higher after the company reported the U.S. FDA approved its Purified Cortrophin Gel for use in treating multiple sclerosis, rheumatoid arthritis and nephrotic syndrome.
Shares of Aspen Aerogels Inc. reached a new 52-week high after the company reported Q3/21 financial results that included a 26% increase in YoY revenues. The firm raised its FY/21 revenue estimates by greater than $10 million and said it is beefing up planned investments during Q4/21 to position it for even stronger revenue growth and profitability in future years.
Shares of Allegheny Technologies Inc. traded 13% higher after the company reported it has returned to profitability fueled by recovery in the aerospace market and implementation of its own business transformation initiatives.
Fundamental Research Corp. reported it is initiating coverage on Blue Sky Uranium Corp. with a "Buy" rating. According to the research firm, Blue Sky could become Argentina's first domestic uranium producer well-suited to meet the rising demand for uranium needed to fuel nuclear energy plants in that country.
The target company "brings numerous positives to Stem Holdings dba Driven By Stem," noted a Noble Capital markets report.
Enphase Energy Inc. shares traded 27% higher after the company reported Q3/21 financial results that included a nearly 97% increase in YoY revenue.
Streetwise Reports recently caught up with Ian Slater about his career trajectory from a chartered accountant to mining mogul whose companies include Libero Copper & Gold Corp., Zacapa Resources, and Outcrop Silver & Gold Corp.
GameOn Entertainment Technologies is using the most innovative fan engagement technologies to power the most-watched content in the world. GameOn's platform lets viewers play for leaderboard rankings, bragging rights, and valuable NFT collectibles. The tech startup already has licensing and revenue sharing deals with MX Player, the most popular OTT app in India. And it’s just getting started.
Streetwise Reports sat down with Riley Gold Corp.’s President and CEO Todd Hilditch to talk about the progress of their Pipeline West/Clipper gold project in Nevada.
Forward Water Technologies' system affords users savings in terms of water, energy, and dirty water disposal costs.
Shares of Medpace Holdings Inc. climbed to a new 52-week high after the CRO, a provider of full-service clinical trial development services, reported financial results for Q3/21 that included a 28.3% increase in YoY revenue.
Adrian Day of Global Analyst discusses recent developments at several exploration companies and explains why he believes share prices may be lower before the end of the year.
Citing the company’s “long-term potential for significant share price improvement,” BMO Capital Markets has upgraded Teck Resources to Outperform.
Analyst David Bautz at Zacks Small-Cap Research wrote bullishly on Avivagen's eight-year distribution deal targeting the U.S., Brazil, and Thailand in an Oct. 11 report: The AB Vista deal “could be a game changer for the company as Avivagen now has a global partner that gives immediate credibility to the OxC-beta technology."
Precious metals expert Michael Ballanger delves into the Federal Reserve's actions going back decades that affect the price of gold.
Bloom Energy Corp. shares traded 37% higher after the company reported it is significantly expanding its partnership with SK ecoplant of South Korea to establish a market leadership position in the hydrogen economy.
Arianne Phosphate has a very advanced stage, shovel-ready, phosphate rock project in mining-friendly Quebec with two off-take agreements signed, a BFS and cooperation agreement with nearby First Nation groups, writes Peter Epstein of Epstein Research.
Golden Arrow Resources is looking to benefit from current positive sentiment in metals, as it recently commenced drilling at the Terra Dorada gold project in Paraguay and at its Rosales Copper project in Chile, but it also optioned the Libanesa silver-gold project in Argentina, and is planning early stage exploration at this and two other projects.
A recent drop in Aurania Resources' share price due to the financings has created a buying opportunity, a Noble Capital Markets report noted.
Emerita Resources Corp. shares traded nearly 15% higher after the company reported step-out drill results from a hole at its La Infanta project in Spain that returned 8.2m of 2.5% Cu, 17.3% Zn, 8.7% Pb, 223.5 g/t Ag, 0.5 g/t Au. Clarus Securities advised in a research note Friday that it is maintaining its "Speculative Buy" rating and CA$4.50/share price target for Emerita's (EMO) shares and stated it sees significant resource expansion potential for the Iberia Belt West property.
The explorer's recent drilling success at its namesake property is expected to help improve the economics of the project prefeasibility study expected next year.
TriState Capital Holdings Inc. shares hit a new 52-week high after the company reported it entered into a definitive agreement to be acquired by Raymond James Financial in a combination cash and stock transaction valued at $1.1 billion.
Here’s why New York City investment group Long State has invested in GameOn Entertainment Technologies, an interactive media disruptor that just teamed up with Chibi Dinos.
The explorer's extensive drilling at its Troilus project has resulted in "mineral continuity and [a] new, structurally focused geological model," noted a Laurentian Bank Securities report.
Shares of Radius Health Inc. traded 17% higher after the firm reported positive topline results from the Phase 3 EMERALD study of elacestrant in ER+/HER2- advanced or metastatic breast cancer (mBC).
GameOn Entertainment Technologies Inc. (GET) is ushering in a next generation gamification platform to drive engagement and interaction with sports and entertainment fans worldwide.
Shaun Cartwright, Managing Director & Chief Investment Officer of Viriathus Capital, has a bullish view for the energy sector, where billions of dollars are being invested globally into initiatives to reduce our carbon footprint by 2050.
NaturalShrimp Inc.'s shares traded 12% higher after the company reported it entered into an agreement with Gulf Seafood Inc. for delivery of 25,000 lbs. of naturally grown, chemical and antibiotic-free, live shrimp.
Streetwise Reports talked to GameOn CEO Matt Bailey and Board Chairman J Moses of Grand Theft Auto fame about the success of the platform, which makes money through licensing and revenue sharing.
Valneva SE shares traded 40% higher after the company reported positive results from its Phase 3 clinical trial of its COVID-19 vaccine candidate, VLA2001. The firm claimed that VLA2001 produced superior neutralizing antibody titer levels compared to AstraZeneca's AZD1222 (ChAdOx1-S) vaccine in the study.
Underperformance in the Ula field led to Aker BP's 2–3% production shortfall during the quarter, a Pareto Securities report noted.
These new data from Cassiar Gold's project "successfully confirmed the high-grade nature of mineralization and continuity of the shear quartz veins at Bain," noted a Red Cloud Securities report.
Adrian Day of Global Analyst takes a look at Wheaton Precious Metals' holdings and also provides updates on several other companies.
Shares of Alcoa Corp. traded 15% higher to a new 52-week high after the company reported it achieved record net income of $337 million and earnings per share of $1.76 in Q3/21. The firm advised it is instituting a new $0.10 per share quarterly dividend and is raising its corporate share buyback program by $500 million.
DarioHealth Corp. shares traded 17% higher after the company reported it entered into an agreement with an unnamed national healthcare provider to make its behavioral health products available to millions of the plan's members.
The potential is "enormous" for Stem Holdings Inc. dba Driven By Stem's new app, Budee Cannabis Delivery, given it is available in the Apple App Store, a Noble Capital Markets report noted.
Funds from a new $4 million private placement will advance exploration in Mexico and Alaska for a “proven” management team building a high-grade portfolio.
GameOn Entertainment Technologies Inc. announced this morning their new partnership with non-fungible tokens creator, Chibi Dinos.
Peter Epstein of Epstein Research notes that five major lithium transactions have occurred in the past six months: Galaxy, Millennial, Neo Lithium and Bacanora Lithium were acquired (or are in the process), and ioneer ltd. sold half its project for US$490 million. Cypress Development is one of the few remaining companies with a 100%-owned project at PFS or BFS stage.
Plug Power Inc. shares traded 12% higher after the company reported it entered into a collaboration agreement with Phillips 66 to develop and advance low-carbon hydrogen business opportunities. The company advised that it is also joining forces with Airbus on efforts to decarbonize air travel and airport operations with green hydrogen.
Shares of multinational oilfield service company Weatherford International Plc. reached a new 52-week high after the firm reported preliminary financial results for Q3/21 featuring an expected 75% sequential increase in cash flow from operations and free cash flow.
The acquisition of Santa Maria will afford Fabled Silver Gold additional exploration and mining opportunities.
In the second part of his quarterly review, Adrian Day, founder of Adrian Day Asset Management, discusses the macroeconomic situation in Europe, China, and emerging markets.
Once in place, this Smart Age program should result in Liquid Avatar Technologies growing organically in the short and long term.
As the Sprott Physical Uranium Trust almost singlehandedly caused spot uranium oxide prices to explode recently, sentiment for uranium juniors turned pretty positive as a consequence. Because of these developments, the Critical Investor is interested in the current state of affairs at Blue Sky Uranium.
Flexion Therapeutics Inc. shares traded 60% higher after the company reported it entered into a definitive agreement to be acquired by Pacira BioSciences Inc. for $8.00 per share in cash plus an additional non-tradeable contingent value right worth up to $8.00 per share in cash if five specific milestones are met.
Shares of ChemoCentryx Inc. traded 96% higher after the company reported the U.S. FDA approved its orally administered TAVNEOS™ (avacopan) for use in treatment of ANCA-associated vasculitis, a systemic autoimmune disease that often results in kidney or other major organ damage and failure that can be fatal if left untreated.
In his review of the past quarter, Adrian Day, founder of Adrian Day Asset Management, discusses recent moves in the resource markets and why he believes gold and gold stocks are positioned to rise.
In this review of the quarter, Adrian Day, founder of Adrian Day Asset Management, discusses the Federal Reserve's asset purchases, its talk of tapering them, and what that could mean for the broader markets.
First Cobalt Corp. is fully-funded to build a Battery Materials Park (BMP) in northern Ontario, Canada. The BMP will be operating years ahead of dozens of other BMPs in North America, making it a very valuable asset. First Cobalt is poised to generate cash flows from cobalt sulfate, Li-ion battery recycling, and nickel sulfate.
Shares of Dutch oncology company Merus NV traded higher after the firm presented early and preclinical data for two full-length, multispecific antibodies, MCLA-158 and zenocutuzumab, to the AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics.
Avrupa Minerals is getting closer to solving the Sesmarias puzzle in Portugal, and the Critical Investor wants to know all about its exploration strategy.
Shopping meets entertainment meets community in the latest form of online commerce, which just received a lift through its partnership with TikTok.
With two goals, to identify new mineralized deposits at Amarillo Grande and to expand the resource at the project's Ivana deposit, Blue Sky Uranium is carrying out two concurrent drill programs.
Simultaneously, demand is growing for Reliq Health's iUGO Care software as virtual healthcare delivery increases during the COVID-19 pandemic.
Silver Viper aims to achieve this at La Virginia via a deep-penetrating geophysical survey of the El Rubi target.
Precious metals expert Michael Ballanger decries last week's manipulations in the silver market.
Shares of Voyager Therapeutics Inc. traded 51% higher after the company reported it entered into a license and option agreement with Pfizer Inc. for two of its TRACERᵀᴹ AAV capsids that will be utilized to enhance Pfizer's neurologic and cardiovascular gene therapy programs. Voyager will receive an upfront payment of $30 million and is eligible to receive up to $600 million more plus product sales-based royalties, if all options are exercised and certain milestones are achieved.
SmileDirectClub Inc. shares traded 15% higher after the company reported that the U.S. Patent & Trademark Office has allowed its new patent for the firm's mobile SmileBus concept whereby its SmileShop on wheels is mobilized to expand access to convenient, affordable oral care in remote areas across the U.S. and the U.K.
McAlinden Research Partners takes a look into the cruise ship industry and sees some calmer waters ahead.
Shares of Xenon Pharmaceuticals Inc. soared to a new 52-week high after the company reported topline data from its Phase 2b X-TOLE clinical study demonstrating that its epilepsy drug candidate XEN1101 successfully met several primary and secondary efficacy endpoints and decreased monthly focal seizure frequency by 50% or greater from baseline.
Sector expert Michael Ballanger links debt and wolf packs in this exploration of the effects that the troubled Chinese company will have on gold.
Shares of Merck & Co. Inc. traded 9% higher after the company reported that in a global Phase 3 clinical trial conducted together with its partner Ridgeback Biotherapeutics, oral antiviral molnupiravir reduced risk of hospitalization or death by 50% versus placebo in patients with mild or moderate COVID-19. Merck plans to submit an Emergency Use Authorization application to the U.S. FDA and if authorized it would make molnupiravir the first approved oral antiviral medicine for COVID-19.
Argentina Lithium is in the process of revitalizing its business, and right on time as lithium product prices are going through the roof these days.
The Critical Investor catches up with Gold Terra management about the first results of their Phase 2 drill program at the Yellorex target at the Campbell Shear, part of their Yellowknife City Gold project in Northwest Territories, Canada.
Several external factors have hampered Scatec's ability to deliver projects in its backlog, a problem discussed in a Pareto Securities report.
Gatling Exploration completed metallurgical tests on its three deposits at Larder, which provided initial gold recovery levels on which the company aims to improve.
"With Clene's potential to realize several multibillion-dollar revenue opportunities, we see its roughly $480 million enterprise value as offering attractive risk-reward," an Oppenheimer report noted.
Brian May, the newest addition to Triumph Gold's leadership team, is intimately familiar with the company's flagship Freegold Mountain project, given his extensive involvement in recent exploration work there.
Defense Metals intends to determine if restarting exploration work at Geiger North and Klaproth will increase the value it is currently creating for shareholders.
Shares of Alzamend Neuro Inc. traded 36% higher after the company reported that the U.S. FDA responded favorably to its Pre-IND application for AL002, a cell-based therapeutic vaccine designed to restore patients' immunological systems, providing them with the ability to combat Alzheimer's Disease. The FDA has granted the firm approval to initiate a combined Phase 1/2 clinical trial in Q1/22.
"Label extension for BioNTech and Pfizer's Comirnaty [vaccine] to include use in these younger individuals ought to buoy revenue growth near term," noted an H.C. Wainwright & Co. report.
“Dominant” silver projects led by experienced, local teams in mining-friendly jurisdiction and proven locations are the foundation for Norseman Silver’s plans for the next 12 months.
Westhaven Gold's 2021 exploration and resource drilling at its Shovelnose property resumes after wildfires halted the project temporarily this summer, continues to bear positive results this autumn.
Algernon Pharmaceuticals will now pursue Ifenprodil in chronic cough based on encouraging recent study results in a Phase 2 trial.
Shares of Dollar Tree Inc. traded 16% higher after the company reported it is expanding the offerings and pricing of items in its stores to more than one dollar due to recent successful market test results at its newly formatted Combo and Dollar Tree Plus stores. The firm also announced that its Board of Directors has raised authorized share repurchases to US$2.5 billion.
Alianza Minerals recently completed its 2021 drilling campaign at its flagship Haldane silver project in the historic Keno Hill Mining District, and the last assays of this program have been received recently. Another batch of solid results implies the company is on the right track, but is looking for a bigger prize.
Bill Powers of Mining Stock Education profiles QC Copper and Gold's newly defined Opemiska copper-gold deposit in Chibougamau, Quebec.
Silver X Mining is evolving into a growing silver-lead-zinc producer in Peru. A plan is in place to boost production, get the company re-rated, and eventually sell it. Members of the management team have done it many times before. For investors, it’s only a matter of time and patience.
Aurania Resources' hole SH-003, drilled in the Tiria-Shimpia target at Los Cities–Cutucu, returned silver grades up to 10.5 grams per tonne and zinc grades up to 2.5%.
"The expansion is expected to drive topline sales with greater efficiency," noted a Noble Capital Markets report.
Shares of Thor Industries traded 8% higher after the company reported that net sales in FY/21 increased by 50.8% to $12.32 billion and advised that as of July 31, 2021, its consolidated RV backlog grew by 190% YoY to $16.86 billion.
Usha Resources has multiple copper, cobalt and gold properties and projects across the U.S. and Canada. Cobalt in the U.S. would be hugely desirable; Usha could find meaningful deposits of cobalt and copper. A small market cap with near-term drill results make Usha a compelling risk/reward proposition.
In part two of a two-part look at investing in junior precious metals equities, Denver-based Crescat Capital CIO Kevin Smith discusses the Lassonde Curve and how he uses it in combination with Geologic and Technical Director Dr. Quinton Hennigh’s hands-on knowledge to invest in what they believe are the best opportunities in the gold and silver space.
G Mining’s recently announced US$110 million acquisition of the TZ gold project from Eldorado Gold should result in one of Brazil’s largest gold mines and highlights the potential of the Tapajos region, which was the site of the world’s largest gold rush.
Outcrop Silver and Gold's most recent batch extended mineralization in the north part of Santa Ana and generated a new target in the project's southern end.
During Crescat Capital's Sept. 20, 2021 broadcast, Dr. Quinton Hennigh, Geologic and Technical Director of Crescat Capital, reviewed news released in the past two weeks on multiple companies in Crescat's portfolio of mining explorers.
Shares of Red Cat Holdings Inc. traded 53% higher after the company reported that its subsidiary Skypersonic Inc. received a five-year contract from NASA to provide drone and rover software, hardware, and support for its simulated Mars mission.
Adrian Day of Adrian Day's Global Analyst discusses company presentations from recent back-to-back Colorado gold conferences. 15 specific companies are assessed.
In a Sept. 20, 2021 Crescat Capital broadcast, the firm's Portfolio Manager Tavi Costa and Chief Investment Officer Kevin Smith presented statistical evidence that China is heading toward an economic crash and its spiraling is affecting other economies around the world. The two experts also explained how Crescat Capital has positioned its funds in preparation for the likely Chinese event.
Aehr Test Systems shares reached a new 52-week high after the firm reported it achieved record bookings in Q1/22 and increased its FY/22 revenue guidance by 80% due to increased demand for semiconductor test and burn-in services for electric vehicles.
Reliq Health Technologies signs contracts with three new clients for its proprietary remote healthcare delivery and care tracking platform, which has particularly significant implications during the era of the COVID-19 pandemic.
Kenorland Minerals options up to 80% of its South Uchi project in Alaska, one of the company's eight assets, to mining major, Barrick Gold.
Teck Resources, a CA$26 billion company, is the second largest steelmaking coal producer in the world. In its Investor Day presentation earlier this week it reiterated the long-term strength of the seaborne coking coal market. Colonial Coal is also 100% coking coal, with two valuable projects for sale in B.C., Canada.
Blue Sky Uranium has "low-cost extraction prospects and local market opportunities in a market with high growth potential," a Globe Small Cap Research report noted.
Logiq Inc. has been a champion of small and medium sized businesses, providing tools to help them compete in an e-commerce world dominated by large players. And now the company inked several large, potentially lucrative deals in emerging markets.
In a September 10, 2021, Crescat Capital briefing from the Precious Metals Summit in Beaver Creek, Colorado, the firm's Dr. Quinton Hennigh, Geologic and Technical Director, provided updates on 15 exploration companies of note.
Sector expert Michael Ballanger breaks down market moves for the week of September 13 and discusses one of the highlights of 2021, which has been the explosive performance of the uranium space, citing companies such as Sprott Inc. and Western Uranium and Vanadium Corp, as we look toward a net-zero carbon future.
ZEN Graphene Solutions Ltd. shares traded 13.5% higher after the company reported it delivered its first revenue-generating shipment of ZENGuard, a patent-pending coating with 99% antimicrobial activity. The first commercial shipment follows the firm's announcement yesterday that Health Canada determined ZENGuard enhanced surgical masks are safe for use by Canadians.
E2Gold Inc., a Toronto-based small-cap gold exploration company, recently received positive attention from Dr. Quinton Hennigh, Geologic and Technical Director of Crescat Capital, and independent technical analyst Clive Maund. Hennigh’s firm is a Denver-based global macro asset management firm that recently led a financing round for E2Gold and now holds 11% of the company.
The Critical Investor and Gerardo Del Real look forward to the first set of drill results from this Canadian explorer's Rosales project in the prolific Atacama mining district.
In a Sept. 10, 2021 Crescat Capital broadcast from the Precious Metals Summit in Beaver Creek, the firm's Portfolio Manager, Tavi Costa, and its Chief Investment Officer, Kevin Smith, talked about the current macroeconomic environment and highlighted the opportunity in gold and silver mining equities.
Shares of Dynavax Technologies Corp. established a new 52-week high after the company reported that in the global Phase 2/3 SPECTRA COVID-19 vaccine study its collaborative partner Clover Biopharmaceuticals met all primary and secondary efficacy endpoints. Clover's vaccine, which was developed using Dynavax's CpG 1018 adjuvant, demonstrated 100% efficacy against severe COVID-19 and 84% efficacy against moderate-to-severe COVID-19 caused by any strain of SARS-CoV-2, including the Delta, Gamma, and Mu variants.
Assays from Getchell Gold’s first drill hole of 2021 support the company’s “high expectations” for its Fondaway Canyon gold project.
Mike Swanson, the editor of WallStreetWindow.com tells Streetwise Reports that small-cap exploration stock Norseman Silver is projected to have a fall end-of-the-year rally. Here's why.
Rezolute's two drug candidates, one for congenital hyperinsulinism and the other for diabetic macular edema, are discussed in an H.C. Wainwright & Co. report.
Research Capital Corp. mentioned in a recent presentation that Jericho Energy Ventures Inc. has developed a next generation hydrogen-based boiler that combines pure hydrogen and pure oxygen to generate heat, hot water, and high temperature steam through a zero-emission, closed-loop process.
Shares of Inotiv Inc. traded 27% higher to a new 52-week high after the company reported it entered into agreement to acquire Envigo RMS Holding Corp. in a cash and stock deal valued at $545 million which will serve to create a one-stop-shop, discovery-to-approval solution for drug developers.
"All the pieces are in place for a new bull market in gold to develop” for this small-cap gold exploration company with operations in Northern Ontario.
During Crescat Capital's Sept. 3, 2021 broadcast, Quinton Hennigh, Geologic and Technical Director of Crescat Capital, provided updates and commented on 10 companies in the firm's exploration portfolio.
AzurRx BioPharma now has five additional shots on goal "with the imminent full acquisition of just one compound," a ROTH Capital Partners report noted.
The Critical Investor explains why he thinks Vior (TSXV:VIO) has a good risk/reward investment profile, with its flagship Belleterre in Quebec, which contains the historic Belleterre Mine (produced 750koz Au @ 10.7g/t Au between 1936 and 1959), and very recently provided excellent sampling results, with results up to 274.9g/t Au.
Edesa Biotech Inc. shares reached a new 52-week high after the company reported positive results from its Phase 2/3 monoclonal antibody study in hospitalized COVID-19 patients.
Innate Pharma S.A. shares traded 38% higher after the company reported its development partner AstraZeneca Plc. reported positive interim results from its Phase 2 COAST Study to the European Society for Medical Oncology Congress. When taken together with durvalumab, monalizumab was shown to improve progression-free survival and objective response rates in patients with unresectable, Stage III non-small cell lung cancer.
Red Cloud Securities Inc. stated in a research report that high-grade samples exceeding 50% U3O8 at Skyharbour Resources Ltd.'s Hook Lake property provide a clear indication that a high-grade uranium zone may be located close by. Red Cloud said it is maintaining its "Speculative Buy" rating for Skyharbour and 12-month price target of CA$0.95/share.
In a Sept. 3, 2021 broadcast, two Crescat Capital representatives discussed the current macroeconomic environment. Portfolio Manager, Tavi Costa, highlighted the bearish part of the picture along with investment opportunities with bullish potential. Chief Investment Officer, Kevin Smith, presented evidence of an overvalued equity market and noted what that means for the precious metals sector.
Shares of Leap Therapeutics Inc. traded 38% higher after the company reported positive preliminary data from the Phase 2a DisTinGuish Study of DKN-01 plus tislelizumab at the European Society for Medical Oncology Congress.
Puma Exploration intersected 5.55 grams/tonne of gold over 50.15 meters starting at surface on its Williams Brook Gold Project.
In a recent Crescat Capital briefing, Portfolio Manager Tavi Costa presented current financial metrics that are expected to affect the rising inflation thesis. Also, Chief Investment Officer Kevin Smith discussed his firm's view that the current market is creating an equity bubble and highlighted catalysts that could burst it.
Joining us is Morgan Lekstrom, the CEO of Lakewood Exploration, which is on track to become the next pure silver play in the US. In this interview, Mr. Lekstrom discusses the latest update on the pending NI43-101 on the flagship Silver Strand, along with current exploration successes and new additions to the property bank, both in the prolific Hamilton District of Nevada, which are the Eliza Silver Project and Silverton Silver Mine, and we will conclude with pending catalysts.
Sector expert Michael Ballanger explores how modern financial times mirror his formative years in the 1970s.
ROTH Capital Partners LLC advised in a research report that Inventiva S.A. has initiated enrollment in its highly anticipated pivotal Phase 3 Study of Lanifibranor in individuals diagnosed with nonalcoholic steatohepatitis. ROTH rates Inventiva a "Buy" with a 12-month price target of €55/share which represents a nearly four-fold increase over the current share price.
Shares of Instil Bio Inc. traded 16% higher after the company reported it received IND clearance from the U.S. FDA to initiate a Phase 2 clinical trial in advanced melanoma patients.
In a recent broadcast, Geologic and Technical Director to Crescat Capital, Dr. Quinton Hennigh, provided updates on three exploration companies with recent news and covered seven other exploration stories of note.
H.C. Wainwright & Co. advised in a research report that updated data from Mersana Therapeutics Inc.'s expansion study supports its UPLIFT Study and will provide the basis for a new Phase 3 study in 2022. H.C. Wainwright rates Mersana a "Buy" with a target price of $28.00/share.
Streetwise Live! Presents Heliostar Metals Ltd. Featuring Charles Funk, CEO and Director of Heliostar Metals Ltd., Adrian Day of Adrian Day Asset Management, and Joe Mazumdar, Editor/Analyst and Publisher of Exploration Insights.
Shares of FuelCell Energy Inc. traded 15% higher after the company reported Q3/21 financial results highlighting positive YoY increases in revenue and gross margins driven by a 102% increase in revenues derived from licenses and service agreements.
Streetwise Reports spoke to Riley Gold Corp. CEO Todd Hilditch about how they will put “funds in the ground” following an oversubscribed private round.
Streetwise Live! Presents E2Gold Featuring Eric Owens, President, CEO and Director of E2Gold and Dr. Quinton Hennigh, Geologic and Technical Director, Crescat Capital.
"Aker's discounted pricing and stellar track record stand out as an attractive opportunity in the current market," a Pareto Securities report noted.
"We think the still out of favor [oil] exploration and production sector offers a good risk/reward," a Pareto Securities report noted.
Shares of aTyr Pharma Inc. traded 48% higher after the firm reported its ATYR1923 produced positive results in a Phase 1b/2a clinical study by demonstrating consistent favorable dose responses in pulmonary sarcoidosis patients.
Echo Global Logistics Inc. shares traded 50% higher to a new 52-week high after the technology-enabled logistics company reported it entered into a definitive agreement to be acquired by The Jordan Company for $48.25 per share in cash.
About 200 km east of Calgary in Canada’s prairies, a small exploration and production company has a plan to become a vertically integrated helium producer. It has the money, a proven helium-producing asset, and signed agreements with partners. Now it’s all about execution — and it’s off to a solid start.
Clarus Securities Inc. advised in a research report that Emerita Resources Corp.'s recent infill drill results at its La Infanta Project in southern Spain demonstrate significant expansion potential. Clarus stated it is maintaining Emerita's "Speculative Buy" rating and 12-month price target of CA$4.50/share.
A Haywood Securities report noted that "initial 2021 reverse circulation results highlight deep value in Liberty Gold's asset portfolio."
Shares of renewable fuels technology and development company Gevo Inc. traded 35% higher after the company reported it is teaming up with Chevron U.S.A. Inc. to invest in development and production of sustainable aviation fuel derived from inedible corn.
Cortus Metals plans to use the funds to continue exploring its Nevada properties.
"At Quebec Precious Metals' Lloyd discovery area, results received from a 2021 summer surface sampling program highlight several gold discoveries" that show "excellent gold potential."
Auctus Advisors LLP commented in a research note that helium developer Imperial Helium Corp. obtained encouraging results from the second well drilled at its Steveville project. Auctus advised that pending receipt of the well flow rate data, it is maintaining its CA$1.00/share target price for IHC shares.
Atlas Salt has a unique project on the west coast of Newfoundland. I would venture to say it is the best risk/reward scenario in the province. Strategically located, the Great Atlantic Salt Project can serve significant North American demand and is uniquely positioned to capture market share from overseas countries with higher shipping costs.
Shares of Kadmon Holdings Inc. traded 70% higher after the firm reported it agreed to be acquired by Sanofi SA for $9.50 per share in cash. Sanofi aims to strengthen its transplant business with the addition of Kadmon's Rezurock™ (belumosudil), an FDA-approved, first-in-class treatment for patients 12 years and older with chronic graft-versus-host disease.
In this interview, Maurice Jackson, founder of Proven and Probable, sits down with Kyle Floyd, the CEO of Vox Royalty, which is a global royalty generator with a royalty portfolio consisting of over 8,000 royalties. Jackson and Floyd address the merits of royalty companies for shareholders and what makes Vox Royalty stand out from the pack.
The Global Analyst has been focusing on the senior producers more in the last many months, since they are undervalued and more certain to respond to a higher gold price. They remain good buys. However, many of the juniors have seen their stock prices slide and there are excellent buys in that sector. Below are three of our favorite resource juniors, all buys.
Various targets "continue to emerge in the southwestern portion of Aurania Resources' Lost Cities–Cutucu project," a Noble Capital Markets report noted.
The contents of this memo between Defense Metals and a Chinese minerals processing expert are described in a Highballer Stocks report, which notes "demand from every corner of the tech arena."
ROTH Capital Partners LLC commented in a research report that it is maintaining its "Buy" rating and raising its FY/22 revenue estimates for Dynatronics Corp. to $41 million after the firm pre-announced Q4/21 revenue figures that exceeded prior estimates.
CIBC World Markets Inc. commented in a research report that oil and gas producer Advantage Energy Ltd.'s capital spending plans are creating an intriguing free cash flow profile. The firm stated it is maintaining its "Outperformer" rating for Advantage and is increasing its price target for the firm's shares by CA$1.00 to CA$7.00 per share.
CIBC World Markets Inc. commented in a research report that Canadian Western Bank's loan and deposit growth exceeded estimates in Q3/21 and that company is poised to benefit from improved net interest margins in FY/22. CIBC is maintaining its "Outperformer" rating for CWB and raised its target price for CWB shares from CA$42 to CA$44.00.
Adaptimmune Therapeutics Plc. shares traded 33% higher after the firm reported it formed a strategic partnership with Genentech to develop several "off-the-shelf" and advanced personalized cancer-targeting allogeneic T-cell therapies.
Shares of Impel NeuroPharma Inc. traded to a new 52-week high after the company reported that the U.S. Food and Drug Administration has approved TRUDHESA™ (dihydroergotamine mesylate), a patient friendly nasal spray that delivers rapid relief and treatment for acute migraine.
Maurice Jackson spoke with Michael Rowley, CEO of Group Ten Metals, about Heritage Mining Ltd.'s deal to acquire up to a 90% interest in Group Ten's Black Lake-Drayton gold project in Ontario, Canada. According to the details, Heritage is poised to make payments of 7.2 million shares and CA$320,000 to Group Ten Metals, complete the exploration & development work, and grant Group Ten a 10% carried interest in the project through completion of a feasibility study.
Global telemedicine company will turn a profit in the current quarter and experience rapid growth after new contracts to provide chronic care management and medicare and medicaid reimbursements expand.
Edison Investment Research Ltd. commented in a research report that it is raising its revenue and adjusted EPS targets for CentralNic Group Plc. for FY/21 thru FY/23. Edison noted that shares of the global internet domain and platform provider, which derives revenue from sales of online presence and marketing services, trades at a valuation far below its peers with much lower growth rates.
ChargePoint Holdings Inc. shares powered 8.25% higher after the firm reported a 61% increase in Q2/22 YoY revenue and raised its FY/22 revenue guidance by 15% to $225-235 million.
Haywood Capital Markets commented in a research report that the newly announced discoveries at Liberty Gold Corp.'s Black Pine Project highlight the unbounded nature of the underlying gold system. Haywood rates Liberty Gold as a "Buy" and recommends accumulating shares at current price levels.
A co-branded API agreement between Marble Financial and Citadel Mortgages offers both companies a platform for growth.
Fabled Silver Gold continues successful exploration in Mexico while preparing to spin off its copper project in Canada.
Even though to meet this guidance, Kopy Goldfields must achieve significantly higher production in this year's second half, "we believe H2/21 will show such growth," an Edison Investment Research report noted.
Standard Lithium Ltd. shares traded 25% higher after the company reported that installation work at its SiFT lithium carbonate crystallization plant near El Dorado, Arkansas is now finished and that it expects fully integrated operations to get underway this month.
Results of MAG Silver's 2020 drill program at its Mexico joint venture project Juanicipio are interpreted in a National Bank of Canada report.
Gatling Exploration’s CEO, Jason Billan, answers the big questions about the company’s high-grade gold deposit in Ontario.
With inflation on the rise and gold at $1,700 an ounce, now is a good time to invest in gold, billionaire hedge fund manager John Paulson proclaimed — and Mark Mobius, founder of Mobius Capital Partners, strongly agrees.
"This marks the first regulatory approval of an OmniAb antibody discovery engine-derived antibody since Ligand Pharmaceuticals first acquired the technology in 2016," noted an H.C. Wainwright & Co. report.
AC Immune SA shares set a new 52-week intraday high after the company reported positive cognitive results for tau-targeting monoclonal antibody semorinemab in a clinical study of patients with mild-to-moderate Alzheimer's disease.
Sierra Madre executes on ‘Hub & Spoke’ strategy with its La Tigra acquisition.
Red Cat Holdings is one of only four companies invited to bid on massive U.S. DOD contracts that could significantly lift sales and boost recurring revenues.
Red Metal Resources' geological team is eyeballing a global copper supply crunch.
Noble Capital Markets commented in a research report that junior mining explorer Aurania Resources Ltd. is presently zeroing in on the most immediate high potential targets at The Lost Cities-Cutucu Project. Noble rates Aurania an "Outperform" as the company's exploration program is delivering an abundance of drilling targets for a variety of metals and offers potential for multiple new discoveries across its large concession package.
The progress Can-Fite BioPharma made with these studies is briefly summarized in a Dawson James Securities report.
An H.C. Wainwright & Co. report noted that Carmat's Aeson implant "could save many patients who may die, due to [a] shortage of donor hearts, while waiting for a heart transplant."
Sector expert Michael Ballanger explains why he expects to "see sharp rebounds in the precious metals" sectors in the next five months.
Shares of Poseida Therapeutics traded 10% higher after the company reported that the U.S. Food and Drug Administration granted clearance for its Investigational New Drug Application for P-BCMA-ALLO1, an allogeneic CAR-T candidate for use in treating relapsed/refractory multiple myeloma.
BMO Capital Markets commented in a research report that MAG Silver Corp. remains on-track with the buildout of its advanced material processing plant at its Juanicipio JV project in Zacatecas state, Mexico expected in Q4/21.
The contents of the preliminary economic assessment on Azarga Uranium's Gas Hills asset and uranium prices are discussed in a Fundamental Research Corp. report.
Shares of Bolt Biotherapeutics Inc. traded nearly 10% higher after the company reported it is collaborating with Innovent Biologics to develop three new oncology Boltbody™ ISAC programs.
In part one of a two-part look at investing in junior precious metals equities, Denver-based Crescat Capital CIO, Kevin Smith, discusses his firm’s perspective on the broad market, its success to date in the precious metals space, and how Crescat’s novel "friendly activist" approach with Geologic and Technical Director Dr. Quinton Hennigh is paying off with the small-cap gold and silver names.
In this episode of Streetwise Live! you will learn about a royalty company that has delivered 492% average quarterly revenue growth (Q3-2020 to Q2-2021).
In today’s Bulletin, we follow-up with developments at some of the junior companies that we omitted from our last letter — all positive — and we comment on two popular music legends who have passed away.
Shares of American Lithium Corp. traded 15% higher after the company reported it registered the highest lithium extraction rates to date of 97.4% from its Tonopah Lithium Claims claystones using a sulfuric acid leaching process.
CIBC World Markets Inc. stated in a research report that MAG Silver posted solid results from its 2020 110-hole drill program at its Juanicipio JV Project in Fresnillo, Mexico. CIBC commented that when the new 4,000 tpd Juanicipio mill comes online it will provide a key catalyst towards growing throughput processing capabilities and expanding the resource.
Adrian Day of Adrian Day's Global Analyst discusses Pan American Silver and Fortuna Silver, two companies he believes, despite their rough patches, offer value to investors.
Investors had been waiting nearly two months, but now the big derisking event has been announced — a US$45M funding package to expand, enhance, and optimize First Cobalt's 100%-owned battery materials refinery in northern Ontario. First Cobalt is one of only a small group of battery materials juniors that will generate meaningful cash flow in 2023.
DICK'S Sporting Goods shares traded nearly 14% higher and climbed to a new 52-week high after the largest U.S.-based, full-line sporting goods retailer reported record quarterly sales and earnings in Q2/21 and boosted its dividend and share repurchases.
MAG Silver's Q2/21 production at Juanicipio is reviewed in a ROTH Capital Partners report.
An H.C. Wainwright report noted that "this deal is an opportunity for STRATA Skin Sciences to substantially increase its long-term, recurring revenue base."
A BTIG report noted that Legend Biotech's cilta-cel has the potential "to take significant market share within the relapsed-refractory multiple myeloma market and establish a best-in-class profile."
Palo Alto Networks shares reached a new 52-week high after the company reported that Q4/21 revenues increased 28% YoY. The company expects the trend to continue and is now anticipating that billings in FY/22 will increase by 21-22% to $6.60-6.65 billion.
New results validate Fabled Silver Gold's interpretation of the mineralized system at its Santa Maria project.
Studies suggest that Galmed Pharmaceuticals' Amilo-5MER has "therapeutic potential in a number of inflammatory diseases," according to an H.C. Wainwright & Co. report.
Trillium Therapeutics shares traded 190% higher after the company reported it agreed to be acquired by pharmaceutical giant Pfizer Inc. for $18.50 per share in cash.
A ROTH Capital Partners report noted that Assertio Therapeutics' business model is starting to gain traction.
Maurice Jackson, of Proven and Probable, and Christian Easterday, CEO of Hot Chili Ltd., discuss the announcement of a new strategic partner, Glencore, and the company's evolution from exploration to now development.
Silver X Mining Corp. reported it intersected intervals of 928.13 g/t Ag eq. over 1.38 m and 631.71 g/t Ag eq over 0.92 m while carrying out expansion drilling at its Tangana 1 Project in Peru.
The recently sluggish gold market is now poised for a major upleg, and Clive Maund points to a dramatic reversal candle at key support as a "major Buy sign."
Chris Temple, editor and publisher of The National Investor, explains why he is adding Carbon Streaming Corp. as a "BUY" to his list of growth-oriented companies.
Pretium Resources "accomplished another profitable quarter," ending with $400.8M in-hand.
Recent drill results from two targets at Aurania Resources' Lost Cities–Cutucu project are reviewed in a Noble Capital Markets report.
A Stifel report noted MAG Silver "demands a higher premium given its 'royalty-like' structure and strong, near-term-free cash flow."
Sitka Gold reported that during its 2021 drilling campaign, it intercepted 318m of 0.45 g/t gold in the Saddle Zone along with 354m of 0.41 g/t gold in the Eiger Zone at its RC Gold Project in the Yukon.
Shares of natural cannabis firm Flora Growth Corp. rose 43% after the company reported H1/21 financial results and indicated it expects H2/21 revenues will be in the range of US$9-11 million.
Streetwise Reports speaks to Frontier Lithium CEO Trevor Walker about this 'serious project with huge opportunity and upside.'
Freeport Resources Inc. reported it has completed its previously announced acquisition of Carpo Resources Inc. giving it a controlling interest in the exploration license for the Yandera Copper Project.
Macy's shares traded 20% higher after the company reported Q2/21 financial results and significantly raised its FY/21 sales and earnings guidance, reinstated its regular quarterly dividend, and instituted a $500 million share repurchase program.
Inovalon Holdings Inc. shares traded 8% higher after the cloud healthcare technology platform firm reported it entered into an agreement to be acquired by an equity consortium led by Nordic Capital and Insight Partners for $41.00 per share in cash.
A Raymond James report noted that MAG Silver "is one of the better options for investors looking for exposure to silver."
An H.C. Wainwright & Co. report noted Oncolytics Biotech's overall pelareorep program is on track with several near-term catalysts expected.
The deal validates Red Cat Holdings' strategy of supplying the drone industry with an array of products, services, and solutions.
In Adrian Day's Global Analyst, Adrian Day writes about the major gold companies on his list that have held quarterly earnings calls or have other news to share.
Paradigm Capital Inc. stated in a research report that Knight Therapeutics Inc. posted significantly better than expected operating and financial results in Q2/21 that greatly exceeded analysts' estimates. Meanwhile, insiders continue to add to their positions, and the company has filed a new NCIB allowing it to purchase up to 10% of the float during the next 12 months.
Key points regarding Pan Orient Energy's second quarter performance and activities are made in a Research Capital Corp. report.
Dawson James Securities Inc. stated in a research update that Fortress Biotech Inc.'s dermatology business shows good growth potential and helped drive a positive revenue surprise in Q2/21. Dawson James has a "Buy" rating on the stock but noted that the real opportunity for the company lies with its vast pipeline and partnerships, which offer real upside potential.
Joining us is Shawn Khunkhun, CEO of StrikePoint Gold. We discuss the value proposition of the Willoughby gold project and Porter silver project, both located in British Columbia's prolific Golden Triangle. This is the most comprehensive interview to date on StrikePoint Gold, which is currently undertaking an exploration program on some very compelling projects. Find out why Eric Sprott, Crescat Capital, and Sprott Global are shareholders in StrikePoint Gold.
Technical analyst Clive Maund charts silver and explains why he believes the metal is in the “perfect” buy spot.
Shares of home improvement retailer Lowe's Companies Inc. traded higher after the company reported Q2/21 financial results and raised its FY/21 sales outlook.
Promising early results and a new line of equity support Avisa Diagnostic’s drive for IDE approval of its rapid-response breath test for pneumonia, TB, CF, and other lung ailments.
Scotiabank stated in a research report that its outlook for MAG Silver Corp. remains positive as the firm is expected to commission a new processing plant at its Juanicipio JV project in Q4/21.
The findings from the 2020 drill program at MAG Silver's joint venture project are reviewed in a PI Financial report.
Clarus Securities Inc. stated in a research report that Emerita Resources Corp.'s initial drill results from La Infanta confirm historic high grades and represent a resource with significant growth potential.
Gross sales of Stem Holdings dba Driven by Stem during the quarter were 104% higher than they were a year ago.
Troilus Gold's "Southwest zone will see a significant increase in contribution to the new resource estimate expected later in Q3/21," noted a Laurentian Bank Securities report.
Sector expert Michael Ballanger explores the reasons behind the recent "flash crash" in gold and sees opportunity given the recent market fluctuations.
Riley Gold has two cornerstone Nevada assets: the Tokop Gold Project in the Walker Lane Trend and the Pipeline West/Clipper Project in the Battle Mountain Eureka Trend—and the first results from Tokop's maiden drill program show high grades.
A Research Capital Corp. report noted "there remains upside as [Emerita Resources] continues drilling on the IBW project and the Aznalcollar dispute approaches a conclusion."
H.C. Wainwright & Co. reiterated its "Buy" recommendation for MAG Silver Corp. based upon the success of the company's FY/20 drill program that used infill and expansion drilling to greatly define surface and underground mineralization.
In a recent broadcast, Geologic and Technical Director, Dr. Quinton Hennigh discussed E2Gold Inc. and provided an update on eight other companies, all in Crescat Capital's mining exploration portfolio.
Travere Therapeutics shares traded 14% higher after the company reported positive interim results from its ongoing Phase 3 PROTECT study of sparsentan in treating IgA nephropathy, a chronic kidney disease that can lead to end-stage renal disease.
Jericho Energy Ventures focuses on advancing the low-carbon energy transition with investments in hydrogen technologies, energy storage, carbon capture and new energy systems.
Pretium Resources Inc. shares traded 17% higher after the firm reported Q2/21 financial results and advised that its cash reserves are now larger than its outstanding debt and that it remains on pace to achieve its previously issued FY/21 guidance.
McAlinden Research Partners discusses how a rise in US demand and pressures on top copper producers may spell a rebound for the red metal.
Between 1978 and 1995 estimates suggest as much as 30 million ounces of gold left the Tapajós region of Brazil in the pockets and rucksacks belonging to artisanal miners known as garimpeiros. Today, junior gold exploration company, Cabral Gold, is doing all it can to find the source of much of that gold. If successful, Cabral just might become the most successful gold junior operating in northern Brazil.
NevGold's plan to complete a resource estimate update in Q1/22 for Limousine Butte is outlined in a Caesars Report report.
An Echelon Capital Markets report noted that Osino Resources' latest drill results highlight the project's "substantial exploration potential."
The Critical Investor looks into Hawkmoon Resources' gold projects in Quebec.
Peter Epstein of Epstein Research delves into the company's exploration plans at its many Canadian gold projects.
Shares of Clover Health Investments Corp. traded higher after the company reported Q2/21 financial results that included a 140% increase in YoY revenue.
A BTIG report noted that CTI Biopharma's Pacritinib "has the potential to be a lead therapeutic in the myelofibrosis space and in additional indications that could provide material value to CTI and CTI's shares over time."
Behind that forecast, in part, are positive cannabis legislative developments and increasing consumer cannabis use, which are covered in a ROTH Capital Partners report.
Azarga Uranium Corp. has filed a robust PEA for its Gas Hills In-situ Recovery Uranium Project that estimates a total of 6.5 million pounds of U3O8 production over 7 years.
With the advent of international travel bottlenecks and a huge leap in online purchases, reliable online identity and verification is essential to derisk transactions for both consumers and merchants alike. David Lucatch, CEO of Liquid Avatar Technologies, believes his team has the right technology to derisk those "triangular" online transactions, writes Knox Henderson.
The Liquid Avatar Credential Ecosystem, or LAVCE, is designed to carry a secure, digital record of a person’s verifiable COVID-19 testing credentials, and future healthcare applications of the technology are expected.
SandRidge Energy shares rose to a new 52-week high after the company reported Q2/21 financial results and raised FY/21 production guidance after reactivating 49 producing wells.
Algernon Pharmaceuticals reported its acquisition of the exclusive rights from Dartmouth College for a method of use patent for use in treatment of neuroendocrine cancers expressing functional NMDA receptors.
Fulcrum Therapeutics shares rose 125% and set a new 52-week high after the company reported Q2/21 financial results and released positive interim results from its Phase 1 sickle cell disease trial.
Roger Moss, the CEO of Labrador Gold, sits down with Maurice Jackson of Proven and Probable to discuss his company's exploration in Newfoundland.
James Kwantes of Resource Opportunities profiles Visionary Gold and its Wyoming gold project.
A Clarus Securities report noted Emerita Resources' "IBW project alone offers significant value proposition and mergers and acquisitions appeal," and "a big prize for Emerita will be the awarding of the Aznalcollar [project] public tender."
Gatling Exploration reported it intersected 17.0m of 7.7 g/t gold and extended the Bear Deposit at its Larder Gold Project 150m up plunge confirming continuity with high-grade, near-surface mineralization.
Aurania Resources' Fruta del Norte is touted in Ecuador as a "mining operation that fits the framework envisioned by the government."
Shares of Cortexyme Inc. traded 47% higher to a new 52-week high after the company reported Q2/21 financial results and provided an update regarding its ongoing Alzheimer's and periodontal disease clinical trials.
Bill Powers of Mining Stock Education talks with Lotus Resources Managing Director Keith Bowes about the company's plans to advance its past-producing uranium project in Malawi.
Sector expert Michael Ballanger describes his strategy for investing in gold and silver markets in August, which has historically been, in his experience, the "singular best month of the year to acquire gold and the miners."
This acquisition "further bolsters Argentina Lithium and Energy's presence in this highly prospective salar."
Shares of Westport Fuel Systems Inc. traded 28% higher after the company announced Q2/21 financial results that highlighted a 135% YOY increase in revenues, which was attributed to substantial recovery in its independent aftermarket and light-duty OEM businesses.
Shares of STAAR Surgical Co. traded 20% higher after the company reported Q2/21 financial results highlighting a 93% YoY increase in net sales of its Implantable Collamer® Lenses.
Royal Helium Ltd. reported it has received the necessary drilling and production permits for its Climax-4 helium well in southwestern Saskatchewan and has scheduled a spud date of August 7, 2021.
In a recent Crescat Capital broadcast, Geologic and Technical Director, Dr. Quinton Hennigh introduced a new exploration company, Snowline Gold, and provided an update on seven other exploration companies, all in Crescat Capital's mining exploration portfolio.
A report by CIBC contains its full-year 2021 estimates for top pick, Endeavour Mining.
Kazatomprom's quarterly outperformance and numbers were analyzed in a BMO Capital Markets report.
Golden Sky Minerals is mobilizing for a summer of drilling in the Yukon, while acquiring additional projects.
In Adrian Day's Global Analyst, Adrian Day reviews recent developments and earnings reports at several companies, including some with high yields.
ProStar Holdings advised that its common shares have been deemed to be DTC Eligible by The Depository Trust Co. of New York.